{"trialResultsOutput": {"Filters": {"@total": "37", "Filter": [{"@total": "100", "@label": "Exclusion Criteria Index", "@name": "trialExclusionCriteriaIndex", "FilterOption": [{"@id": "12863", "@count": "577", "@label": "Plasmodium infection - Subjects with Contraindications to Medications/Vaccines"}, {"@id": "12857", "@count": "546", "@label": "Plasmodium infection - Subjects with Other Systemic Disorders"}, {"@id": "12862", "@count": "381", "@label": "Plasmodium infection - Subjects on Other Local/Systemic Therapy"}, {"@id": "12853", "@count": "338", "@label": "Plasmodium infection - Subjects with Hepatobiliary Disorders"}, {"@id": "12848", "@count": "336", "@label": "Plasmodium infection - Subjects with Cardiovascular Disorders"}, {"@id": "12847", "@count": "325", "@label": "Plasmodium infection - Subjects with Other Infectious Diseases"}, {"@id": "12841", "@count": "305", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria"}, {"@id": "12856", "@count": "298", "@label": "Plasmodium infection - Immunocompromised Subjects"}, {"@id": "12855", "@count": "290", "@label": "Plasmodium infection - Subjects with Renal Disorders"}, {"@id": "12860", "@count": "278", "@label": "Plasmodium infection - Subjects on Anti-malarial Therapy"}, {"@id": "12866", "@count": "259", "@label": "Plasmodium infection - Subjects with Abnormal Laboratory Values - Subjects with abnormal/unacceptable hematological values"}, {"@id": "12854", "@count": "223", "@label": "Plasmodium infection - Subjects with Hematological Disorders"}, {"@id": "12851", "@count": "201", "@label": "Plasmodium infection - Subjects with Respiratory Disorders"}, {"@id": "12849", "@count": "182", "@label": "Plasmodium infection - Subjects with CNS Disorders"}, {"@id": "12850", "@count": "153", "@label": "Plasmodium infection - Subjects with Psychiatric Disorders"}, {"@id": "12845", "@count": "152", "@label": "Plasmodium infection - Subjects with Mixed Plasmodium Infection"}, {"@id": "12132", "@count": "123", "@label": "Malaria Vaccine - Subjects with Contraindications to Vaccine/Vaccine Ingredients"}, {"@id": "12840", "@count": "120", "@label": "Plasmodium infection - Subjects with Malaria(Unspecified Species)"}, {"@id": "12117", "@count": "117", "@label": "Malaria Vaccine - Immunocompromised Subjects"}, {"@id": "12867", "@count": "115", "@label": "Plasmodium infection - Subjects with Abnormal Laboratory Values - Subjects with abnormal/unacceptable liver function tests"}, {"@id": "12124", "@count": "114", "@label": "Malaria Vaccine - Subjects with Hepatobiliary Disorders"}, {"@id": "12133", "@count": "109", "@label": "Malaria Vaccine - Subjects with Abnormal Laboratory Values"}, {"@id": "12868", "@count": "105", "@label": "Plasmodium infection - Subjects with Abnormal Laboratory Values - Subjects with abnormal/unacceptable renal function tests"}, {"@id": "12128", "@count": "102", "@label": "Malaria Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "12858", "@count": "101", "@label": "Plasmodium infection - Subjects With Prior/Scheduled Immunization"}, {"@id": "12130", "@count": "100", "@label": "Malaria Vaccine - Subjects on Other Medications - Blood/blood products/immunoglobulins"}, {"@id": "12865", "@count": "100", "@label": "Plasmodium infection - Subjects with Abnormal Laboratory Values"}, {"@id": "12126", "@count": "99", "@label": "Malaria Vaccine - Subjects with Other Systemic Disorders"}, {"@id": "12131", "@count": "98", "@label": "Malaria Vaccine - Subjects on Other Medications - Immunosuppressants"}, {"@id": "12120", "@count": "96", "@label": "Malaria Vaccine - Subjects with Cardiovascular Disorders"}, {"@id": "12118", "@count": "95", "@label": "Malaria Vaccine - Immunocompromised Subjects - Subjects with HIV"}, {"@id": "12116", "@count": "93", "@label": "Malaria Vaccine - Subjects with Other Infectious Diseases"}, {"@id": "12127", "@count": "84", "@label": "Malaria Vaccine - Subjects with Prior Malaria Vaccination"}, {"@id": "12859", "@count": "82", "@label": "Plasmodium infection - Subjects With Prior/Scheduled Immunization - Subjects with prior/scheduled malaria vaccination"}, {"@id": "12852", "@count": "80", "@label": "Plasmodium infection - Subjects with Malignancy"}, {"@id": "12125", "@count": "77", "@label": "Malaria Vaccine - Subjects with Renal Disorders"}, {"@id": "12129", "@count": "74", "@label": "Malaria Vaccine - Subjects on Other Medications"}, {"@id": "12115", "@count": "72", "@label": "Malaria Vaccine - Subjects with History of Malaria"}, {"@id": "12123", "@count": "69", "@label": "Malaria Vaccine - Subjects with Respiratory Disorders"}, {"@id": "12843", "@count": "66", "@label": "Plasmodium infection - Subjects with Plasmodium Ovale Malaria"}, {"@id": "12121", "@count": "66", "@label": "Malaria Vaccine - Subjects with CNS Disorders"}, {"@id": "12844", "@count": "65", "@label": "Plasmodium infection - Subjects with Plasmodium Malariae Malaria"}, {"@id": "12842", "@count": "64", "@label": "Plasmodium infection - Subjects with Plasmodium Vivax Malaria"}, {"@id": "12839", "@count": "58", "@label": "Plasmodium infection - Subjects at Risk of Malaria - Travellers"}, {"@id": "12122", "@count": "54", "@label": "Malaria Vaccine - Subjects with Psychiatric Disorders"}, {"@id": "11815", "@count": "39", "@label": "Anemia - Subjects with Concurrent Systemic/Medical Illness"}, {"@id": "6859", "@count": "37", "@label": "HIV infection - Pregnant or Breast Feeding Subjects"}, {"@id": "11824", "@count": "34", "@label": "Anemia - Subjects with Concurrent Systemic/Medical Illness - Subjects with infectious/inflammatory/immunological diseases/disorders"}, {"@id": "6843", "@count": "33", "@label": "HIV infection - Subjects with Other Systemic Disorders"}, {"@id": "12119", "@count": "33", "@label": "Malaria Vaccine - Immunocompromised Subjects - Subjects with malignancy"}, {"@id": "6892", "@count": "32", "@label": "HIV infection - Subjects on Other Local/Systemic Therapy"}, {"@id": "11848", "@count": "32", "@label": "Anemia - Subjects with Hypersensitivity/Contraindication to Therapy"}, {"@id": "12838", "@count": "25", "@label": "Plasmodium infection - Subjects at Risk of Malaria - Subjects residing in endemic areas"}, {"@id": "11103", "@count": "24", "@label": "Rabies Vaccine - Subjects with Contraindications to Vaccine/Vaccine Ingredients"}, {"@id": "12864", "@count": "24", "@label": "Plasmodium infection - Subjects with Hypersensitivity to Mosquito Bites"}, {"@id": "6941", "@count": "23", "@label": "HIV infection - Subjects with Hypersensitivity/Contraindications to Medications - Hypersensitivity/contraindications to study drugs/excepients"}, {"@id": "6820", "@count": "23", "@label": "HIV infection - Subjects with Opportunistic/Other Infections"}, {"@id": "11100", "@count": "22", "@label": "Rabies Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "11871", "@count": "22", "@label": "Anemia - Subjects with History of Other Therapies"}, {"@id": "11104", "@count": "20", "@label": "Rabies Vaccine - Subjects with Abnormal Laboratory Values"}, {"@id": "15278", "@count": "20", "@label": "Hepatitis B Vaccine - Subjects with Contraindications to Vaccines/Vaccine Ingredients"}, {"@id": "11102", "@count": "20", "@label": "Rabies Vaccine - Subjects on Other Medications - Blood/blood products/immunoglobulins"}, {"@id": "11096", "@count": "19", "@label": "Rabies Vaccine - Subjects with Hepatobiliary Disorders"}, {"@id": "11853", "@count": "18", "@label": "Anemia - Subjects with Hypersensitivity/Contraindication to Therapy - Subjects with hypersensitivity/contraindication to any investigational agents"}, {"@id": "4510", "@count": "18", "@label": "new name - Subjects with Erythrodermic Psoriasis"}, {"@id": "4512", "@count": "18", "@label": "new name - Subjects with Pustular Psoriasis"}, {"@id": "6824", "@count": "18", "@label": "HIV infection - Subjects with Cardiovascular Disorders"}, {"@id": "4572", "@count": "18", "@label": "new name - Subjects with History of/Scheduled for Psoriasis Treatment - Subjects with history of/scheduled for phototherapy/photochemotherapy"}, {"@id": "4573", "@count": "18", "@label": "new name - Subjects with History of/Scheduled for Psoriasis Treatment - Subjects with history of/scheduled for topical therapy"}, {"@id": "15260", "@count": "17", "@label": "Hepatitis B Vaccine - Subjects with Impaired Immune Function - Subjects on immunomodulators/corticosteroids/chemotherapeutic drugs"}, {"@id": "6861", "@count": "17", "@label": "HIV infection - Subjects with Abnormal/Unacceptable Laboratory Profiles - Abnormal/unacceptable hematology"}, {"@id": "6845", "@count": "17", "@label": "HIV infection - Subjects with Other Systemic Disorders - Subjects with hepatobiliary disorders"}, {"@id": "15262", "@count": "16", "@label": "Hepatitis B Vaccine - Subjects with Other Systemic Disorders"}, {"@id": "12846", "@count": "16", "@label": "Plasmodium infection - Subjects with Symptomatic Malaria"}, {"@id": "4574", "@count": "16", "@label": "new name - Subjects with History of Other Medication"}, {"@id": "4525", "@count": "16", "@label": "new name - Subjects with Skin Conditions Other Than Psoriasis"}, {"@id": "11087", "@count": "15", "@label": "Rabies Vaccine - Immunocompromised Subjects"}, {"@id": "11822", "@count": "15", "@label": "Anemia - Subjects with Concurrent Systemic/Medical Illness - Subjects with endocrine/metabolic diseases/disorders"}, {"@id": "4567", "@count": "15", "@label": "new name - Subjects with History of/Scheduled for Psoriasis Treatment - Subjects with history of/scheduled for immunosuppressants"}, {"@id": "6952", "@count": "15", "@label": "HIV infection - Subjects with Opportunistic/Other Infections - Subjects with tuberculosis"}, {"@id": "936", "@count": "14", "@label": "Non-insulin dependent diabetes - Subjects with Other Systemic Disorders - Hematological disorders"}, {"@id": "11847", "@count": "14", "@label": "Anemia - Subjects with Abnormal Laboratory Findings - Subjects with abnormal/unacceptable hematological functions"}, {"@id": "4511", "@count": "14", "@label": "new name - Subjects with Guttate Psoriasis"}, {"@id": "20201", "@count": "14", "@label": "Plasmodium infection - Subjects with Plasmodium Knowlesi Malaria"}, {"@id": "11092", "@count": "14", "@label": "Rabies Vaccine - Subjects with Cardiovascular Disorders"}, {"@id": "11097", "@count": "14", "@label": "Rabies Vaccine - Subjects with Renal Disorders"}, {"@id": "15274", "@count": "13", "@label": "Hepatitis B Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "11095", "@count": "13", "@label": "Rabies Vaccine - Subjects with Respiratory Disorders"}, {"@id": "11090", "@count": "13", "@label": "Rabies Vaccine - Immunocompromised Subjects - Subjects on immunosuppressants"}, {"@id": "6848", "@count": "13", "@label": "HIV infection - Subjects with Other Systemic Disorders - Subjects with renal disorders"}, {"@id": "15275", "@count": "13", "@label": "Hepatitis B Vaccine - Subjects Scheduled to Receive Vaccination"}, {"@id": "11098", "@count": "12", "@label": "Rabies Vaccine - Subjects with Other Systemic Disorders"}, {"@id": "6862", "@count": "12", "@label": "HIV infection - Subjects with Abnormal/Unacceptable Laboratory Profiles - Abnormal/unacceptable renal function tests"}, {"@id": "925", "@count": "12", "@label": "Non-insulin dependent diabetes - Subjects with Tumors/Malignancy"}, {"@id": "4620", "@count": "12", "@label": "new name - Subjects with Contraindication to Drugs - Subjects with contraindication to study drugs or its excipients"}, {"@id": "6863", "@count": "12", "@label": "HIV infection - Subjects with Abnormal/Unacceptable Laboratory Profiles - Abnormal/unacceptable liver function tests"}, {"@id": "11093", "@count": "12", "@label": "Rabies Vaccine - Subjects with CNS Disorders"}, {"@id": "6834", "@count": "12", "@label": "HIV infection - Subjects with Psychiatric Disorders"}, {"@id": "4565", "@count": "12", "@label": "new name - Subjects with History of/Scheduled for Psoriasis Treatment - Subjects with history of/scheduled for systemic therapy"}, {"@id": "11816", "@count": "12", "@label": "Anemia - Subjects with Concurrent Systemic/Medical Illness - Subjects with central nervous system diseases/disorders"}]}, {"@total": "100", "@label": "Endpoint Index", "@name": "trialEndpointIndex", "FilterOption": [{"@id": "16496", "@count": "364", "@label": "Plasmodium infection - Assessment of Safety and Tolerability - Adverse events/reactogenicity"}, {"@id": "16480", "@count": "185", "@label": "Plasmodium infection - Assessment of Parasitological Response - Assessment of parasitological cure/parasitic clearance"}, {"@id": "16484", "@count": "184", "@label": "Plasmodium infection - Assessment of Therapeutic/Global Response"}, {"@id": "16476", "@count": "180", "@label": "Plasmodium infection - Assessment of Clinical Response"}, {"@id": "16479", "@count": "179", "@label": "Plasmodium infection - Assessment of Parasitological Response"}, {"@id": "16510", "@count": "173", "@label": "Plasmodium infection - Pharmacokinetic/Pharmacodynamic Assessments"}, {"@id": "16513", "@count": "159", "@label": "Plasmodium infection - Hematological Assessments - Assessment of hemoglobin/iron levels"}, {"@id": "16495", "@count": "151", "@label": "Plasmodium infection - Assessment of Safety and Tolerability"}, {"@id": "16486", "@count": "119", "@label": "Plasmodium infection - Assessment of Clinical Symptoms - Fever"}, {"@id": "16492", "@count": "116", "@label": "Plasmodium infection - Assessment of Immune Response - Assessment of anti-malarial antibodies"}, {"@id": "15366", "@count": "109", "@label": "Malaria Vaccine - Assessment of Immunogenicity - Assessment of anti-malarial antibodies"}, {"@id": "16482", "@count": "105", "@label": "Plasmodium infection - Assessment of Parasitological Response - Assessment of gametocytaemia"}, {"@id": "16467", "@count": "101", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria"}, {"@id": "16485", "@count": "91", "@label": "Plasmodium infection - Assessment of Clinical Symptoms"}, {"@id": "16477", "@count": "86", "@label": "Plasmodium infection - Assessment of Clinical Response - Assessment of clinical cure"}, {"@id": "16518", "@count": "84", "@label": "Plasmodium infection - Other Laboratory Assessments"}, {"@id": "16491", "@count": "79", "@label": "Plasmodium infection - Assessment of Immune Response"}, {"@id": "16478", "@count": "76", "@label": "Plasmodium infection - Assessment of Clinical Response - Assessment of clinical failure"}, {"@id": "15371", "@count": "75", "@label": "Malaria Vaccine - Assessment of Safety and Tolerability - Adverse events/serious adverse events"}, {"@id": "16483", "@count": "74", "@label": "Plasmodium infection - Assessment of Parasitological Response - Assessment of parasitic failure"}, {"@id": "16512", "@count": "69", "@label": "Plasmodium infection - Hematological Assessments"}, {"@id": "15370", "@count": "66", "@label": "Malaria Vaccine - Assessment of Safety and Tolerability"}, {"@id": "16488", "@count": "55", "@label": "Plasmodium infection - Assessment of Relapse/Recurrences"}, {"@id": "15372", "@count": "55", "@label": "Malaria Vaccine - Assessment of Safety and Tolerability - Reactogenicity(local/systemic reactions)"}, {"@id": "16497", "@count": "50", "@label": "Plasmodium infection - Assessment of Mortality"}, {"@id": "16522", "@count": "47", "@label": "Plasmodium infection - Anthropometric Assessments"}, {"@id": "17220", "@count": "42", "@label": "Anemia - Assessment of Hematologic Parameters - Assessment of hemoglobin status"}, {"@id": "16494", "@count": "41", "@label": "Plasmodium infection - Assessment of Immune Response - Assessment of cellular immunity"}, {"@id": "16504", "@count": "40", "@label": "Plasmodium infection - Assessment of Pregnancy Related Outcomes - Birthweight"}, {"@id": "17283", "@count": "38", "@label": "Anemia - Laboratory Measurements - Assessment of parasitaemia"}, {"@id": "9247", "@count": "38", "@label": "HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"}, {"@id": "15368", "@count": "35", "@label": "Malaria Vaccine - Assessment of Immunogenicity - Assessment of cellular immunity"}, {"@id": "16472", "@count": "34", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Incidence/prevalence of placental malaria"}, {"@id": "16469", "@count": "34", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Incidence/prevalence of clinical malaria"}, {"@id": "16474", "@count": "33", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Development of malarial parasitemia"}, {"@id": "17197", "@count": "33", "@label": "Anemia - Assessment of Incidence/Prevalence of Anemia"}, {"@id": "16515", "@count": "33", "@label": "Plasmodium infection - Blood Chemistry Assessments"}, {"@id": "16511", "@count": "32", "@label": "Plasmodium infection - Assessment of Vital Signs"}, {"@id": "17265", "@count": "32", "@label": "Anemia - Assessment of Other Systemic Illness - Assessment of malaria"}, {"@id": "16470", "@count": "32", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Incidence/prevalence of plasmodium falciparum malaria"}, {"@id": "16473", "@count": "28", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Incidence/prevalence of peripheral malaria"}, {"@id": "17356", "@count": "28", "@label": "Anemia - Assessment of Safety and Tolerability - Assessment of adverse events"}, {"@id": "16490", "@count": "24", "@label": "Plasmodium infection - Assessment of Anti-malarial Resistance - Assessment of drug resistance markers"}, {"@id": "15374", "@count": "23", "@label": "Malaria Vaccine - Assessment of Incidence of Malaria - Development of malarial parasitemia"}, {"@id": "16481", "@count": "23", "@label": "Plasmodium infection - Assessment of Parasitological Response - Time to parasite reduction"}, {"@id": "17256", "@count": "22", "@label": "Anemia - Other Clinical Assessments - Anthropometric assessments"}, {"@id": "31817", "@count": "21", "@label": "Plasmodium infection - Patient Reported Outcomes/Quality of Life Assessments - Other patient reported outcomes"}, {"@id": "16493", "@count": "21", "@label": "Plasmodium infection - Assessment of Immune Response - Immunogenic response to other vaccine/infectious agent"}, {"@id": "15365", "@count": "21", "@label": "Malaria Vaccine - Assessment of Immunogenicity"}, {"@id": "15379", "@count": "20", "@label": "Malaria Vaccine - Other Laboratory Assessments"}, {"@id": "16508", "@count": "20", "@label": "Plasmodium infection - Assessment of Pregnancy Related Outcomes - Death"}, {"@id": "14494", "@count": "19", "@label": "Rabies Vaccine - Assessment of Immunogenicity - Immunogenic response to other vaccine/infectious agent"}, {"@id": "19043", "@count": "19", "@label": "Hepatitis B Vaccine - Assessment of Immunogenicity - Immunogenic response to other antigens"}, {"@id": "16503", "@count": "19", "@label": "Plasmodium infection - Assessment of Pregnancy Related Outcomes"}, {"@id": "16489", "@count": "18", "@label": "Plasmodium infection - Assessment of Anti-malarial Resistance"}, {"@id": "15369", "@count": "18", "@label": "Malaria Vaccine - Assessment of Immunogenicity - Immunogenic response to other vaccine/infectious agent"}, {"@id": "16509", "@count": "18", "@label": "Plasmodium infection - Assessment of Pregnancy Related Outcomes - Congenital defects"}, {"@id": "9218", "@count": "18", "@label": "HIV infection - Assessment of Immune Response"}, {"@id": "17253", "@count": "17", "@label": "Anemia - Other Clinical Assessments"}, {"@id": "19057", "@count": "17", "@label": "Hepatitis B Vaccine - Assessment of Safety and Tolerability - Adverse events/reactogenicity"}, {"@id": "16507", "@count": "17", "@label": "Plasmodium infection - Assessment of Pregnancy Related Outcomes - Still births"}, {"@id": "16468", "@count": "17", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Incidence/prevalence of severe malaria"}, {"@id": "17354", "@count": "17", "@label": "Anemia - Assessment of Safety and Tolerability - Assessment of infections"}, {"@id": "15373", "@count": "17", "@label": "Malaria Vaccine - Assessment of Incidence of Malaria"}, {"@id": "16516", "@count": "17", "@label": "Plasmodium infection - Blood Chemistry Assessments - Liver function tests"}, {"@id": "16517", "@count": "16", "@label": "Plasmodium infection - Blood Chemistry Assessments - Renal function tests"}, {"@id": "17319", "@count": "16", "@label": "Anemia - Assessment of Therapy Related Outcomes"}, {"@id": "17363", "@count": "16", "@label": "Anemia - Assessment of Mortality Rates"}, {"@id": "17324", "@count": "15", "@label": "Anemia - Assessment of Therapy Related Outcomes - Assessment of efficacy"}, {"@id": "9215", "@count": "15", "@label": "HIV infection - Assessment of CD4 Cell Responses - Assessment of CD4 cell count/percentage"}, {"@id": "16506", "@count": "15", "@label": "Plasmodium infection - Assessment of Pregnancy Related Outcomes - Abortions"}, {"@id": "16475", "@count": "15", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Time to development of malarial parasitemia"}, {"@id": "19042", "@count": "14", "@label": "Hepatitis B Vaccine - Assessment of Immunogenicity - Anti-hepatitis B antibody titers"}, {"@id": "14498", "@count": "14", "@label": "Rabies Vaccine - Assessment of Safety and Tolerability - Reactogenicity(local/systemic reactions)"}, {"@id": "14497", "@count": "14", "@label": "Rabies Vaccine - Assessment of Safety and Tolerability - Adverse events/serious adverse events"}, {"@id": "37196", "@count": "14", "@label": "Plasmodium infection - Antimalarial Usage/ Prescription Changes"}, {"@id": "1359", "@count": "13", "@label": "Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) - Change in HbA1c"}, {"@id": "17273", "@count": "13", "@label": "Anemia - Laboratory Measurements"}, {"@id": "16471", "@count": "12", "@label": "Plasmodium infection - Incidence/Prevalence of Malaria - Incidence/prevalence of plasmodium vivax malaria"}, {"@id": "1345", "@count": "12", "@label": "Non-insulin dependent diabetes - Assessment of Blood Glucose - Fasting glucose"}, {"@id": "9246", "@count": "12", "@label": "HIV infection - Assessment of Safety and Tolerability"}, {"@id": "9213", "@count": "12", "@label": "HIV infection - Assessment of HIV Viral Load - Assessment of HIV RNA levels"}, {"@id": "16006", "@count": "11", "@label": "Malaria Vaccine - Hematological Assessments"}, {"@id": "29634", "@count": "11", "@label": "Plasmodium infection - Health Economic Assessments - Cost-effectiveness"}, {"@id": "6504", "@count": "10", "@label": "new name - Global Assessment of Disease Activity Scores - Investigator's/physician's global assessment (PGA) scale"}, {"@id": "17353", "@count": "10", "@label": "Anemia - Assessment of Safety and Tolerability"}, {"@id": "18310", "@count": "10", "@label": "Hepatitis B virus infection - Assessment of Safety and Tolerability - Adverse events/reactogenicity"}, {"@id": "1503", "@count": "10", "@label": "Non-insulin dependent diabetes - Obesity, Body Weight & Fat Tissue Assessment - Body weight"}, {"@id": "9239", "@count": "10", "@label": "HIV infection - Other Laboratory Assessments - Hematological assessments"}, {"@id": "10968", "@count": "10", "@label": "DTP Vaccine - Assessment of Immunogenicity - Assessment of anti-pertussis antibody concentration (PT)"}, {"@id": "15375", "@count": "9", "@label": "Malaria Vaccine - Assessment of Incidence of Malaria - Time to development of malarial parasitemia"}, {"@id": "16521", "@count": "9", "@label": "Plasmodium infection - Other Laboratory Assessments - Assessment of other markers"}, {"@id": "17359", "@count": "9", "@label": "Anemia - Assessment of Hospitalization Rates"}, {"@id": "10966", "@count": "9", "@label": "DTP Vaccine - Assessment of Immunogenicity - Assessment of anti-diphtheria antibody concentration"}, {"@id": "10971", "@count": "9", "@label": "DTP Vaccine - Assessment of Immunogenicity - Assessment of anti-hepatitis B antibody concentration"}, {"@id": "17263", "@count": "9", "@label": "Anemia - Assessment of Other Systemic Illness"}, {"@id": "18511", "@count": "9", "@label": "Polio Vaccine - Assessment of Immunogenicity - Immunogenic response to other antigens"}, {"@id": "10967", "@count": "9", "@label": "DTP Vaccine - Assessment of Immunogenicity - Assessment of anti-tetanus antibody concentration"}, {"@id": "9272", "@count": "8", "@label": "HIV infection - Assessment of Mortality"}, {"@id": "17357", "@count": "8", "@label": "Anemia - Assessment of Safety and Tolerability - Assessment of serious adverse events"}]}, {"@total": "100", "@label": "Trial Indications Adverse", "@name": "trialIndicationsAdverse", "FilterOption": [{"@id": "148", "@count": "63", "@label": "Headache"}, {"@id": "110", "@count": "56", "@label": "Emesis"}, {"@id": "102", "@count": "46", "@label": "Diarrhea"}, {"@id": "226", "@count": "39", "@label": "Nausea"}, {"@id": "20", "@count": "33", "@label": "Pain"}, {"@id": "3472", "@count": "30", "@label": "Abdominal pain"}, {"@id": "1833", "@count": "27", "@label": "Fever"}, {"@id": "17", "@count": "25", "@label": "Anemia"}, {"@id": "82", "@count": "24", "@label": "Cough"}, {"@id": "3038", "@count": "23", "@label": "Appetite loss"}, {"@id": "279", "@count": "22", "@label": "Pruritus"}, {"@id": "268", "@count": "20", "@label": "Plasmodium infection"}, {"@id": "829", "@count": "18", "@label": "Fatigue"}, {"@id": "1039", "@count": "17", "@label": "Myalgia"}, {"@id": "3454", "@count": "16", "@label": "Dizziness"}, {"@id": "516", "@count": "15", "@label": "Upper respiratory tract infection"}, {"@id": "2434", "@count": "14", "@label": "Vertigo"}, {"@id": "2024", "@count": "10", "@label": "Erythema"}, {"@id": "3073", "@count": "10", "@label": "Drowsiness"}, {"@id": "360", "@count": "10", "@label": "Pneumonia"}, {"@id": "750", "@count": "9", "@label": "Insomnia"}, {"@id": "3062", "@count": "9", "@label": "Death"}, {"@id": "2274", "@count": "8", "@label": "Rhinopharyngitis"}, {"@id": "3020", "@count": "8", "@label": "Skin rash"}, {"@id": "77", "@count": "8", "@label": "Conjunctivitis"}, {"@id": "477", "@count": "7", "@label": "Rhinitis"}, {"@id": "2195", "@count": "7", "@label": "Gastroenteritis"}, {"@id": "402", "@count": "6", "@label": "Edema"}, {"@id": "50", "@count": "6", "@label": "Bronchitis"}, {"@id": "3050", "@count": "6", "@label": "Chill"}, {"@id": "746", "@count": "5", "@label": "Infectious disease"}, {"@id": "1009", "@count": "5", "@label": "Urinary tract infection"}, {"@id": "2439", "@count": "5", "@label": "Arthralgia"}, {"@id": "445", "@count": "4", "@label": "Hypoglycemia"}, {"@id": "188", "@count": "4", "@label": "Inflammatory disease"}, {"@id": "1308", "@count": "4", "@label": "Candida infection"}, {"@id": "12", "@count": "4", "@label": "Allergy"}, {"@id": "432", "@count": "4", "@label": "Dyspepsia"}, {"@id": "1973", "@count": "4", "@label": "Palpitation"}, {"@id": "2099", "@count": "4", "@label": "Gastralgia"}, {"@id": "3081", "@count": "4", "@label": "Abscess"}, {"@id": "3221", "@count": "4", "@label": "Back pain"}, {"@id": "1991", "@count": "4", "@label": "Neutropenia"}, {"@id": "665", "@count": "3", "@label": "Mouth ulcer"}, {"@id": "668", "@count": "3", "@label": "Muscle weakness"}, {"@id": "324", "@count": "3", "@label": "Thrombocytopenia"}, {"@id": "221", "@count": "3", "@label": "Mycobacterium tuberculosis infection"}, {"@id": "517", "@count": "3", "@label": "Common cold"}, {"@id": "509", "@count": "3", "@label": "Respiratory tract infection"}, {"@id": "2550", "@count": "3", "@label": "Rhinorrhea"}, {"@id": "453", "@count": "3", "@label": "Pharyngitis"}, {"@id": "105", "@count": "3", "@label": "Dysmenorrhea"}, {"@id": "717", "@count": "3", "@label": "Seizure disorder"}, {"@id": "114", "@count": "3", "@label": "Sepsis"}, {"@id": "3762", "@count": "3", "@label": "Ocular pain"}, {"@id": "304", "@count": "2", "@label": "Sleep disorder"}, {"@id": "252", "@count": "2", "@label": "Parasitic infection"}, {"@id": "2230", "@count": "2", "@label": "Vulvovaginitis"}, {"@id": "394", "@count": "2", "@label": "Otitis media"}, {"@id": "680", "@count": "2", "@label": "Leukopenia"}, {"@id": "998", "@count": "2", "@label": "Tinnitus"}, {"@id": "2334", "@count": "2", "@label": "Otalgia"}, {"@id": "191", "@count": "2", "@label": "Influenza virus infection"}, {"@id": "340", "@count": "2", "@label": "Urticaria"}, {"@id": "484", "@count": "2", "@label": "Skin infection"}, {"@id": "408", "@count": "2", "@label": "Hypotension"}, {"@id": "3078", "@count": "2", "@label": "Genital tract infection"}, {"@id": "129", "@count": "2", "@label": "Gastrointestinal disease"}, {"@id": "25", "@count": "2", "@label": "Anxiety disorder"}, {"@id": "436", "@count": "2", "@label": "Flatulence"}, {"@id": "3", "@count": "2", "@label": "Acne"}, {"@id": "2976", "@count": "2", "@label": "Bronchiolitis"}, {"@id": "150", "@count": "2", "@label": "Helminth infection"}, {"@id": "109", "@count": "2", "@label": "Eczema"}, {"@id": "3059", "@count": "2", "@label": "Enzyme overproduction"}, {"@id": "3034", "@count": "1", "@label": "Status epilepticus"}, {"@id": "309", "@count": "1", "@label": "Staphylococcus infection"}, {"@id": "2223", "@count": "1", "@label": "Splenomegaly"}, {"@id": "26", "@count": "1", "@label": "Appendicitis"}, {"@id": "2240", "@count": "1", "@label": "Bacterial vaginosis"}, {"@id": "552", "@count": "1", "@label": "Bleeding"}, {"@id": "1091", "@count": "1", "@label": "Bone injury"}, {"@id": "555", "@count": "1", "@label": "Bone marrow disease"}, {"@id": "393", "@count": "1", "@label": "Scabies infection"}, {"@id": "296", "@count": "1", "@label": "Salmonella infection"}, {"@id": "412", "@count": "1", "@label": "Bradycardia"}, {"@id": "2613", "@count": "1", "@label": "Carbuncle"}, {"@id": "2624", "@count": "1", "@label": "Cheilitis"}, {"@id": "8", "@count": "1", "@label": "Respiratory distress syndrome"}, {"@id": "3369", "@count": "1", "@label": "Respiratory depression"}, {"@id": "2894", "@count": "1", "@label": "Pyomyositis"}, {"@id": "93", "@count": "1", "@label": "Depression"}, {"@id": "277", "@count": "1", "@label": "Proteinuria"}, {"@id": "1063", "@count": "1", "@label": "Xerostomia"}, {"@id": "3868", "@count": "1", "@label": "Xerosis"}, {"@id": "347", "@count": "1", "@label": "Wound healing"}, {"@id": "3013", "@count": "1", "@label": "Abortion"}, {"@id": "2441", "@count": "1", "@label": "Vision disorder"}, {"@id": "344", "@count": "1", "@label": "Viral infection"}, {"@id": "343", "@count": "1", "@label": "Vibrio cholerae infection"}]}, {"@total": "100", "@label": "Biomarker", "@name": "trialBiomarkerNames", "FilterOption": [{"@id": "1236", "@count": "127", "@label": "Hemoglobin"}, {"@id": "1735", "@count": "29", "@label": "Glucose"}, {"@id": "213", "@count": "28", "@label": "Creatinine"}, {"@id": "1857", "@count": "25", "@label": "T-cell surface glycoprotein CD4"}, {"@id": "1211", "@count": "23", "@label": "Alanine transaminase"}, {"@id": "2387", "@count": "20", "@label": "Bilirubin"}, {"@id": "3451", "@count": "20", "@label": "Immunoglobulin G"}, {"@id": "252", "@count": "19", "@label": "Interferon gamma"}, {"@id": "2054", "@count": "17", "@label": "Blood platelets"}, {"@id": "2527", "@count": "17", "@label": "Aspartate aminotransferase"}, {"@id": "4522", "@count": "15", "@label": "Erythrocytes"}, {"@id": "12058", "@count": "15", "@label": "Total body mass"}, {"@id": "289", "@count": "14", "@label": "Hemoglobin A, glycosylated"}, {"@id": "2586", "@count": "14", "@label": "Blood pressure"}, {"@id": "2662", "@count": "13", "@label": "Sodium"}, {"@id": "2098", "@count": "13", "@label": "Potassium"}, {"@id": "28899", "@count": "13", "@label": "Alkaline phosphatase"}, {"@id": "3475", "@count": "12", "@label": "Urea"}, {"@id": "118", "@count": "12", "@label": "Albumin"}, {"@id": "46", "@count": "11", "@label": "C-reactive protein"}, {"@id": "1051", "@count": "11", "@label": "Ferritin"}, {"@id": "164", "@count": "10", "@label": "Glucose-6-phosphate 1-dehydrogenase"}, {"@id": "1925", "@count": "10", "@label": "Neutrophils"}, {"@id": "3447", "@count": "10", "@label": "T-cell surface glycoprotein CD8 alpha chain"}, {"@id": "8097", "@count": "9", "@label": "Monocytes"}, {"@id": "36136", "@count": "9", "@label": "Cytokines"}, {"@id": "1904", "@count": "8", "@label": "Heart rate"}, {"@id": "1221", "@count": "8", "@label": "Hematocrit"}, {"@id": "154", "@count": "8", "@label": "Lactate dehydrogenase"}, {"@id": "274", "@count": "8", "@label": "Tumor necrosis factor"}, {"@id": "8024", "@count": "7", "@label": "Creatine kinase"}, {"@id": "4806", "@count": "7", "@label": "Lymphocytes"}, {"@id": "2358", "@count": "7", "@label": "Urea nitrogen"}, {"@id": "175", "@count": "7", "@label": "Interleukin-10"}, {"@id": "11580", "@count": "7", "@label": "T-lymphocytes"}, {"@id": "133", "@count": "7", "@label": "Total cholesterol"}, {"@id": "4565", "@count": "6", "@label": "Dihydrofolate reductase"}, {"@id": "217", "@count": "6", "@label": "Triglycerides"}, {"@id": "330", "@count": "6", "@label": "Systolic blood pressure"}, {"@id": "8458", "@count": "6", "@label": "gamma-Glutamyltransferase"}, {"@id": "9842", "@count": "6", "@label": "Birth weight"}, {"@id": "9807", "@count": "6", "@label": "Basophils"}, {"@id": "176", "@count": "6", "@label": "Interleukin-6"}, {"@id": "248", "@count": "5", "@label": "Eosinophils"}, {"@id": "5375", "@count": "5", "@label": "Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide"}, {"@id": "812", "@count": "5", "@label": "Interleukin-2"}, {"@id": "1239", "@count": "5", "@label": "Iron"}, {"@id": "323", "@count": "5", "@label": "CD40 ligand"}, {"@id": "17171", "@count": "4", "@label": "Deoxyhypusine synthase"}, {"@id": "332", "@count": "4", "@label": "Diastolic blood pressure"}, {"@id": "907", "@count": "4", "@label": "Transferrin receptor protein 1"}, {"@id": "153", "@count": "4", "@label": "High-density lipoprotein cholesterol"}, {"@id": "316", "@count": "4", "@label": "Interleukin-4"}, {"@id": "3054", "@count": "4", "@label": "Reticulocyte Count"}, {"@id": "2170", "@count": "4", "@label": "Vitamin A"}, {"@id": "6663", "@count": "4", "@label": "B-lymphocytes"}, {"@id": "988", "@count": "3", "@label": "Ig gamma-3 chain C region"}, {"@id": "125", "@count": "3", "@label": "Leukocyte count"}, {"@id": "152", "@count": "3", "@label": "Low-density lipoprotein cholesterol"}, {"@id": "808", "@count": "3", "@label": "Insulin"}, {"@id": "288", "@count": "3", "@label": "Uric acid"}, {"@id": "8532", "@count": "3", "@label": "Anti-HBs antigen antibodies"}, {"@id": "17697", "@count": "3", "@label": "Body height"}, {"@id": "2367", "@count": "3", "@label": "Methemoglobin"}, {"@id": "551", "@count": "3", "@label": "Interleukin-5"}, {"@id": "38439", "@count": "3", "@label": "Plasmodium falciparum chloroquine resistance transporter"}, {"@id": "3247", "@count": "3", "@label": "Chlorides"}, {"@id": "245", "@count": "3", "@label": "CD8-Positive T-Lymphocytes"}, {"@id": "1937", "@count": "2", "@label": "Immunoglobulin E"}, {"@id": "33132", "@count": "2", "@label": "Plasmodium falciparum apical membrane antigen 1"}, {"@id": "2169", "@count": "2", "@label": "Zinc"}, {"@id": "44212", "@count": "2", "@label": "Plasmodium falciparum dihydrofolate reductase"}, {"@id": "367", "@count": "2", "@label": "Intercellular adhesion molecule-1"}, {"@id": "3083", "@count": "2", "@label": "Phosphate"}, {"@id": "418", "@count": "2", "@label": "Waist circumference"}, {"@id": "40288", "@count": "2", "@label": "Plasmodium falciparum dihydropteroate synthetase"}, {"@id": "2664", "@count": "2", "@label": "Anti-Clostridium tetani antibodies"}, {"@id": "11622", "@count": "2", "@label": "Interleukin 1"}, {"@id": "467", "@count": "2", "@label": "Angiopoietin-2"}, {"@id": "36885", "@count": "2", "@label": "Plasmodium falciparum multidrug resistance protein"}, {"@id": "174", "@count": "2", "@label": "Interleukin-12"}, {"@id": "2626", "@count": "2", "@label": "Total protein"}, {"@id": "2272", "@count": "2", "@label": "Cytochrome P450 2C19"}, {"@id": "7832", "@count": "2", "@label": "Citrate synthase, mitochondrial"}, {"@id": "177", "@count": "2", "@label": "Fibrinogen"}, {"@id": "3098", "@count": "2", "@label": "Calprotectin"}, {"@id": "2417", "@count": "2", "@label": "Calcium"}, {"@id": "9539", "@count": "2", "@label": "Globulins"}, {"@id": "113", "@count": "2", "@label": "Body Mass Index"}, {"@id": "4529", "@count": "2", "@label": "Bicarbonates"}, {"@id": "794", "@count": "2", "@label": "Serotransferrin"}, {"@id": "1296", "@count": "2", "@label": "Mean corpuscular volume"}, {"@id": "22801", "@count": "2", "@label": "Head circumference"}, {"@id": "30572", "@count": "2", "@label": "Peripheral blood mononuclear cell"}, {"@id": "1856", "@count": "2", "@label": "B-cell antigen receptor complex-associated protein alpha chain"}, {"@id": "11214", "@count": "2", "@label": "ATP-binding cassette sub-family B member 7, mitochondrial"}, {"@id": "1913", "@count": "2", "@label": "Arterial oxygen saturation"}, {"@id": "159", "@count": "2", "@label": "Lactic Acid"}, {"@id": "262", "@count": "1", "@label": "Nitric oxide"}, {"@id": "371", "@count": "1", "@label": "Pappalysin-1"}]}, {"@total": "100", "@label": "Inclusion Criteria Index", "@name": "trialInclusionCriteriaIndex", "FilterOption": [{"@id": "15445", "@count": "345", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria"}, {"@id": "15454", "@count": "286", "@label": "Plasmodium infection - Subjects with Symptomatic Malaria"}, {"@id": "15465", "@count": "257", "@label": "Plasmodium infection - Healthy Subjects"}, {"@id": "15451", "@count": "215", "@label": "Plasmodium infection - Subjects with Uncomplicated Malaria"}, {"@id": "14688", "@count": "147", "@label": "Malaria Vaccine - Healthy Subjects"}, {"@id": "15466", "@count": "96", "@label": "Plasmodium infection - Subjects with Protocol Specified Laboratory Values"}, {"@id": "15448", "@count": "80", "@label": "Plasmodium infection - Subjects with Plasmodium Vivax Malaria"}, {"@id": "15467", "@count": "75", "@label": "Plasmodium infection - Subjects with Protocol Specified Laboratory Values - Subjects with protocol specified hematological values"}, {"@id": "15464", "@count": "69", "@label": "Plasmodium infection - Pregnant Women"}, {"@id": "15443", "@count": "61", "@label": "Plasmodium infection - Subjects at Risk of Malaria - Subjects residing in endemic areas"}, {"@id": "14690", "@count": "56", "@label": "Malaria Vaccine - Subjects at Risk of Malaria - People living in endemic regions"}, {"@id": "14695", "@count": "42", "@label": "Malaria Vaccine - Subjects Naive to Malaria Vaccine"}, {"@id": "15460", "@count": "30", "@label": "Plasmodium infection - Immunocompromised Subjects - Subjects with HIV"}, {"@id": "13592", "@count": "25", "@label": "Rabies Vaccine - Healthy Subjects"}, {"@id": "14415", "@count": "25", "@label": "Anemia - Subjects with Co-morbid Disorders - Subjects with infectious/inflammatory/immunological diseases/disorders"}, {"@id": "14359", "@count": "22", "@label": "Anemia - Subjects at Risk of Anemia - Pregnant women"}, {"@id": "5322", "@count": "22", "@label": "HIV infection - Subjects with Protocol Specified CD4+ T Cell Counts"}, {"@id": "15463", "@count": "22", "@label": "Plasmodium infection - Subjects with Other Medical Conditions"}, {"@id": "14382", "@count": "21", "@label": "Anemia - Subjects with Hemolytic Anemia - Subjects with anemia due to malarial infection"}, {"@id": "15446", "@count": "20", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria - Subjects with severe malaria"}, {"@id": "5278", "@count": "20", "@label": "HIV infection - Subjects with HIV Infection"}, {"@id": "14493", "@count": "20", "@label": "Anemia - Subjects with Normal/Acceptable Hemoglobin Count"}, {"@id": "3285", "@count": "19", "@label": "new name - Subjects with Plaque Psoriasis/Psoriasis Vulgaris"}, {"@id": "15468", "@count": "19", "@label": "Plasmodium infection - Subjects with Protocol Specified Laboratory Values - Subjects with protocol specified liver function tests"}, {"@id": "5418", "@count": "17", "@label": "HIV infection - Subjects with HIV Infection - Subjects with HIV-1 infection"}, {"@id": "15450", "@count": "16", "@label": "Plasmodium infection - Subjects with Plasmodium Malariae Malaria"}, {"@id": "15449", "@count": "14", "@label": "Plasmodium infection - Subjects with Plasmodium Ovale Malaria"}, {"@id": "17658", "@count": "14", "@label": "Hepatitis B Vaccine - Healthy Subjects"}, {"@id": "584", "@count": "14", "@label": "Non-insulin dependent diabetes - Subjects with Diabetes Mellitus - Subjects with type 2 diabetes mellitus"}, {"@id": "15457", "@count": "14", "@label": "Plasmodium infection - Subjects on Other Medications"}, {"@id": "15453", "@count": "13", "@label": "Plasmodium infection - Subjects with Asymptomatic Malaria"}, {"@id": "15469", "@count": "13", "@label": "Plasmodium infection - Subjects with Protocol Specified Laboratory Values - Subjects with protocol specified renal function tests"}, {"@id": "901", "@count": "13", "@label": "Non-insulin dependent diabetes - Subjects with Moderate Glycemic Control"}, {"@id": "6173", "@count": "13", "@label": "HIV infection - Subjects with HIV Infection - Pregnant women with HIV infection"}, {"@id": "5344", "@count": "12", "@label": "HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy"}, {"@id": "610", "@count": "12", "@label": "Non-insulin dependent diabetes - Obese Subjects - Obese subjects (Grade 2 obesity, BMI= 30 to 39.9)"}, {"@id": "609", "@count": "12", "@label": "Non-insulin dependent diabetes - Obese Subjects - Overweight subjects (Grade 1 obesity, BMI= 25 to 29.9)"}, {"@id": "15456", "@count": "12", "@label": "Plasmodium infection - Subjects with Prior/Concurrent Antimalarial Therapy"}, {"@id": "14425", "@count": "12", "@label": "Anemia - Subjects with Normal/Acceptable Clinical Assessments - Subjects with normal/acceptable anthropometric assessment"}, {"@id": "607", "@count": "11", "@label": "Non-insulin dependent diabetes - Subjects with Poor/Inadequate Glycemic Control"}, {"@id": "15442", "@count": "11", "@label": "Plasmodium infection - Subjects at Risk of Malaria"}, {"@id": "3296", "@count": "11", "@label": "new name - Subjects with Moderate Psoriasis"}, {"@id": "606", "@count": "10", "@label": "Non-insulin dependent diabetes - Subjects with Good Glycemic Control"}, {"@id": "6174", "@count": "9", "@label": "HIV infection - Subjects with HIV Infection - HIV positive children/adolescents"}, {"@id": "14424", "@count": "9", "@label": "Anemia - Subjects with Normal/Acceptable Clinical Assessments - Subjects with normal/acceptable vital signs"}, {"@id": "14698", "@count": "9", "@label": "Malaria Vaccine - Subjects with Protocol Specified Laboratory Values"}, {"@id": "3368", "@count": "9", "@label": "new name - Subjects with History of/Scheduled for Psoriasis Therapy - Subjects with history of/scheduled for topical treatment"}, {"@id": "15447", "@count": "9", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria - Subjects with cerebral malaria"}, {"@id": "5297", "@count": "9", "@label": "HIV infection - Subjects with Opportunistic/Other Infections"}, {"@id": "5339", "@count": "9", "@label": "HIV infection - Treatment Naive HIV Subjects"}, {"@id": "14358", "@count": "8", "@label": "Anemia - Subjects at Risk of Anemia - Infants/children"}, {"@id": "14357", "@count": "8", "@label": "Anemia - Subjects at Risk of Anemia"}, {"@id": "612", "@count": "8", "@label": "Non-insulin dependent diabetes - Obese Subjects - Subjects with morbid obesity (Grade 3 obesity, BMI=40)"}, {"@id": "3297", "@count": "8", "@label": "new name - Subjects with Severe Psoriasis"}, {"@id": "691", "@count": "8", "@label": "Non-insulin dependent diabetes - Subjects on Diet/Exercise Therapy"}, {"@id": "1043", "@count": "8", "@label": "Non-insulin dependent diabetes - Non-Obese Subjects (BMI= 18.5\u201324.9)"}, {"@id": "22356", "@count": "8", "@label": "Plasmodium infection - Subjects with Mixed Malaria Infection"}, {"@id": "22461", "@count": "7", "@label": "DTP Vaccine - Healthy Subjects"}, {"@id": "17709", "@count": "7", "@label": "Haemophilus Influenzae Type B Vaccine - Healthy Subjects"}, {"@id": "14406", "@count": "7", "@label": "Anemia - Subjects with Co-morbid Disorders"}, {"@id": "5311", "@count": "7", "@label": "HIV infection - Subjects with Specific HIV Test Results"}, {"@id": "3322", "@count": "7", "@label": "new name - Subjects with Protocol Specific Investigator's/Physician Global Assessment Scale (IGA/PGA) Scores"}, {"@id": "13594", "@count": "7", "@label": "Rabies Vaccine - Subjects Naive to Rabies Vaccine"}, {"@id": "22464", "@count": "6", "@label": "Pneumococcal Vaccine - Healthy Subjects"}, {"@id": "14391", "@count": "6", "@label": "Anemia - Subjects with Other Forms of Anemia"}, {"@id": "5331", "@count": "6", "@label": "HIV infection - Subjects with Normal/Acceptable Other Laboratory Profile - Subjects with normal/acceptable liver function tests"}, {"@id": "3295", "@count": "6", "@label": "new name - Subjects with Mild Psoriasis"}, {"@id": "3286", "@count": "6", "@label": "new name - Subjects with Plaque Psoriasis/Psoriasis Vulgaris - Subjects with protocol specified plaque characteristics"}, {"@id": "15589", "@count": "5", "@label": "Pneumonia - Healthy Subjects"}, {"@id": "672", "@count": "5", "@label": "Non-insulin dependent diabetes - Subjects on Anti-Diabetic Therapy - Subjects on/treated with biguanides"}, {"@id": "22463", "@count": "5", "@label": "Meningococcal Vaccine - Healthy Subjects"}, {"@id": "1047", "@count": "5", "@label": "Non-insulin dependent diabetes - Specific Treatment Naive Subjects"}, {"@id": "6771", "@count": "5", "@label": "DTP Vaccine - Subjects with Protocol Specified Birth Criteria - Subjects born at full-term pregnancy"}, {"@id": "14696", "@count": "5", "@label": "Malaria Vaccine - Subjects with Prior Malaria Vaccination"}, {"@id": "17660", "@count": "5", "@label": "Hepatitis B Vaccine - Protocol Specified Birth Criteria - Subjects born at full-term pregnancy"}, {"@id": "3302", "@count": "5", "@label": "new name - Psoriasis Subjects with Specific Disease Activity - Subjects with stable/stationary psoriasis"}, {"@id": "22333", "@count": "5", "@label": "new name - Subjects with Protocol Specified Body Surface Area Involvement"}, {"@id": "15444", "@count": "5", "@label": "Plasmodium infection - Subjects at Risk of Malaria - Travellers"}, {"@id": "22465", "@count": "5", "@label": "HIV infection - Healthy Subjects"}, {"@id": "3289", "@count": "5", "@label": "new name - Subjects with Localized Psoriasis"}, {"@id": "14451", "@count": "5", "@label": "Anemia - Subjects with History of Other Therapies"}, {"@id": "5352", "@count": "5", "@label": "HIV infection - Subjects on Prior/Concurrent Other Systemic Therapies"}, {"@id": "5330", "@count": "5", "@label": "HIV infection - Subjects with Normal/Acceptable Other Laboratory Profile - Subjects with normal/acceptable blood chemistry"}, {"@id": "5329", "@count": "5", "@label": "HIV infection - Subjects with Normal/Acceptable Other Laboratory Profile - Subjects with normal/acceptable hematological tests"}, {"@id": "14492", "@count": "5", "@label": "Tuberculosis Vaccine - Protocol Specified Other Inclusion Criteria"}, {"@id": "5332", "@count": "5", "@label": "HIV infection - Subjects with Normal/Acceptable Other Laboratory Profile - Subjects with normal/acceptable renal function tests"}, {"@id": "6176", "@count": "4", "@label": "HIV infection - Subjects with Specific HIV Test Results - Subjects with HIV seropositivity"}, {"@id": "22271", "@count": "4", "@label": "Plasmodium infection - Subjects with Plasmodium Knowlesi Malaria"}, {"@id": "18920", "@count": "4", "@label": "Pruritus - Subjects with Pruritus Associated with Dermatological Disorders - Subjects with psoriasis"}, {"@id": "6775", "@count": "4", "@label": "DTP Vaccine - Subjects with Protocol Specified Birth Criteria - Subjects born to mother seronegative for HIV/Hepatitis"}, {"@id": "20156", "@count": "4", "@label": "Renal failure - Subjects with Prerenal Causes for Acute Renal Failure(ARF) - Subjects with sepsis/infection"}, {"@id": "15452", "@count": "4", "@label": "Plasmodium infection - Subjects with Complicated Malaria"}, {"@id": "17724", "@count": "4", "@label": "Haemophilus Influenzae Type B Vaccine - Subjects Fulfilling Protocol Specified Birth Criteria - Infants born after normal gestational period"}, {"@id": "5346", "@count": "4", "@label": "HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent non-nucleoside reverse transcriptase inhibitors"}, {"@id": "16822", "@count": "4", "@label": "Hepatitis B virus infection - Protocol Specified Birth Criteria - Subjects born at full-term pregnancy"}, {"@id": "17639", "@count": "4", "@label": "Hepatitis B Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "14431", "@count": "4", "@label": "Anemia - Subjects with Normal/Acceptable Laboratory Criteria"}, {"@id": "14373", "@count": "4", "@label": "Anemia - Subjects with Sickle Cell Anemia"}, {"@id": "14490", "@count": "4", "@label": "Tuberculosis Vaccine - Healthy Subjects"}, {"@id": "14400", "@count": "4", "@label": "Anemia - Protocol Specified Clinical Manifestation of Anemia"}]}, {"@total": "100", "@label": "Patient Segment Index", "@name": "trialPatientSegmentIndex", "FilterOption": [{"@id": "10403", "@count": "326", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria"}, {"@id": "10409", "@count": "275", "@label": "Plasmodium infection - Subjects with Uncomplicated Malaria"}, {"@id": "10412", "@count": "219", "@label": "Plasmodium infection - Subjects with Symptomatic Malaria"}, {"@id": "10417", "@count": "203", "@label": "Plasmodium infection - Others - Pediatric Subjects"}, {"@id": "10401", "@count": "132", "@label": "Plasmodium infection - Subjects at Risk of Malaria - Subjects residing in endemic areas"}, {"@id": "10406", "@count": "71", "@label": "Plasmodium infection - Subjects with Plasmodium Vivax Malaria"}, {"@id": "10418", "@count": "70", "@label": "Plasmodium infection - Pregnant Women"}, {"@id": "10000", "@count": "54", "@label": "Malaria Vaccine - Subjects at Risk of Malaria - People living in endemic regions"}, {"@id": "7126", "@count": "50", "@label": "HIV infection - Subjects with HIV-1 Infection"}, {"@id": "10001", "@count": "45", "@label": "Malaria Vaccine - Subjects Naive to Malaria Vaccine"}, {"@id": "10416", "@count": "32", "@label": "Plasmodium infection - Subjects with Other Medical Conditions - Subjects with HIV"}, {"@id": "10404", "@count": "23", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria - Subjects with severe malaria"}, {"@id": "7652", "@count": "22", "@label": "Anemia - Subjects at Risk of Anemia - Pregnant women"}, {"@id": "3434", "@count": "21", "@label": "new name - Subjects with Plaque Psoriasis/Psoriasis Vulgaris"}, {"@id": "7649", "@count": "20", "@label": "Anemia - Subjects at Risk of Anemia"}, {"@id": "7534", "@count": "20", "@label": "Anemia - Subjects with Hemolytic Anemia - Subjects with anemia due to malarial infection"}, {"@id": "7651", "@count": "19", "@label": "Anemia - Subjects at Risk of Anemia - Infants/children"}, {"@id": "10415", "@count": "15", "@label": "Plasmodium infection - Subjects with Other Medical Conditions"}, {"@id": "7063", "@count": "14", "@label": "HIV infection - Pregnant Women with HIV Infection"}, {"@id": "145", "@count": "13", "@label": "Non-insulin dependent diabetes - Subjects with Moderate Glycemic Control"}, {"@id": "10400", "@count": "13", "@label": "Plasmodium infection - Subjects at Risk of Malaria"}, {"@id": "7108", "@count": "12", "@label": "HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy"}, {"@id": "103", "@count": "11", "@label": "Non-insulin dependent diabetes - Subjects with Poor/Inadequate Glycemic Control"}, {"@id": "7382", "@count": "11", "@label": "HIV infection - Subjects with Co-morbid Conditions - Subjects with opportunistic/other infections"}, {"@id": "10411", "@count": "11", "@label": "Plasmodium infection - Subjects with Asymptomatic Malaria"}, {"@id": "3451", "@count": "10", "@label": "new name - Subjects with Moderate Psoriasis"}, {"@id": "108", "@count": "10", "@label": "Non-insulin dependent diabetes - Type 2 Diabetes Subjects with Comorbid Conditions - Subjects with obesity"}, {"@id": "102", "@count": "10", "@label": "Non-insulin dependent diabetes - Subjects with Good Glycemic Control"}, {"@id": "10408", "@count": "9", "@label": "Plasmodium infection - Subjects with Plasmodium Malariae Malaria"}, {"@id": "10413", "@count": "9", "@label": "Plasmodium infection - Subjects with Prior/Concurrent Antimalarial Therapy"}, {"@id": "7128", "@count": "9", "@label": "HIV infection - HIV Positive Children/Adolescents"}, {"@id": "10018", "@count": "8", "@label": "Rabies Vaccine - Subjects Naive to Rabies Vaccine"}, {"@id": "7061", "@count": "8", "@label": "HIV infection - Subjects at Risk of Developing HIV Infection"}, {"@id": "7107", "@count": "8", "@label": "HIV infection - Treatment Naive Subjects"}, {"@id": "3452", "@count": "7", "@label": "new name - Subjects with Severe Psoriasis"}, {"@id": "96", "@count": "7", "@label": "Non-insulin dependent diabetes - Type 2 Diabetes Subjects Controlled by Diet/Exercise"}, {"@id": "10407", "@count": "7", "@label": "Plasmodium infection - Subjects with Plasmodium Ovale Malaria"}, {"@id": "11947", "@count": "7", "@label": "Plasmodium infection - Subjects with Mixed Malaria Infection"}, {"@id": "10405", "@count": "7", "@label": "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria - Subjects with cerebral malaria"}, {"@id": "3450", "@count": "5", "@label": "new name - Subjects with Mild Psoriasis"}, {"@id": "144", "@count": "5", "@label": "Non-insulin dependent diabetes - Oral Hypoglycemic Treatment Naive Type 2 Diabetes Subjects"}, {"@id": "7543", "@count": "5", "@label": "Anemia - Subjects with Other Forms of Anemia"}, {"@id": "10002", "@count": "5", "@label": "Malaria Vaccine - Subjects with Prior Malaria Vaccination"}, {"@id": "10402", "@count": "5", "@label": "Plasmodium infection - Subjects at Risk of Malaria - Travellers"}, {"@id": "7309", "@count": "5", "@label": "HIV infection - Subjects with Low CD4 Cell Count"}, {"@id": "10284", "@count": "4", "@label": "Hepatitis B Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "7085", "@count": "4", "@label": "HIV infection - Subjects with Co-morbid Conditions"}, {"@id": "11834", "@count": "4", "@label": "Plasmodium infection - Subjects with Plasmodium Knowlesi Malaria"}, {"@id": "10003", "@count": "4", "@label": "Malaria Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "10414", "@count": "4", "@label": "Plasmodium infection - Subjects with Drug Resistant Malaria"}, {"@id": "9249", "@count": "4", "@label": "Pruritus - Subjects with Pruritus Associated with Dermatological Disorders - Subjects with psoriasis"}, {"@id": "10568", "@count": "4", "@label": "Sepsis - Subjects with Sepsis"}, {"@id": "100", "@count": "4", "@label": "Non-insulin dependent diabetes - Subjects on Treatment/Requiring >1 Antidiabetic Agent"}, {"@id": "8110", "@count": "4", "@label": "Renal failure - Subjects with Prerenal Causes for Acute Renal Failure(ARF) - Subjects with sepsis/infection"}, {"@id": "97", "@count": "4", "@label": "Non-insulin dependent diabetes - Subjects on Monotherapy"}, {"@id": "3438", "@count": "4", "@label": "new name - Subjects with Localized Psoriasis"}, {"@id": "98", "@count": "4", "@label": "Non-insulin dependent diabetes - Subjects on Monotherapy - Subjects only on metformin"}, {"@id": "3459", "@count": "4", "@label": "new name - Subjects with History of/Scheduled for Psoriasis Therapy - Subjects with history of/scheduled for topical therapy"}, {"@id": "3442", "@count": "3", "@label": "new name - Subjects with Localized Psoriasis - Subjects with face psoriasis"}, {"@id": "8877", "@count": "3", "@label": "Pneumonia - Subjects at Risk of Pneumonia - Immunocompromised subjects"}, {"@id": "7065", "@count": "3", "@label": "HIV infection - Subjects with AIDS"}, {"@id": "10895", "@count": "3", "@label": "Polio Vaccine - Subjects with Prior Other Vaccination"}, {"@id": "7110", "@count": "3", "@label": "HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent non-nucleoside reverse transcriptase inhibitors"}, {"@id": "3617", "@count": "3", "@label": "Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"}, {"@id": "7526", "@count": "3", "@label": "Anemia - Subjects with Sickle Cell Anemia"}, {"@id": "10316", "@count": "3", "@label": "Epilepsy - Subjects with Symptomatic Epilepsy"}, {"@id": "3623", "@count": "3", "@label": "Lung tumor - Subjects with Advanced Stage Lung Cancer"}, {"@id": "11420", "@count": "3", "@label": "End stage renal disease - Subjects with Proteinuria/Albuminuria"}, {"@id": "3443", "@count": "3", "@label": "new name - Subjects with Generalized Psoriasis"}, {"@id": "7712", "@count": "3", "@label": "End stage renal disease - Subjects with Glomerular Disorder"}, {"@id": "9244", "@count": "3", "@label": "Pruritus - Subjects with Moderate Pruritus"}, {"@id": "3461", "@count": "3", "@label": "new name - Subjects Refractory to Psoriasis Therapy"}, {"@id": "3634", "@count": "3", "@label": "Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with metastatic/stage IV lung cancer"}, {"@id": "7525", "@count": "3", "@label": "Anemia - Subjects with Iron Deficiency Anemia"}, {"@id": "7112", "@count": "3", "@label": "HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent HAART"}, {"@id": "7531", "@count": "3", "@label": "Anemia - Subjects with Hemolytic Anemia"}, {"@id": "10917", "@count": "3", "@label": "Tuberculosis Vaccine - Subjects Naive to Tuberculosis Vaccine"}, {"@id": "3441", "@count": "3", "@label": "new name - Subjects with Localized Psoriasis - Subjects with scalp psoriasis"}, {"@id": "7111", "@count": "2", "@label": "HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent protease inhibitors"}, {"@id": "11016", "@count": "2", "@label": "Rotavirus Vaccine - Subjects Naive to Rotavirus Vaccine"}, {"@id": "7381", "@count": "2", "@label": "HIV infection - Subjects with Co-morbid Conditions - Subjects with malignancy"}, {"@id": "10579", "@count": "2", "@label": "Sepsis - Subjects with Septic Shock"}, {"@id": "3965", "@count": "2", "@label": "Breast tumor - Subjects with Treatment Refractory Breast Cancer"}, {"@id": "3954", "@count": "2", "@label": "Breast tumor - Subjects with Advanced/Metastatic Breast Cancer/Stage IV Breast Cancer"}, {"@id": "11087", "@count": "2", "@label": "HIV Vaccine - HIV Seronegative Subjects"}, {"@id": "11448", "@count": "2", "@label": "Bacterial Conjunctivitis - Subjects with Chronic Bacterial Conjunctivitis - Subjects with trachoma"}, {"@id": "3650", "@count": "2", "@label": "Lung tumor - Subjects with Recurrent/Relapsed Lung Cancer"}, {"@id": "7500", "@count": "2", "@label": "Non-insulin dependent diabetes - Subjects Inadequately Controlled with Diet/Exercise Therapy"}, {"@id": "11075", "@count": "2", "@label": "Insomnia - Subjects with Sleep Onset Insomnia"}, {"@id": "10918", "@count": "2", "@label": "Tuberculosis Vaccine - Subjects with Prior Tuberculosis Vaccination"}, {"@id": "10295", "@count": "2", "@label": "Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with locally advanced/stage III lung cancer"}, {"@id": "8421", "@count": "2", "@label": "Pain - Subjects with Visceral Pain - Subjects with abdominal pain"}, {"@id": "8186", "@count": "2", "@label": "DTP Vaccine - Subjects with Prior DTP Vaccination"}, {"@id": "10303", "@count": "2", "@label": "Epilepsy - Subjects at Risk of Developing Epilepsy"}, {"@id": "11497", "@count": "2", "@label": "Renal failure - Subjects with Acute Renal Failure(ARF) - Subjects in failure(F) category"}, {"@id": "10894", "@count": "2", "@label": "Polio Vaccine - Subjects with Prior Polio Vaccination"}, {"@id": "10004", "@count": "2", "@label": "Malaria Vaccine - Subjects with History of Malaria"}, {"@id": "9999", "@count": "2", "@label": "Malaria Vaccine - Subjects at Risk of Malaria"}, {"@id": "11440", "@count": "2", "@label": "Haemophilus Influenzae Type B Vaccine - Subjects with Prior Other Vaccination - Subjects with prior polio vaccination"}, {"@id": "201", "@count": "2", "@label": "Coronary artery disease - Subjects Undergoing/Underwent Percutaneous Coronary Intervention (PCI)"}]}, {"@total": "93", "@label": "Trial Interventions Primary In Regimen Name Display", "@name": "trialInterventionsPrimaryInRegimenNameDisplay", "FilterOption": [{"@id": "8896", "@count": "25", "@label": "artemether + lumefantrine, Novartis"}, {"@id": "2587", "@count": "22", "@label": "azithromycin"}, {"@id": "53041", "@count": "17", "@label": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis"}, {"@id": "53724", "@count": "16", "@label": "artenimol + piperaquine (malaria), Sigma-Tau"}, {"@id": "14681", "@count": "8", "@label": "lopinavir + ritonavir"}, {"@id": "23459", "@count": "8", "@label": "atovaquone + proguanil, GlaxoSmithKline"}, {"@id": "10172", "@count": "7", "@label": "efavirenz"}, {"@id": "6050", "@count": "7", "@label": "metformin hydrochloride"}, {"@id": "17091", "@count": "6", "@label": "agatolimod"}, {"@id": "12132", "@count": "6", "@label": "albendazole"}, {"@id": "44370", "@count": "6", "@label": "clindamycin"}, {"@id": "44719", "@count": "6", "@label": "malaria vaccine, NIAID"}, {"@id": "2577", "@count": "6", "@label": "atovaquone"}, {"@id": "17210", "@count": "5", "@label": "chlorproguanil + dapsone (malaria), University of Liverpool/WHO/GlaxoSmithKline"}, {"@id": "3700", "@count": "5", "@label": "nevirapine"}, {"@id": "63927", "@count": "5", "@label": "artefenomel mesylate (Plasmodium infections), MMV/UNMC/STPI/Monash University"}, {"@id": "14289", "@count": "4", "@label": "malaria vaccine, GlaxoSmithKline/Malaria Vaccine Initiative"}, {"@id": "3474", "@count": "4", "@label": "lamivudine"}, {"@id": "58762", "@count": "4", "@label": "empagliflozin"}, {"@id": "58508", "@count": "4", "@label": "PlaMavax"}, {"@id": "44316", "@count": "4", "@label": "zidovudine"}, {"@id": "53751", "@count": "3", "@label": "pyronaridine + artesunate (oral), Medicines for Malaria Venture/Shin Poong/WHO"}, {"@id": "16696", "@count": "3", "@label": "lamivudine + zidovudine, GlaxoSmithKline"}, {"@id": "60942", "@count": "3", "@label": "recombinant adenovirus-poxvirus prime-boost malaria vaccine, Oxford University/MRC/Wellcome"}, {"@id": "49219", "@count": "3", "@label": "tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"}, {"@id": "53051", "@count": "2", "@label": "artesunate + mefloquine combination tablet (malaria), DNDi"}, {"@id": "3803", "@count": "2", "@label": "paclitaxel"}, {"@id": "55852", "@count": "2", "@label": "linagliptin"}, {"@id": "59839", "@count": "2", "@label": "retagliptin"}, {"@id": "83710", "@count": "2", "@label": "FP9 ME-TRAP"}, {"@id": "7310", "@count": "2", "@label": "ritonavir"}, {"@id": "8976", "@count": "2", "@label": "rosiglitazone"}, {"@id": "41758", "@count": "2", "@label": "ferroquine"}, {"@id": "6242", "@count": "2", "@label": "abacavir"}, {"@id": "54590", "@count": "2", "@label": "chlorproguanil + dapsone + artesunate (malaria), WHO/University of Liverpool/GlaxoSmithKline/Medicines for Malaria Venture"}, {"@id": "2935", "@count": "2", "@label": "didanosine"}, {"@id": "9752", "@count": "2", "@label": "tafenoquine"}, {"@id": "46927", "@count": "2", "@label": "doxycycline hyclate"}, {"@id": "8047", "@count": "2", "@label": "bevacizumab"}, {"@id": "11459", "@count": "2", "@label": "Synflorix"}, {"@id": "6877", "@count": "1", "@label": "miltefosine"}, {"@id": "60210", "@count": "1", "@label": "MK-2206"}, {"@id": "66505", "@count": "1", "@label": "MSP1 prime-boost vaccine (Plasmodium infection), University of Oxford"}, {"@id": "39618", "@count": "1", "@label": "artemisone"}, {"@id": "11089", "@count": "1", "@label": "nitazoxanide"}, {"@id": "59557", "@count": "1", "@label": "whole-cell pneumococcal vaccine, PATH/Children's Hospital Boston"}, {"@id": "16755", "@count": "1", "@label": "pafuramidine"}, {"@id": "9286", "@count": "1", "@label": "Typhim Vi"}, {"@id": "59852", "@count": "1", "@label": "Pentaxim"}, {"@id": "44306", "@count": "1", "@label": "pentoxifylline"}, {"@id": "2503", "@count": "1", "@label": "amphotericin B (liposomal iv, visceral leishmaniasis), Drugs for Neglected Diseases initiative"}, {"@id": "21066", "@count": "1", "@label": "Plasmodium falciparum CSP DNA vaccine, Virogenetics"}, {"@id": "63103", "@count": "1", "@label": "Plasmodium vivax vaccine, Walter Reed Army Institute of Research"}, {"@id": "29831", "@count": "1", "@label": "sorafenib"}, {"@id": "44363", "@count": "1", "@label": "trimethoprim + sulphamethoxazole"}, {"@id": "14493", "@count": "1", "@label": "tenofovir disoproxil fumarate"}, {"@id": "4529", "@count": "1", "@label": "temozolomide"}, {"@id": "12834", "@count": "1", "@label": "rifaximin"}, {"@id": "60199", "@count": "1", "@label": "sevuparin sodium"}, {"@id": "50840", "@count": "1", "@label": "Sanaria PfSPZ Vaccine"}, {"@id": "12813", "@count": "1", "@label": "Rotarix"}, {"@id": "44383", "@count": "1", "@label": "carboplatin"}, {"@id": "44369", "@count": "1", "@label": "cefotaxime"}, {"@id": "12242", "@count": "1", "@label": "calcipotriol"}, {"@id": "44438", "@count": "1", "@label": "ciprofloxacin hydrochloride"}, {"@id": "50974", "@count": "1", "@label": "calcipotriol + betamethasone dipropionate, LEO"}, {"@id": "57760", "@count": "1", "@label": "colchicine (oral, gout/familial Mediterranean fever), Takeda"}, {"@id": "32981", "@count": "1", "@label": "darunavir"}, {"@id": "9283", "@count": "1", "@label": "DNA vaccine (malaria), Vical"}, {"@id": "74347", "@count": "1", "@label": "E-2006"}, {"@id": "66250", "@count": "1", "@label": "azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine"}, {"@id": "4728", "@count": "1", "@label": "emtricitabine"}, {"@id": "3268", "@count": "1", "@label": "Engerix B"}, {"@id": "44292", "@count": "1", "@label": "fluconazole"}, {"@id": "64288", "@count": "1", "@label": "FMP1/AS02A"}, {"@id": "3167", "@count": "1", "@label": "fosphenytoin"}, {"@id": "11603", "@count": "1", "@label": "gefitinib"}, {"@id": "68744", "@count": "1", "@label": "glucopyranosyl lipid A adjuvant, Immune Design Corp"}, {"@id": "3411", "@count": "1", "@label": "itraconazole"}, {"@id": "51284", "@count": "1", "@label": "azithromycin (sustained release, microsphere formulation), Pfizer"}, {"@id": "3482", "@count": "1", "@label": "lazabemide"}, {"@id": "70575", "@count": "1", "@label": "LEO-27989"}, {"@id": "59534", "@count": "1", "@label": "LEO-29102"}, {"@id": "65925", "@count": "1", "@label": "LEO-90100"}, {"@id": "3492", "@count": "1", "@label": "levofloxacin"}, {"@id": "2807", "@count": "1", "@label": "atorvastatin"}, {"@id": "41077", "@count": "1", "@label": "malaria vaccine (virosomes, PeviPRO), Mymetics"}, {"@id": "16898", "@count": "1", "@label": "AS-02 adjuvant"}, {"@id": "65312", "@count": "1", "@label": "AS-01 adjuvant"}, {"@id": "32077", "@count": "1", "@label": "MalariVax"}, {"@id": "68730", "@count": "1", "@label": "Matrix M"}, {"@id": "39031", "@count": "1", "@label": "Menveo"}, {"@id": "44303", "@count": "1", "@label": "midazolam"}]}, {"@total": "100", "@label": "Trial Actions Secondary Interventions Primary", "@name": "trialActionsSecondaryInterventionsPrimary", "FilterOption": [{"@id": "2638", "@count": "513", "@label": "Antiparasitic"}, {"@id": "59620", "@count": "336", "@label": "Unspecified drug target"}, {"@id": "12378", "@count": "172", "@label": "Prophylactic vaccine"}, {"@id": "12372", "@count": "108", "@label": "Protein subunit vaccine"}, {"@id": "415", "@count": "97", "@label": "Radical donator"}, {"@id": "1594", "@count": "67", "@label": "Antibacterial"}, {"@id": "2953", "@count": "57", "@label": "Anti-inflammatory"}, {"@id": "518", "@count": "53", "@label": "Electron transport inhibitor"}, {"@id": "1748", "@count": "52", "@label": "Fungicide"}, {"@id": "1538", "@count": "38", "@label": "Bacterial protein synthesis inhibitor"}, {"@id": "12370", "@count": "37", "@label": "Recombinant viral vector vaccine"}, {"@id": "15187", "@count": "36", "@label": "Systemic dermatological antibacterial product"}, {"@id": "1540", "@count": "34", "@label": "Macrolide antibiotic"}, {"@id": "12379", "@count": "32", "@label": "Therapeutic vaccine"}, {"@id": "991", "@count": "31", "@label": "Antiviral"}, {"@id": "8165", "@count": "25", "@label": "Protozoacide"}, {"@id": "1545", "@count": "18", "@label": "Anticancer"}, {"@id": "399", "@count": "17", "@label": "Hypoglycemic agent"}, {"@id": "15183", "@count": "16", "@label": "Topical antipsoriatic product"}, {"@id": "1596", "@count": "16", "@label": "Immunomodulator"}, {"@id": "140", "@count": "14", "@label": "DNA synthesis inhibitor"}, {"@id": "1833", "@count": "13", "@label": "Non-nucleoside reverse transcriptase inhibitor"}, {"@id": "563", "@count": "13", "@label": "Microtubule modulator"}, {"@id": "463", "@count": "11", "@label": "Ribosome binding agent"}, {"@id": "524", "@count": "11", "@label": "Adjuvant"}, {"@id": "2593", "@count": "11", "@label": "Vitamin D analog"}, {"@id": "32904", "@count": "11", "@label": "Live attenuated protozoal vaccine"}, {"@id": "38206", "@count": "9", "@label": "Biguanide antidiabetic product"}, {"@id": "3189", "@count": "8", "@label": "Corticosteroid agonist"}, {"@id": "393", "@count": "8", "@label": "Immunostimulant"}, {"@id": "1832", "@count": "8", "@label": "Nucleoside reverse transcriptase inhibitor"}, {"@id": "2954", "@count": "8", "@label": "Steroidal anti-inflammatory"}, {"@id": "18805", "@count": "8", "@label": "Keratinocyte inhibitor"}, {"@id": "12371", "@count": "7", "@label": "Subunit vaccine"}, {"@id": "15184", "@count": "7", "@label": "Systemic antipsoriatic product"}, {"@id": "55685", "@count": "7", "@label": "Anticancer monoclonal antibody"}, {"@id": "1879", "@count": "7", "@label": "DNA vaccine"}, {"@id": "3984", "@count": "6", "@label": "Bacterial nucleic acid synthesis inhibitor"}, {"@id": "70", "@count": "6", "@label": "Anticonvulsant agent"}, {"@id": "38439", "@count": "6", "@label": "DPP IV inhibitor antidiabetic product"}, {"@id": "747", "@count": "5", "@label": "HIV replication inhibitor"}, {"@id": "61", "@count": "5", "@label": "Angiogenesis inhibitor"}, {"@id": "2944", "@count": "5", "@label": "Hypnotic"}, {"@id": "1694", "@count": "4", "@label": "Glycosaminoglycan agonist"}, {"@id": "62255", "@count": "4", "@label": "Anticancer protein kinase inhibitor"}, {"@id": "2664", "@count": "4", "@label": "Heparin agonist"}, {"@id": "955", "@count": "4", "@label": "Antimicrobial permeability enhancer"}, {"@id": "50", "@count": "4", "@label": "Anticancer alkylating agent"}, {"@id": "2660", "@count": "4", "@label": "Vasoprotectant"}, {"@id": "1615", "@count": "4", "@label": "Neuroprotectant"}, {"@id": "1919", "@count": "3", "@label": "Insulin sensitizer"}, {"@id": "2576", "@count": "3", "@label": "Microtubule stabilizer"}, {"@id": "12366", "@count": "3", "@label": "Inactivated bacterial vaccine"}, {"@id": "396", "@count": "3", "@label": "Immunosuppressant"}, {"@id": "12375", "@count": "3", "@label": "Toxoid vaccine"}, {"@id": "561", "@count": "3", "@label": "Anticancer permeability enhancer"}, {"@id": "12373", "@count": "3", "@label": "Polysaccharide subunit vaccine"}, {"@id": "1732", "@count": "3", "@label": "Energy metabolism modulator"}, {"@id": "2946", "@count": "3", "@label": "Analgesic"}, {"@id": "659", "@count": "3", "@label": "Coagulation inhibitor"}, {"@id": "449", "@count": "3", "@label": "Antiarrhythmic agent"}, {"@id": "12369", "@count": "3", "@label": "Recombinant bacterial vector vaccine"}, {"@id": "721", "@count": "3", "@label": "TNF binding agent"}, {"@id": "104", "@count": "3", "@label": "Bacterial cell wall synthesis inhibitor"}, {"@id": "7292", "@count": "2", "@label": "Vulnerary agent"}, {"@id": "15178", "@count": "2", "@label": "Systemic dermatological antifungal product"}, {"@id": "15181", "@count": "2", "@label": "Systemic antipruritic product"}, {"@id": "1610", "@count": "2", "@label": "Surfactant"}, {"@id": "1591", "@count": "2", "@label": "Spermicide"}, {"@id": "15128", "@count": "2", "@label": "Ophthalmological agent"}, {"@id": "284", "@count": "2", "@label": "Nootropic agent"}, {"@id": "2955", "@count": "2", "@label": "Non-steroidal anti-inflammatory"}, {"@id": "2947", "@count": "2", "@label": "Antiparkinsonian"}, {"@id": "2942", "@count": "2", "@label": "Anxiolytic"}, {"@id": "2659", "@count": "2", "@label": "Cardioprotectant"}, {"@id": "767", "@count": "2", "@label": "Cell cycle inhibitor"}, {"@id": "655", "@count": "2", "@label": "Choline uptake inhibitor"}, {"@id": "1629", "@count": "2", "@label": "Corticosteroid modulator"}, {"@id": "839", "@count": "2", "@label": "Ergosterol modulator"}, {"@id": "12364", "@count": "2", "@label": "Live attenuated viral vaccine"}, {"@id": "610", "@count": "2", "@label": "Hematopoietic stimulant"}, {"@id": "5567", "@count": "2", "@label": "Isoprenoid lipid metabolism modulator"}, {"@id": "6290", "@count": "1", "@label": "Actin polymerization inhibitor"}, {"@id": "74", "@count": "1", "@label": "Antioxidant agent"}, {"@id": "2657", "@count": "1", "@label": "Antihypertensive"}, {"@id": "7760", "@count": "1", "@label": "T-lymphocyte inhibitor"}, {"@id": "72", "@count": "1", "@label": "Antihyperlipidemic agent"}, {"@id": "71", "@count": "1", "@label": "Antihypercholesterolemic agent"}, {"@id": "4780", "@count": "1", "@label": "Adenovirus based gene therapy"}, {"@id": "15180", "@count": "1", "@label": "Topical antipruritic product"}, {"@id": "1532", "@count": "1", "@label": "Viral replication inhibitor"}, {"@id": "4007", "@count": "1", "@label": "Antidiarrhoeal"}, {"@id": "2667", "@count": "1", "@label": "Antiarteriosclerotic"}, {"@id": "759", "@count": "1", "@label": "Anticancer multidrug resistance inhibitor"}, {"@id": "9660", "@count": "1", "@label": "Unspecified cytokine receptor modulator"}, {"@id": "4855", "@count": "1", "@label": "Antibacterial multidrug resistance inhibitor"}, {"@id": "1808", "@count": "1", "@label": "Uric acid modulator"}, {"@id": "386", "@count": "1", "@label": "Vaccine"}, {"@id": "388", "@count": "1", "@label": "Vasodilator"}, {"@id": "2575", "@count": "1", "@label": "Microtubule inhibitor"}]}, {"@total": "50", "@label": "Trial Actions Secondary Interventions Control", "@name": "trialActionsSecondaryInterventionsControl", "FilterOption": [{"@id": "2638", "@count": "44", "@label": "Antiparasitic"}, {"@id": "59620", "@count": "28", "@label": "Unspecified drug target"}, {"@id": "12378", "@count": "10", "@label": "Prophylactic vaccine"}, {"@id": "415", "@count": "9", "@label": "Radical donator"}, {"@id": "12372", "@count": "8", "@label": "Protein subunit vaccine"}, {"@id": "15183", "@count": "6", "@label": "Topical antipsoriatic product"}, {"@id": "2953", "@count": "4", "@label": "Anti-inflammatory"}, {"@id": "1545", "@count": "4", "@label": "Anticancer"}, {"@id": "991", "@count": "4", "@label": "Antiviral"}, {"@id": "399", "@count": "3", "@label": "Hypoglycemic agent"}, {"@id": "518", "@count": "3", "@label": "Electron transport inhibitor"}, {"@id": "12375", "@count": "3", "@label": "Toxoid vaccine"}, {"@id": "1594", "@count": "3", "@label": "Antibacterial"}, {"@id": "1833", "@count": "3", "@label": "Non-nucleoside reverse transcriptase inhibitor"}, {"@id": "2593", "@count": "3", "@label": "Vitamin D analog"}, {"@id": "524", "@count": "3", "@label": "Adjuvant"}, {"@id": "1540", "@count": "2", "@label": "Macrolide antibiotic"}, {"@id": "2954", "@count": "2", "@label": "Steroidal anti-inflammatory"}, {"@id": "12371", "@count": "2", "@label": "Subunit vaccine"}, {"@id": "472", "@count": "2", "@label": "Phosphate lowering agent"}, {"@id": "393", "@count": "2", "@label": "Immunostimulant"}, {"@id": "15187", "@count": "2", "@label": "Systemic dermatological antibacterial product"}, {"@id": "1748", "@count": "2", "@label": "Fungicide"}, {"@id": "3189", "@count": "2", "@label": "Corticosteroid agonist"}, {"@id": "15180", "@count": "2", "@label": "Topical antipruritic product"}, {"@id": "484", "@count": "2", "@label": "Calcium metabolic inhibitor"}, {"@id": "38206", "@count": "2", "@label": "Biguanide antidiabetic product"}, {"@id": "1538", "@count": "2", "@label": "Bacterial protein synthesis inhibitor"}, {"@id": "38205", "@count": "1", "@label": "Sulphonylurea antidiabetic product"}, {"@id": "12379", "@count": "1", "@label": "Therapeutic vaccine"}, {"@id": "12373", "@count": "1", "@label": "Polysaccharide subunit vaccine"}, {"@id": "1808", "@count": "1", "@label": "Uric acid modulator"}, {"@id": "7292", "@count": "1", "@label": "Vulnerary agent"}, {"@id": "7227", "@count": "1", "@label": "Anthelmintic"}, {"@id": "449", "@count": "1", "@label": "Antiarrhythmic agent"}, {"@id": "2667", "@count": "1", "@label": "Antiarteriosclerotic"}, {"@id": "71", "@count": "1", "@label": "Antihypercholesterolemic agent"}, {"@id": "72", "@count": "1", "@label": "Antihyperlipidemic agent"}, {"@id": "2943", "@count": "1", "@label": "Antipsychotic"}, {"@id": "833", "@count": "1", "@label": "Chloride metabolism modulator"}, {"@id": "38439", "@count": "1", "@label": "DPP IV inhibitor antidiabetic product"}, {"@id": "747", "@count": "1", "@label": "HIV replication inhibitor"}, {"@id": "12365", "@count": "1", "@label": "Inactivated vaccine"}, {"@id": "12367", "@count": "1", "@label": "Inactivated viral vaccine"}, {"@id": "3246", "@count": "1", "@label": "Insulin release stimulator"}, {"@id": "12374", "@count": "1", "@label": "Lipid subunit vaccine"}, {"@id": "12364", "@count": "1", "@label": "Live attenuated viral vaccine"}, {"@id": "2575", "@count": "1", "@label": "Microtubule inhibitor"}, {"@id": "563", "@count": "1", "@label": "Microtubule modulator"}, {"@id": "1832", "@count": "1", "@label": "Nucleoside reverse transcriptase inhibitor"}]}, {"@total": "100", "@label": "Trial Country", "@name": "trialCountries", "FilterOption": [{"@id": "KE", "@count": "86", "@label": "Kenya"}, {"@id": "US", "@count": "86", "@label": "US"}, {"@id": "TZ", "@count": "76", "@label": "Tanzania"}, {"@id": "TH", "@count": "74", "@label": "Thailand"}, {"@id": "UG", "@count": "71", "@label": "Uganda"}, {"@id": "IN", "@count": "62", "@label": "India"}, {"@id": "BF", "@count": "58", "@label": "Burkina Faso"}, {"@id": "GH", "@count": "47", "@label": "Ghana"}, {"@id": "GB", "@count": "47", "@label": "UK"}, {"@id": "ML", "@count": "45", "@label": "Mali"}, {"@id": "ZA", "@count": "45", "@label": "South Africa"}, {"@id": "GM", "@count": "42", "@label": "Gambia"}, {"@id": "MW", "@count": "42", "@label": "Malawi"}, {"@id": "GA", "@count": "33", "@label": "Gabon"}, {"@id": "AU", "@count": "30", "@label": "Australia"}, {"@id": "MZ", "@count": "26", "@label": "Mozambique"}, {"@id": "DE", "@count": "23", "@label": "Germany"}, {"@id": "ID", "@count": "23", "@label": "Indonesia"}, {"@id": "NG", "@count": "21", "@label": "Nigeria"}, {"@id": "FR", "@count": "21", "@label": "France"}, {"@id": "KH", "@count": "20", "@label": "Cambodia"}, {"@id": "ZM", "@count": "19", "@label": "Zambia"}, {"@id": "NL", "@count": "18", "@label": "Netherlands"}, {"@id": "SN", "@count": "18", "@label": "Senegal"}, {"@id": "CA", "@count": "17", "@label": "Canada"}, {"@id": "VN", "@count": "16", "@label": "Vietnam"}, {"@id": "GW", "@count": "15", "@label": "Guinea-Bissau"}, {"@id": "CN", "@count": "15", "@label": "China"}, {"@id": "BR", "@count": "14", "@label": "Brazil"}, {"@id": "BJ", "@count": "13", "@label": "Benin"}, {"@id": "CH", "@count": "13", "@label": "Switzerland"}, {"@id": "SD", "@count": "13", "@label": "Sudan"}, {"@id": "BD", "@count": "12", "@label": "Bangladesh"}, {"@id": "CO", "@count": "11", "@label": "Colombia"}, {"@id": "PK", "@count": "11", "@label": "Pakistan"}, {"@id": "MM", "@count": "11", "@label": "Burma"}, {"@id": "CD", "@count": "11", "@label": "Congo, The Democratic Republic of the"}, {"@id": "PE", "@count": "10", "@label": "Peru"}, {"@id": "PH", "@count": "10", "@label": "Philippines"}, {"@id": "CM", "@count": "10", "@label": "Cameroon"}, {"@id": "CG", "@count": "10", "@label": "Congo"}, {"@id": "LA", "@count": "10", "@label": "Laos"}, {"@id": "MY", "@count": "8", "@label": "Malaysia"}, {"@id": "AF", "@count": "8", "@label": "Afghanistan"}, {"@id": "CI", "@count": "8", "@label": "Ivory Coast"}, {"@id": "RW", "@count": "8", "@label": "Rwanda"}, {"@id": "ES", "@count": "8", "@label": "Spain"}, {"@id": "ET", "@count": "7", "@label": "Ethiopia"}, {"@id": "JP", "@count": "7", "@label": "Japan"}, {"@id": "TW", "@count": "7", "@label": "Taiwan"}, {"@id": "MX", "@count": "6", "@label": "Mexico"}, {"@id": "PG", "@count": "6", "@label": "Papua New Guinea"}, {"@id": "ZW", "@count": "6", "@label": "Zimbabwe"}, {"@id": "KR", "@count": "6", "@label": "South Korea"}, {"@id": "CZ", "@count": "5", "@label": "Czech Republic"}, {"@id": "DK", "@count": "5", "@label": "Denmark"}, {"@id": "NE", "@count": "5", "@label": "Niger"}, {"@id": "IT", "@count": "4", "@label": "Italy"}, {"@id": "SG", "@count": "4", "@label": "Singapore"}, {"@id": "TG", "@count": "4", "@label": "Togo"}, {"@id": "BE", "@count": "4", "@label": "Belgium"}, {"@id": "SE", "@count": "3", "@label": "Sweden"}, {"@id": "CF", "@count": "3", "@label": "Central African Republic"}, {"@id": "BW", "@count": "3", "@label": "Botswana"}, {"@id": "RU", "@count": "3", "@label": "Russian Federation"}, {"@id": "PL", "@count": "3", "@label": "Poland"}, {"@id": "UA", "@count": "3", "@label": "Ukraine"}, {"@id": "NO", "@count": "3", "@label": "Norway"}, {"@id": "HK", "@count": "3", "@label": "Hong Kong"}, {"@id": "LB", "@count": "3", "@label": "Lebanon"}, {"@id": "IL", "@count": "3", "@label": "Israel"}, {"@id": "X0", "@count": "2", "@label": "Africa"}, {"@id": "KM", "@count": "2", "@label": "Comoros"}, {"@id": "LK", "@count": "2", "@label": "Sri Lanka"}, {"@id": "HR", "@count": "2", "@label": "Croatia"}, {"@id": "SO", "@count": "2", "@label": "Somalia"}, {"@id": "SB", "@count": "2", "@label": "Solomon Islands"}, {"@id": "LR", "@count": "2", "@label": "Liberia"}, {"@id": "MG", "@count": "2", "@label": "Madagascar"}, {"@id": "RS", "@count": "2", "@label": "Serbia"}, {"@id": "BT", "@count": "2", "@label": "Bhutan"}, {"@id": "SA", "@count": "2", "@label": "Saudi Arabia"}, {"@id": "EG", "@count": "2", "@label": "Egypt"}, {"@id": "RO", "@count": "2", "@label": "Romania"}, {"@id": "IE", "@count": "2", "@label": "Ireland"}, {"@id": "PT", "@count": "2", "@label": "Portugal"}, {"@id": "AR", "@count": "2", "@label": "Argentina"}, {"@id": "TR", "@count": "2", "@label": "Turkey"}, {"@id": "MR", "@count": "2", "@label": "Mauritania"}, {"@id": "AT", "@count": "2", "@label": "Austria"}, {"@id": "GR", "@count": "2", "@label": "Greece"}, {"@id": "NZ", "@count": "2", "@label": "New Zealand"}, {"@id": "GT", "@count": "2", "@label": "Guatemala"}, {"@id": "YE", "@count": "1", "@label": "Yemen"}, {"@id": "TD", "@count": "1", "@label": "Chad"}, {"@id": "VU", "@count": "1", "@label": "Vanuatu"}, {"@id": "AO", "@count": "1", "@label": "Angola"}, {"@id": "X2", "@count": "1", "@label": "Asia"}, {"@id": "AE", "@count": "1", "@label": "United Arab Emirates"}, {"@id": "JO", "@count": "1", "@label": "Jordan"}]}, {"@total": "74", "@label": "Trial Actions Primary Interventions Primary", "@name": "trialActionsPrimaryInterventionsPrimary", "FilterOption": [{"@id": "61683", "@count": "20", "@label": "Thrombospondin relate anonymous protein modulator"}, {"@id": "204", "@count": "13", "@label": "HIV protease inhibitor"}, {"@id": "35746", "@count": "13", "@label": "Tubulin beta inhibitor"}, {"@id": "135", "@count": "11", "@label": "DHFR inhibitor"}, {"@id": "8805", "@count": "9", "@label": "AMP activated protein kinase stimulator"}, {"@id": "9166", "@count": "8", "@label": "Nuclease inhibitor"}, {"@id": "138", "@count": "8", "@label": "DNA polymerase inhibitor"}, {"@id": "142", "@count": "8", "@label": "Topoisomerase II inhibitor"}, {"@id": "4020", "@count": "7", "@label": "Sodium glucose transporter-2 inhibitor"}, {"@id": "7827", "@count": "7", "@label": "TLR-9 agonist"}, {"@id": "5537", "@count": "7", "@label": "Dipeptidyl peptidase IV inhibitor"}, {"@id": "9320", "@count": "6", "@label": "Topoisomerase IV inhibitor"}, {"@id": "50423", "@count": "6", "@label": "Plasmodium apical membrane protein modulator"}, {"@id": "431", "@count": "6", "@label": "DNA gyrase inhibitor"}, {"@id": "551", "@count": "5", "@label": "RNA DNA polymerase inhibitor"}, {"@id": "57226", "@count": "5", "@label": "Merozoite surface protein 3 modulator"}, {"@id": "345", "@count": "5", "@label": "Reverse transcriptase inhibitor"}, {"@id": "1016", "@count": "4", "@label": "HIV-1 reverse transcriptase inhibitor"}, {"@id": "381", "@count": "3", "@label": "TNF alpha ligand inhibitor"}, {"@id": "12521", "@count": "3", "@label": "VEGF ligand inhibitor"}, {"@id": "498", "@count": "3", "@label": "Sodium channel inhibitor"}, {"@id": "2480", "@count": "3", "@label": "PPAR gamma agonist"}, {"@id": "59", "@count": "3", "@label": "Androgen receptor agonist"}, {"@id": "48492", "@count": "2", "@label": "PDGF receptor beta antagonist"}, {"@id": "33967", "@count": "2", "@label": "Mycobacterial antigen complex 85A modulator"}, {"@id": "3816", "@count": "2", "@label": "RET tyrosine kinase receptor family inhibitor"}, {"@id": "3808", "@count": "2", "@label": "Kit tyrosine kinase inhibitor"}, {"@id": "258", "@count": "2", "@label": "Muscarinic receptor agonist"}, {"@id": "777", "@count": "2", "@label": "Lanosterol-14 demethylase inhibitor"}, {"@id": "34364", "@count": "2", "@label": "Merozoite surface protein 1 modulator"}, {"@id": "3151", "@count": "2", "@label": "GCSF receptor agonist"}, {"@id": "3806", "@count": "2", "@label": "Flt3 tyrosine kinase inhibitor"}, {"@id": "15477", "@count": "2", "@label": "Synaptic vesicle glycoprotein 2A modulator"}, {"@id": "3848", "@count": "2", "@label": "VEGF-2 receptor antagonist"}, {"@id": "6324", "@count": "2", "@label": "DXP reductoisomerase inhibitor"}, {"@id": "1716", "@count": "2", "@label": "Dihydroorotate dehydrogenase inhibitor"}, {"@id": "511", "@count": "2", "@label": "TNF antagonist"}, {"@id": "12770", "@count": "2", "@label": "B-lymphocyte stimulator ligand inhibitor"}, {"@id": "1359", "@count": "2", "@label": "Beta-N-acetylhexosaminidase modulator"}, {"@id": "3850", "@count": "1", "@label": "VEGF-3 receptor antagonist"}, {"@id": "3846", "@count": "1", "@label": "VEGF-1 receptor antagonist"}, {"@id": "8222", "@count": "1", "@label": "Type II TNF receptor modulator"}, {"@id": "36091", "@count": "1", "@label": "Phosphatidylinositol 4 kinase inhibitor"}, {"@id": "50425", "@count": "1", "@label": "Plasmodium apical membrane protein inhibitor"}, {"@id": "7812", "@count": "1", "@label": "TLR-4 agonist"}, {"@id": "318", "@count": "1", "@label": "Prostanoid receptor antagonist"}, {"@id": "4542", "@count": "1", "@label": "Raf protein kinase inhibitor"}, {"@id": "347", "@count": "1", "@label": "RNA polymerase inhibitor"}, {"@id": "421", "@count": "1", "@label": "Acetylcholine receptor agonist"}, {"@id": "3859", "@count": "1", "@label": "AKT protein kinase inhibitor"}, {"@id": "5064", "@count": "1", "@label": "Aminopeptidase N inhibitor"}, {"@id": "5085", "@count": "1", "@label": "B-lymphocyte antigen CD20 inhibitor"}, {"@id": "5089", "@count": "1", "@label": "B-lymphocyte cell adhesion molecule modulator"}, {"@id": "81", "@count": "1", "@label": "Benzodiazepine receptor agonist"}, {"@id": "4010", "@count": "1", "@label": "Calcineurin inhibitor"}, {"@id": "93", "@count": "1", "@label": "Calcium channel inhibitor"}, {"@id": "132", "@count": "1", "@label": "Cyclooxygenase inhibitor"}, {"@id": "6512", "@count": "1", "@label": "DNA methyltransferase inhibitor"}, {"@id": "145", "@count": "1", "@label": "Dopamine receptor antagonist"}, {"@id": "56668", "@count": "1", "@label": "Duffy receptor modulator"}, {"@id": "3754", "@count": "1", "@label": "EGFR family tyrosine kinase receptor inhibitor"}, {"@id": "12162", "@count": "1", "@label": "Erythropoietin ligand"}, {"@id": "175", "@count": "1", "@label": "GABA A receptor agonist"}, {"@id": "173", "@count": "1", "@label": "GABA receptor agonist"}, {"@id": "474", "@count": "1", "@label": "Hemoglobin modulator"}, {"@id": "768", "@count": "1", "@label": "HIV-1 protease inhibitor"}, {"@id": "205", "@count": "1", "@label": "HMG CoA reductase inhibitor"}, {"@id": "1584", "@count": "1", "@label": "IL-12 antagonist"}, {"@id": "9748", "@count": "1", "@label": "IL-23 antagonist"}, {"@id": "629", "@count": "1", "@label": "Inosine monophosphate dehydrogenase inhibitor"}, {"@id": "2952", "@count": "1", "@label": "Integrin alpha-1/beta-1 antagonist"}, {"@id": "3166", "@count": "1", "@label": "Leukotriene BLT receptor antagonist"}, {"@id": "255", "@count": "1", "@label": "MAO B inhibitor"}, {"@id": "4760", "@count": "1", "@label": "MEK protein kinase inhibitor"}]}, {"@total": "100", "@label": "Sponsors/Collaborators", "@name": "trialCompanies", "FilterOption": [{"@id": "28355", "@count": "93", "@label": "GlaxoSmithKline plc"}, {"@id": "20947", "@count": "81", "@label": "World Health Organization"}, {"@id": "22182", "@count": "78", "@label": "University of Oxford"}, {"@id": "23508", "@count": "70", "@label": "London School of Hygiene and Tropical Medicine"}, {"@id": "20520", "@count": "63", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "30573", "@count": "57", "@label": "Medicines for Malaria Venture"}, {"@id": "26857", "@count": "34", "@label": "Centers for Disease Control and Prevention"}, {"@id": "21129", "@count": "31", "@label": "Walter Reed Army Institute of Research"}, {"@id": "24869", "@count": "31", "@label": "Wellcome Trust"}, {"@id": "1043066", "@count": "30", "@label": "Gates Malaria Partnership"}, {"@id": "1066037", "@count": "25", "@label": "European and Developing Countries Clinical Trials Partnership"}, {"@id": "23137", "@count": "25", "@label": "Novartis AG"}, {"@id": "1039059", "@count": "24", "@label": "Kenya Medical Research Institute"}, {"@id": "1032580", "@count": "22", "@label": "Bill & Melinda Gates Foundation"}, {"@id": "1017623", "@count": "20", "@label": "The PATH Malaria Vaccine Initiative"}, {"@id": "1038607", "@count": "19", "@label": "United States Agency for International Development"}, {"@id": "1069084", "@count": "19", "@label": "US Army Medical Research and Materiel Command"}, {"@id": "1031299", "@count": "18", "@label": "Radboud University"}, {"@id": "18767", "@count": "17", "@label": "Pfizer Inc"}, {"@id": "20518", "@count": "17", "@label": "National Institutes of Health"}, {"@id": "28877", "@count": "17", "@label": "Mahidol University"}, {"@id": "20606", "@count": "16", "@label": "Liverpool School of Tropical Medicine"}, {"@id": "1013599", "@count": "16", "@label": "Drugs for Neglected Diseases Initiative"}, {"@id": "1036590", "@count": "16", "@label": "Makerere University"}, {"@id": "1054027", "@count": "16", "@label": "United Nations International Children's Fund"}, {"@id": "1009547", "@count": "15", "@label": "Sanofi"}, {"@id": "24773", "@count": "15", "@label": "University of California San Francisco"}, {"@id": "1039239", "@count": "14", "@label": "Institute of Tropical Medicine, Belgium"}, {"@id": "27025", "@count": "14", "@label": "Menzies School of Health Research"}, {"@id": "18438", "@count": "14", "@label": "Medical Research Council (MRC)"}, {"@id": "17774", "@count": "13", "@label": "LEO Pharma A/S"}, {"@id": "19896", "@count": "13", "@label": "Shin Poong Pharmaceutical Co Ltd"}, {"@id": "1081279", "@count": "12", "@label": "United Nations Development Program"}, {"@id": "1009888", "@count": "12", "@label": "Swiss Tropical & Public Health Institute"}, {"@id": "1061913", "@count": "12", "@label": "University of Bamako"}, {"@id": "1038964", "@count": "12", "@label": "Bandim Health Project"}, {"@id": "21242", "@count": "12", "@label": "The University of Liverpool"}, {"@id": "21126", "@count": "11", "@label": "Queensland Institute of Medical Research"}, {"@id": "1059673", "@count": "10", "@label": "Department for International Development"}, {"@id": "23005", "@count": "10", "@label": "US Naval Medical Research Center"}, {"@id": "1079686", "@count": "9", "@label": "Medical Research Council Unit, The Gambia"}, {"@id": "1039250", "@count": "9", "@label": "Albert Schweitzer Hospital"}, {"@id": "1008493", "@count": "9", "@label": "Sanaria Inc"}, {"@id": "17195", "@count": "9", "@label": "Immtech Pharmaceuticals Inc"}, {"@id": "1038866", "@count": "9", "@label": "Medecins Sans Frontieres"}, {"@id": "1040477", "@count": "9", "@label": "Centre Muraz"}, {"@id": "1043068", "@count": "8", "@label": "Eunice Kennedy Shriver National Institutes of Child Health and Human Development"}, {"@id": "1039067", "@count": "8", "@label": "African Malaria Network Trust"}, {"@id": "1069368", "@count": "8", "@label": "National Institutes of Health Clinical Center"}, {"@id": "1025724", "@count": "8", "@label": "European Vaccine Initiative"}, {"@id": "1081350", "@count": "8", "@label": "The Global Fund to Fight AIDS, Tuberculosis & Malaria"}, {"@id": "1039031", "@count": "8", "@label": "DBL -Institute for Health Research and Development"}, {"@id": "1047287", "@count": "8", "@label": "US Army Office of the Surgeon General"}, {"@id": "20519", "@count": "8", "@label": "National Cancer Institute"}, {"@id": "30690", "@count": "8", "@label": "University of Cape Town"}, {"@id": "26971", "@count": "8", "@label": "Artecef BV"}, {"@id": "1039229", "@count": "8", "@label": "Armed Forces Research Institute of Medical Sciences"}, {"@id": "1002549", "@count": "8", "@label": "Epicentre (MSF)"}, {"@id": "17810", "@count": "8", "@label": "Eli Lilly & Co"}, {"@id": "27038", "@count": "7", "@label": "Institut de Recherche pour le Developpement (IRD)"}, {"@id": "1040733", "@count": "7", "@label": "Cheikh Anta Diop University"}, {"@id": "1037293", "@count": "7", "@label": "Ministry of Health of Uganda"}, {"@id": "15350", "@count": "7", "@label": "Central Drug Research Institute"}, {"@id": "1038258", "@count": "7", "@label": "Kintampo Health Research Centre"}, {"@id": "1039738", "@count": "7", "@label": "Medical Research Council Laboratories"}, {"@id": "1070974", "@count": "7", "@label": "National Center for Parasitology, Entomology and Malaria Control"}, {"@id": "1039423", "@count": "7", "@label": "Hospital Clinic of Barcelona"}, {"@id": "1037980", "@count": "7", "@label": "University of Malawi College of Medicine"}, {"@id": "1009479", "@count": "7", "@label": "IPCA Laboratories Ltd"}, {"@id": "1086429", "@count": "6", "@label": "The World Bank"}, {"@id": "28348", "@count": "6", "@label": "University of Heidelberg"}, {"@id": "20634", "@count": "6", "@label": "University of North Carolina"}, {"@id": "1039334", "@count": "6", "@label": "Muhimbili University College of Health Sciences"}, {"@id": "1038146", "@count": "6", "@label": "National Health and Medical Research Council"}, {"@id": "24166", "@count": "6", "@label": "GlaxoSmithKline Biologicals"}, {"@id": "21110", "@count": "6", "@label": "Karolinska Institutet"}, {"@id": "16842", "@count": "6", "@label": "University of Western Australia"}, {"@id": "14881", "@count": "6", "@label": "Boehringer Ingelheim Corp"}, {"@id": "17237", "@count": "6", "@label": "Institut Pasteur"}, {"@id": "1081281", "@count": "6", "@label": "World Bank Research Committee"}, {"@id": "16994", "@count": "5", "@label": "Hospital for Sick Children"}, {"@id": "21266", "@count": "5", "@label": "Ranbaxy Laboratories Ltd"}, {"@id": "1089680", "@count": "5", "@label": "Bureau of Vector-Borne Disease (BVBD)"}, {"@id": "1039237", "@count": "5", "@label": "kwame Nkrumah University of Science and Technology"}, {"@id": "1046214", "@count": "5", "@label": "National Institute Of Health Research & Development (Nihrd)- Ministry Of Health Of The Republic Of Indonesia"}, {"@id": "1076213", "@count": "5", "@label": "UGANDA MALARIA SURVEILLANCE PROJECT"}, {"@id": "1051495", "@count": "5", "@label": "University of Kinshasa"}, {"@id": "1051066", "@count": "5", "@label": "National Institute for Medical Research, Tanzania"}, {"@id": "21159", "@count": "5", "@label": "Sigma-Tau Ind Farm Riunite SpA"}, {"@id": "16453", "@count": "5", "@label": "Glaxo Group Ltd"}, {"@id": "26093", "@count": "5", "@label": "Karolinska Hospital"}, {"@id": "19946", "@count": "5", "@label": "Sigma-Tau Pharmaceuticals Inc"}, {"@id": "1015721", "@count": "5", "@label": "Medical University of Vienna"}, {"@id": "1038857", "@count": "5", "@label": "Papua New Guinea Institute of Medical Research"}, {"@id": "23577", "@count": "5", "@label": "Imperial College London"}, {"@id": "19620", "@count": "5", "@label": "Eisai Inc"}, {"@id": "CM28008", "@count": "5", "@label": "Seattle Biomedical Research Institute"}, {"@id": "1044714", "@count": "5", "@label": "Ifakara Health Institute"}, {"@id": "27406", "@count": "5", "@label": "Leiden University Medical Center"}, {"@id": "29945", "@count": "4", "@label": "Pevion Biotech Ltd"}]}, {"@total": "100", "@label": "Trial Company Collaborator", "@name": "trialCompaniesCollaborator", "FilterOption": [{"@id": "20947", "@count": "59", "@label": "World Health Organization"}, {"@id": "23508", "@count": "32", "@label": "London School of Hygiene and Tropical Medicine"}, {"@id": "24869", "@count": "27", "@label": "Wellcome Trust"}, {"@id": "1066037", "@count": "25", "@label": "European and Developing Countries Clinical Trials Partnership"}, {"@id": "21129", "@count": "24", "@label": "Walter Reed Army Institute of Research"}, {"@id": "30573", "@count": "23", "@label": "Medicines for Malaria Venture"}, {"@id": "28355", "@count": "21", "@label": "GlaxoSmithKline plc"}, {"@id": "1032580", "@count": "18", "@label": "Bill & Melinda Gates Foundation"}, {"@id": "1017623", "@count": "18", "@label": "The PATH Malaria Vaccine Initiative"}, {"@id": "1038607", "@count": "18", "@label": "United States Agency for International Development"}, {"@id": "20520", "@count": "17", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "1039059", "@count": "16", "@label": "Kenya Medical Research Institute"}, {"@id": "20518", "@count": "15", "@label": "National Institutes of Health"}, {"@id": "19896", "@count": "13", "@label": "Shin Poong Pharmaceutical Co Ltd"}, {"@id": "28877", "@count": "11", "@label": "Mahidol University"}, {"@id": "18438", "@count": "11", "@label": "Medical Research Council (MRC)"}, {"@id": "26857", "@count": "9", "@label": "Centers for Disease Control and Prevention"}, {"@id": "1059673", "@count": "8", "@label": "Department for International Development"}, {"@id": "22182", "@count": "8", "@label": "University of Oxford"}, {"@id": "20606", "@count": "8", "@label": "Liverpool School of Tropical Medicine"}, {"@id": "17810", "@count": "8", "@label": "Eli Lilly & Co"}, {"@id": "1069368", "@count": "8", "@label": "National Institutes of Health Clinical Center"}, {"@id": "1081279", "@count": "7", "@label": "United Nations Development Program"}, {"@id": "1009888", "@count": "7", "@label": "Swiss Tropical & Public Health Institute"}, {"@id": "23005", "@count": "7", "@label": "US Naval Medical Research Center"}, {"@id": "1031299", "@count": "7", "@label": "Radboud University"}, {"@id": "1037293", "@count": "6", "@label": "Ministry of Health of Uganda"}, {"@id": "21110", "@count": "6", "@label": "Karolinska Institutet"}, {"@id": "1061913", "@count": "6", "@label": "University of Bamako"}, {"@id": "1081350", "@count": "6", "@label": "The Global Fund to Fight AIDS, Tuberculosis & Malaria"}, {"@id": "1037980", "@count": "6", "@label": "University of Malawi College of Medicine"}, {"@id": "1039239", "@count": "6", "@label": "Institute of Tropical Medicine, Belgium"}, {"@id": "1038146", "@count": "6", "@label": "National Health and Medical Research Council"}, {"@id": "1043068", "@count": "6", "@label": "Eunice Kennedy Shriver National Institutes of Child Health and Human Development"}, {"@id": "1070974", "@count": "5", "@label": "National Center for Parasitology, Entomology and Malaria Control"}, {"@id": "1051495", "@count": "5", "@label": "University of Kinshasa"}, {"@id": "1079686", "@count": "5", "@label": "Medical Research Council Unit, The Gambia"}, {"@id": "1051066", "@count": "5", "@label": "National Institute for Medical Research, Tanzania"}, {"@id": "20519", "@count": "5", "@label": "National Cancer Institute"}, {"@id": "1038866", "@count": "5", "@label": "Medecins Sans Frontieres"}, {"@id": "27406", "@count": "5", "@label": "Leiden University Medical Center"}, {"@id": "1058902", "@count": "4", "@label": "Department of State for Health and Social Welfare, The Gambia"}, {"@id": "1076213", "@count": "4", "@label": "UGANDA MALARIA SURVEILLANCE PROJECT"}, {"@id": "1086429", "@count": "4", "@label": "The World Bank"}, {"@id": "27918", "@count": "4", "@label": "Nairobi University"}, {"@id": "1054027", "@count": "4", "@label": "United Nations International Children's Fund"}, {"@id": "1038857", "@count": "4", "@label": "Papua New Guinea Institute of Medical Research"}, {"@id": "1044714", "@count": "4", "@label": "Ifakara Health Institute"}, {"@id": "1025724", "@count": "4", "@label": "European Vaccine Initiative"}, {"@id": "1059977", "@count": "4", "@label": "European Commission"}, {"@id": "1003948", "@count": "4", "@label": "Medical Research Council Of South Africa MRC"}, {"@id": "1090211", "@count": "4", "@label": "Malaria Research Training Center, University of Bamakoo"}, {"@id": "1040733", "@count": "4", "@label": "Cheikh Anta Diop University"}, {"@id": "1081281", "@count": "4", "@label": "World Bank Research Committee"}, {"@id": "20634", "@count": "4", "@label": "University of North Carolina"}, {"@id": "27038", "@count": "4", "@label": "Institut de Recherche pour le Developpement (IRD)"}, {"@id": "1038258", "@count": "4", "@label": "Kintampo Health Research Centre"}, {"@id": "1036590", "@count": "4", "@label": "Makerere University"}, {"@id": "1039738", "@count": "4", "@label": "Medical Research Council Laboratories"}, {"@id": "27025", "@count": "4", "@label": "Menzies School of Health Research"}, {"@id": "1064805", "@count": "4", "@label": "Centre National de Recherche et de Formation sur le Paludisme"}, {"@id": "1040477", "@count": "4", "@label": "Centre Muraz"}, {"@id": "1040106", "@count": "4", "@label": "International Atomic Energy Agency"}, {"@id": "1039237", "@count": "3", "@label": "kwame Nkrumah University of Science and Technology"}, {"@id": "1009811", "@count": "3", "@label": "Program for Appropriate Technology in Health"}, {"@id": "23358", "@count": "3", "@label": "Universitat Tubingen"}, {"@id": "21569", "@count": "3", "@label": "Massachusetts General Hospital"}, {"@id": "1039413", "@count": "3", "@label": "Manhica Health Research Center"}, {"@id": "1046204", "@count": "3", "@label": "Kilimanjaro Christian Medical Centre, Tanzania"}, {"@id": "1007264", "@count": "3", "@label": "International Centre For Diarrhoeal Disease Research, Bangladesh"}, {"@id": "1043066", "@count": "3", "@label": "Gates Malaria Partnership"}, {"@id": "1039403", "@count": "3", "@label": "German Federal Ministry of Education and Research"}, {"@id": "21242", "@count": "3", "@label": "The University of Liverpool"}, {"@id": "1076131", "@count": "3", "@label": "HealthNet TPO"}, {"@id": "17237", "@count": "3", "@label": "Institut Pasteur"}, {"@id": "1039423", "@count": "3", "@label": "Hospital Clinic of Barcelona"}, {"@id": "1074780", "@count": "3", "@label": "The Mahidol Oxford Tropical Medicine Research Unit"}, {"@id": "1045801", "@count": "3", "@label": "The European Union"}, {"@id": "1061699", "@count": "3", "@label": "The Global Fund"}, {"@id": "1079074", "@count": "3", "@label": "Universit\u00e9 d'Abomey-Calavi"}, {"@id": "1039377", "@count": "3", "@label": "National Centre for HIV/AIDS, Dermatology and STD Control"}, {"@id": "24588", "@count": "3", "@label": "Copenhagen University"}, {"@id": "1083607", "@count": "3", "@label": "Australian Government, National Health and Medical Research Council"}, {"@id": "1039210", "@count": "3", "@label": "Doris Duke Charitable Foundation"}, {"@id": "CM28215", "@count": "3", "@label": "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq"}, {"@id": "1083523", "@count": "3", "@label": "Vietnam Peoples Army"}, {"@id": "1003992", "@count": "3", "@label": "University of Barcelona"}, {"@id": "1039334", "@count": "3", "@label": "Muhimbili University College of Health Sciences"}, {"@id": "1036091", "@count": "3", "@label": "National Institute of Neurological Disorders and Stroke"}, {"@id": "1039250", "@count": "3", "@label": "Albert Schweitzer Hospital"}, {"@id": "21082", "@count": "3", "@label": "Walter and Eliza Hall Institute of Medical Research"}, {"@id": "1073953", "@count": "3", "@label": "National Fund of Scientific Research"}, {"@id": "27135", "@count": "3", "@label": "University of Maryland Baltimore County"}, {"@id": "1039040", "@count": "2", "@label": "Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnolog\u00eda (COLCIENCIAS)"}, {"@id": "1094396", "@count": "2", "@label": "University of Ouagadougou"}, {"@id": "1035537", "@count": "2", "@label": "Institut Pasteur Du Cambodge"}, {"@id": "1065847", "@count": "2", "@label": "Navrongo Health Research Centre"}, {"@id": "1046214", "@count": "2", "@label": "National Institute Of Health Research & Development (Nihrd)- Ministry Of Health Of The Republic Of Indonesia"}, {"@id": "16842", "@count": "2", "@label": "University of Western Australia"}, {"@id": "25992", "@count": "2", "@label": "Centre Hospitalier Universitaire Vaudois"}]}, {"@total": "100", "@label": "Trial Indications Pioneer", "@name": "trialIndicationsPioneer", "FilterOption": [{"@id": "267", "@count": "65", "@label": "Plasmodium falciparum infection"}, {"@id": "268", "@count": "61", "@label": "Plasmodium infection"}, {"@id": "270", "@count": "14", "@label": "Plasmodium vivax infection"}, {"@id": "281", "@count": "6", "@label": "Psoriasis"}, {"@id": "17", "@count": "6", "@label": "Anemia"}, {"@id": "502", "@count": "4", "@label": "Plasmodium malariae infection"}, {"@id": "158", "@count": "3", "@label": "HIV infection"}, {"@id": "360", "@count": "2", "@label": "Pneumonia"}, {"@id": "271", "@count": "2", "@label": "Pneumocystis carinii infection"}, {"@id": "150", "@count": "2", "@label": "Helminth infection"}, {"@id": "102", "@count": "2", "@label": "Diarrhea"}, {"@id": "88", "@count": "2", "@label": "Cystic fibrosis"}, {"@id": "291", "@count": "2", "@label": "Rheumatoid arthritis"}, {"@id": "298", "@count": "2", "@label": "Schistosomiasis"}, {"@id": "303", "@count": "2", "@label": "Sickle cell anemia"}, {"@id": "221", "@count": "2", "@label": "Mycobacterium tuberculosis infection"}, {"@id": "3", "@count": "2", "@label": "Acne"}, {"@id": "252", "@count": "2", "@label": "Parasitic infection"}, {"@id": "227", "@count": "2", "@label": "Neisseria gonorrhoeae infection"}, {"@id": "65", "@count": "2", "@label": "Stroke"}, {"@id": "239", "@count": "2", "@label": "Ocular disease"}, {"@id": "1803", "@count": "2", "@label": "Bacterial meningitis"}, {"@id": "40", "@count": "2", "@label": "Bacterial infection"}, {"@id": "222", "@count": "1", "@label": "Mycoplasma infection"}, {"@id": "224", "@count": "1", "@label": "Myocardial infarction"}, {"@id": "230", "@count": "1", "@label": "Neoplasm"}, {"@id": "837", "@count": "1", "@label": "Non-insulin dependent diabetes"}, {"@id": "269", "@count": "1", "@label": "Plasmodium knowlesi infection"}, {"@id": "394", "@count": "1", "@label": "Otitis media"}, {"@id": "799", "@count": "1", "@label": "Ovary tumor"}, {"@id": "453", "@count": "1", "@label": "Pharyngitis"}, {"@id": "3140", "@count": "1", "@label": "Pelvic inflammatory disease"}, {"@id": "255", "@count": "1", "@label": "Parkinsons disease"}, {"@id": "739", "@count": "1", "@label": "Urogenital ulcer"}, {"@id": "2951", "@count": "1", "@label": "Urethritis"}, {"@id": "3387", "@count": "1", "@label": "Trypanosoma brucei infection"}, {"@id": "515", "@count": "1", "@label": "Transplant rejection"}, {"@id": "2345", "@count": "1", "@label": "Tonsillitis"}, {"@id": "325", "@count": "1", "@label": "Thromboembolism"}, {"@id": "2000", "@count": "1", "@label": "Tay Sachs disease"}, {"@id": "1475", "@count": "1", "@label": "Streptococcus pyogenes infection"}, {"@id": "313", "@count": "1", "@label": "Streptococcus pneumoniae infection"}, {"@id": "1476", "@count": "1", "@label": "Streptococcus agalactiae infection"}, {"@id": "308", "@count": "1", "@label": "Staphylococcus aureus infection"}, {"@id": "1258", "@count": "1", "@label": "Spinal cord injury"}, {"@id": "52", "@count": "1", "@label": "Skin burns"}, {"@id": "717", "@count": "1", "@label": "Seizure disorder"}, {"@id": "2908", "@count": "1", "@label": "Sandhoff disease"}, {"@id": "348", "@count": "1", "@label": "Salmonella typhi infection"}, {"@id": "1024", "@count": "1", "@label": "Reperfusion injury"}, {"@id": "999", "@count": "1", "@label": "Renal tumor"}, {"@id": "69", "@count": "1", "@label": "Renal failure"}, {"@id": "1781", "@count": "1", "@label": "Psoriatic arthritis"}, {"@id": "279", "@count": "1", "@label": "Pruritus"}, {"@id": "706", "@count": "1", "@label": "Prophylaxis"}, {"@id": "1027", "@count": "1", "@label": "Female genital tract infection"}, {"@id": "113", "@count": "1", "@label": "Endometriosis"}, {"@id": "1185", "@count": "1", "@label": "Chronic obstructive pulmonary disease"}, {"@id": "68", "@count": "1", "@label": "Chlamydia trachomatis infection"}, {"@id": "1819", "@count": "1", "@label": "Chlamydia pneumoniae infection"}, {"@id": "62", "@count": "1", "@label": "Cerebral infarction"}, {"@id": "57", "@count": "1", "@label": "Cardiovascular disease"}, {"@id": "55", "@count": "1", "@label": "Cardiac failure"}, {"@id": "1557", "@count": "1", "@label": "Cardiac arrest"}, {"@id": "3283", "@count": "1", "@label": "Cannabis dependence"}, {"@id": "425", "@count": "1", "@label": "Cachexia"}, {"@id": "50", "@count": "1", "@label": "Bronchitis"}, {"@id": "2976", "@count": "1", "@label": "Bronchiolitis"}, {"@id": "315", "@count": "1", "@label": "Brain hemorrhage"}, {"@id": "485", "@count": "1", "@label": "Bacterial skin infection"}, {"@id": "1484", "@count": "1", "@label": "Bacterial respiratory tract infection"}, {"@id": "1815", "@count": "1", "@label": "Bacterial pneumonia"}, {"@id": "548", "@count": "1", "@label": "Autosomal recessive disorder"}, {"@id": "36", "@count": "1", "@label": "Autoimmune disease"}, {"@id": "28", "@count": "1", "@label": "Arthritis"}, {"@id": "12", "@count": "1", "@label": "Allergy"}, {"@id": "2999", "@count": "1", "@label": "Acute sinusitis"}, {"@id": "3081", "@count": "1", "@label": "Abscess"}, {"@id": "218", "@count": "1", "@label": "Mycobacterium infection"}, {"@id": "215", "@count": "1", "@label": "Muscular dystrophy"}, {"@id": "358", "@count": "1", "@label": "Muscle spasm"}, {"@id": "213", "@count": "1", "@label": "Multiple sclerosis"}, {"@id": "1455", "@count": "1", "@label": "Moraxella catarrhalis infection"}, {"@id": "3441", "@count": "1", "@label": "Membranous glomerulonephritis"}, {"@id": "1489", "@count": "1", "@label": "Lung injury"}, {"@id": "511", "@count": "1", "@label": "Lower respiratory tract infection"}, {"@id": "201", "@count": "1", "@label": "Liver disease"}, {"@id": "1136", "@count": "1", "@label": "Leishmania infection"}, {"@id": "1447", "@count": "1", "@label": "Legionella pneumophila infection"}, {"@id": "2783", "@count": "1", "@label": "Lassa fever"}, {"@id": "936", "@count": "1", "@label": "Kaposis sarcoma"}, {"@id": "188", "@count": "1", "@label": "Inflammatory disease"}, {"@id": "2198", "@count": "1", "@label": "Hepatosplenomegaly"}, {"@id": "152", "@count": "1", "@label": "Hepatitis B virus infection"}, {"@id": "149", "@count": "1", "@label": "Helicobacter pylori infection"}, {"@id": "626", "@count": "1", "@label": "Heart disease"}, {"@id": "145", "@count": "1", "@label": "Haemophilus influenzae infection"}, {"@id": "1075", "@count": "1", "@label": "Haemophilus infection"}, {"@id": "3019", "@count": "1", "@label": "Haemophilus ducreyi infection"}, {"@id": "136", "@count": "1", "@label": "Gout"}]}, {"@total": "19", "@label": "Trial Patient Selection", "@name": "trialTermsPatientSelection", "FilterOption": [{"@id": "EAYAD", "@count": "642", "@label": "Young Adults"}, {"@id": "EAMAA", "@count": "597", "@label": "Middle-aged Adults"}, {"@id": "EAPRE", "@count": "383", "@label": "Preschool Children"}, {"@id": "EAINF", "@count": "324", "@label": "Infants"}, {"@id": "EAAAD", "@count": "305", "@label": "Aged Adults"}, {"@id": "EACHI", "@count": "297", "@label": "Children"}, {"@id": "EAADL", "@count": "296", "@label": "Adolescents"}, {"@id": "EAELD", "@count": "219", "@label": "Elderly Adults"}, {"@id": "EVHVO", "@count": "209", "@label": "Healthy volunteers only"}, {"@id": "EVHVA", "@count": "152", "@label": "Healthy volunteers accepted"}, {"@id": "EGFEM", "@count": "83", "@label": "Female"}, {"@id": "EANEW", "@count": "81", "@label": "Newborn Infants"}, {"@id": "EGMAL", "@count": "57", "@label": "Male"}, {"@id": "ECAFR", "@count": "43", "@label": "African Ancestry"}, {"@id": "ECASI", "@count": "36", "@label": "Asian Ancestry"}, {"@id": "ECEUR", "@count": "11", "@label": "European Ancestry"}, {"@id": "ECJAP", "@count": "5", "@label": "Japanese Ancestry"}, {"@id": "ECOCE", "@count": "4", "@label": "Oceanic Ancestry"}, {"@id": "ECNAM", "@count": "1", "@label": "Native American Ancestry"}]}, {"@total": "25", "@label": "Trial Terms Design", "@name": "trialTermsDesign", "FilterOption": [{"@id": "SSTINV", "@count": "1097", "@label": "Interventional"}, {"@id": "SIPTRE", "@count": "789", "@label": "Treatment"}, {"@id": "SIARND", "@count": "737", "@label": "Randomized"}, {"@id": "SIMOPN", "@count": "541", "@label": "Open Label"}, {"@id": "SISPRL", "@count": "533", "@label": "Parallel Assignment"}, {"@id": "SIMMBD", "@count": "292", "@label": "Multiple Blind"}, {"@id": "SIPPRE", "@count": "289", "@label": "Prevention"}, {"@id": "SICACT", "@count": "243", "@label": "Active Control"}, {"@id": "SICPLC", "@count": "217", "@label": "Placebo Control"}, {"@id": "SISSNG", "@count": "193", "@label": "Single Group Assignment"}, {"@id": "SIANON", "@count": "154", "@label": "Non-Randomized"}, {"@id": "SIMSBD", "@count": "82", "@label": "Single Blind"}, {"@id": "SICNOC", "@count": "40", "@label": "No Control"}, {"@id": "SSTOBS", "@count": "33", "@label": "Observational"}, {"@id": "SISXOV", "@count": "29", "@label": "Crossover Assignment"}, {"@id": "SOTPRO", "@count": "28", "@label": "Prospective"}, {"@id": "SISFCT", "@count": "25", "@label": "Factorial Assignment"}, {"@id": "SICDSC", "@count": "25", "@label": "Dose Comparison"}, {"@id": "SOSCOH", "@count": "13", "@label": "Cohort"}, {"@id": "SICHST", "@count": "6", "@label": "Historical Control"}, {"@id": "SIPDIA", "@count": "5", "@label": "Diagnosis"}, {"@id": "SODXSC", "@count": "4", "@label": "Cross-sectional"}, {"@id": "SOSCSC", "@count": "4", "@label": "Case Control"}, {"@id": "SODLNG", "@count": "3", "@label": "Longitudinal"}, {"@id": "SOSDEF", "@count": "3", "@label": "Defined Population"}]}, {"@total": "100", "@label": "Interventions", "@name": "trialInterventions", "FilterOption": [{"@id": "8896", "@count": "156", "@label": "artemether + lumefantrine, Novartis"}, {"@id": "53041", "@count": "75", "@label": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis"}, {"@id": "53724", "@count": "74", "@label": "artenimol + piperaquine (malaria), Sigma-Tau"}, {"@id": "23459", "@count": "46", "@label": "atovaquone + proguanil, GlaxoSmithKline"}, {"@id": "14289", "@count": "31", "@label": "malaria vaccine, GlaxoSmithKline/Malaria Vaccine Initiative"}, {"@id": "2587", "@count": "28", "@label": "azithromycin"}, {"@id": "53051", "@count": "23", "@label": "artesunate + mefloquine combination tablet (malaria), DNDi"}, {"@id": "17210", "@count": "21", "@label": "chlorproguanil + dapsone (malaria), University of Liverpool/WHO/GlaxoSmithKline"}, {"@id": "58508", "@count": "20", "@label": "PlaMavax"}, {"@id": "44719", "@count": "15", "@label": "malaria vaccine, NIAID"}, {"@id": "53751", "@count": "15", "@label": "pyronaridine + artesunate (oral), Medicines for Malaria Venture/Shin Poong/WHO"}, {"@id": "63927", "@count": "14", "@label": "artefenomel mesylate (Plasmodium infections), MMV/UNMC/STPI/Monash University"}, {"@id": "12132", "@count": "13", "@label": "albendazole"}, {"@id": "9752", "@count": "12", "@label": "tafenoquine"}, {"@id": "14681", "@count": "12", "@label": "lopinavir + ritonavir"}, {"@id": "50840", "@count": "11", "@label": "Sanaria PfSPZ Vaccine"}, {"@id": "44363", "@count": "11", "@label": "trimethoprim + sulphamethoxazole"}, {"@id": "3700", "@count": "9", "@label": "nevirapine"}, {"@id": "2577", "@count": "9", "@label": "atovaquone"}, {"@id": "25498", "@count": "9", "@label": "artemotil"}, {"@id": "54590", "@count": "8", "@label": "chlorproguanil + dapsone + artesunate (malaria), WHO/University of Liverpool/GlaxoSmithKline/Medicines for Malaria Venture"}, {"@id": "16755", "@count": "8", "@label": "pafuramidine"}, {"@id": "10172", "@count": "8", "@label": "efavirenz"}, {"@id": "6050", "@count": "8", "@label": "metformin hydrochloride"}, {"@id": "17091", "@count": "7", "@label": "agatolimod"}, {"@id": "64288", "@count": "6", "@label": "FMP1/AS02A"}, {"@id": "44370", "@count": "6", "@label": "clindamycin"}, {"@id": "58762", "@count": "6", "@label": "empagliflozin"}, {"@id": "50974", "@count": "5", "@label": "calcipotriol + betamethasone dipropionate, LEO"}, {"@id": "74347", "@count": "5", "@label": "E-2006"}, {"@id": "61408", "@count": "5", "@label": "merozoite surface protein 3 long synthetic peptide vaccine (Plasmodium infection), African Malaria Network Trust"}, {"@id": "58045", "@count": "5", "@label": "FMP2.1/AS02A"}, {"@id": "44316", "@count": "5", "@label": "zidovudine"}, {"@id": "65208", "@count": "5", "@label": "SERA5-targeted malaria vaccine, BIKEN"}, {"@id": "3474", "@count": "5", "@label": "lamivudine"}, {"@id": "17253", "@count": "5", "@label": "pyronaridine"}, {"@id": "41077", "@count": "4", "@label": "malaria vaccine (virosomes, PeviPRO), Mymetics"}, {"@id": "58438", "@count": "4", "@label": "arterolane maleate + piperaquine phosphate, Ranbaxy"}, {"@id": "32077", "@count": "4", "@label": "MalariVax"}, {"@id": "73303", "@count": "4", "@label": "artesunate (iv, malaria), WRAIR/Sigma-Tau"}, {"@id": "60199", "@count": "4", "@label": "sevuparin sodium"}, {"@id": "59839", "@count": "4", "@label": "retagliptin"}, {"@id": "9340", "@count": "4", "@label": "bulaquin + chloroquine combination"}, {"@id": "11459", "@count": "4", "@label": "Synflorix"}, {"@id": "8708", "@count": "4", "@label": "vaccine (malaria), WHO/Llorente"}, {"@id": "16943", "@count": "3", "@label": "MSP-1(42)-C1"}, {"@id": "72924", "@count": "3", "@label": "circumsporozoite protein vaccine (modified Vaccinia Ankar Virus vector, malaria), EMVI"}, {"@id": "83844", "@count": "3", "@label": "circumsporozoite vaccine (fowlpox virus vector, malaria), Gates Malaria Partnership/ London School of Hygiene and Tropical Medicine/ Research Council and University of Oxford"}, {"@id": "56581", "@count": "3", "@label": "GMZ-2"}, {"@id": "19980", "@count": "3", "@label": "HE-2000"}, {"@id": "6877", "@count": "3", "@label": "miltefosine"}, {"@id": "9283", "@count": "3", "@label": "DNA vaccine (malaria), Vical"}, {"@id": "16696", "@count": "3", "@label": "lamivudine + zidovudine, GlaxoSmithKline"}, {"@id": "46927", "@count": "3", "@label": "doxycycline hyclate"}, {"@id": "41758", "@count": "3", "@label": "ferroquine"}, {"@id": "8976", "@count": "3", "@label": "rosiglitazone"}, {"@id": "39618", "@count": "3", "@label": "artemisone"}, {"@id": "60942", "@count": "3", "@label": "recombinant adenovirus-poxvirus prime-boost malaria vaccine, Oxford University/MRC/Wellcome"}, {"@id": "19337", "@count": "3", "@label": "AQ-13"}, {"@id": "66250", "@count": "3", "@label": "azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine"}, {"@id": "44279", "@count": "3", "@label": "amoxicillin"}, {"@id": "8047", "@count": "3", "@label": "bevacizumab"}, {"@id": "49219", "@count": "3", "@label": "tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"}, {"@id": "50975", "@count": "3", "@label": "calcipotriol + hydrocortisone, LEO"}, {"@id": "12242", "@count": "3", "@label": "calcipotriol"}, {"@id": "3803", "@count": "3", "@label": "paclitaxel"}, {"@id": "61123", "@count": "3", "@label": "cipargamin"}, {"@id": "64233", "@count": "2", "@label": "GSK-208108"}, {"@id": "14493", "@count": "2", "@label": "tenofovir disoproxil fumarate"}, {"@id": "70881", "@count": "2", "@label": "V-109"}, {"@id": "4225", "@count": "2", "@label": "vepoloxamer"}, {"@id": "6074", "@count": "2", "@label": "levamisole"}, {"@id": "22614", "@count": "2", "@label": "glyminox"}, {"@id": "3492", "@count": "2", "@label": "levofloxacin"}, {"@id": "55852", "@count": "2", "@label": "linagliptin"}, {"@id": "12813", "@count": "2", "@label": "Rotarix"}, {"@id": "83710", "@count": "2", "@label": "FP9 ME-TRAP"}, {"@id": "82840", "@count": "2", "@label": "malaria vaccine (EBA-175 RII-NG), NIAID"}, {"@id": "55311", "@count": "2", "@label": "malaria vaccine (adenovector), GenVec/Naval Medical Research Center"}, {"@id": "3564", "@count": "2", "@label": "malaria vaccine, Biotech Australia/La Trobe University/Vaccine Solutions/QIMR"}, {"@id": "7310", "@count": "2", "@label": "ritonavir"}, {"@id": "16702", "@count": "2", "@label": "Quilimmune-M"}, {"@id": "67921", "@count": "2", "@label": "Plasmodium falciparum LSA-NRC vaccine, Walter Reed Army Institute of Research"}, {"@id": "73905", "@count": "2", "@label": "Pfs25-EPA vaccine (adjuvanted, malaria), NIAID"}, {"@id": "42957", "@count": "2", "@label": "PfCS-102"}, {"@id": "61398", "@count": "2", "@label": "PfAMA-1"}, {"@id": "60876", "@count": "2", "@label": "mometasone furoate (topical, eczema/psoriasis), Almirall"}, {"@id": "12978", "@count": "2", "@label": "moxifloxacin"}, {"@id": "44306", "@count": "2", "@label": "pentoxifylline"}, {"@id": "55317", "@count": "2", "@label": "MVA-85A"}, {"@id": "66505", "@count": "2", "@label": "MSP1 prime-boost vaccine (Plasmodium infection), University of Oxford"}, {"@id": "6242", "@count": "2", "@label": "abacavir"}, {"@id": "56080", "@count": "2", "@label": "Ad35.CS.01"}, {"@id": "53871", "@count": "2", "@label": "albitiazolium bromide"}, {"@id": "2503", "@count": "2", "@label": "amphotericin B (liposomal iv, visceral leishmaniasis), Drugs for Neglected Diseases initiative"}, {"@id": "59674", "@count": "2", "@label": "artemether (sublingual mouth spray, malaria), Star Medical/Suda/LondonPharma"}, {"@id": "49420", "@count": "2", "@label": "arterolane"}, {"@id": "55477", "@count": "2", "@label": "ASF-1075"}, {"@id": "7600", "@count": "2", "@label": "AZD-9773"}, {"@id": "31831", "@count": "2", "@label": "belimumab"}]}, {"@total": "17", "@label": "Trial Interventions Control In Regimen Name Display", "@name": "trialInterventionsControlInRegimenNameDisplay", "FilterOption": [{"@id": "3268", "@count": "3", "@label": "Engerix B"}, {"@id": "44316", "@count": "1", "@label": "zidovudine"}, {"@id": "11459", "@count": "1", "@label": "Synflorix"}, {"@id": "12813", "@count": "1", "@label": "Rotarix"}, {"@id": "4144", "@count": "1", "@label": "Prevnar"}, {"@id": "6050", "@count": "1", "@label": "metformin hydrochloride"}, {"@id": "3474", "@count": "1", "@label": "lamivudine"}, {"@id": "3412", "@count": "1", "@label": "ivermectin"}, {"@id": "64233", "@count": "1", "@label": "GSK-208108"}, {"@id": "8832", "@count": "1", "@label": "glimepiride"}, {"@id": "6047", "@count": "1", "@label": "eflornithine"}, {"@id": "10172", "@count": "1", "@label": "efavirenz"}, {"@id": "2577", "@count": "1", "@label": "atovaquone"}, {"@id": "53051", "@count": "1", "@label": "artesunate + mefloquine combination tablet (malaria), DNDi"}, {"@id": "53041", "@count": "1", "@label": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis"}, {"@id": "8896", "@count": "1", "@label": "artemether + lumefantrine, Novartis"}, {"@id": "12132", "@count": "1", "@label": "albendazole"}]}, {"@total": "100", "@label": "Trial Date End By Month", "@name": "trialDateEndByMonth", "FilterOption": [{"@count": "17", "@label": "201112"}, {"@count": "15", "@label": "201412"}, {"@count": "15", "@label": "201312"}, {"@count": "12", "@label": "201212"}, {"@count": "11", "@label": "200912"}, {"@count": "10", "@label": "201012"}, {"@count": "10", "@label": "200612"}, {"@count": "9", "@label": "200512"}, {"@count": "9", "@label": "200908"}, {"@count": "9", "@label": "201501"}, {"@count": "9", "@label": "201206"}, {"@count": "9", "@label": "201307"}, {"@count": "9", "@label": "201207"}, {"@count": "8", "@label": "200903"}, {"@count": "8", "@label": "200812"}, {"@count": "8", "@label": "200811"}, {"@count": "8", "@label": "201406"}, {"@count": "8", "@label": "200610"}, {"@count": "8", "@label": "201302"}, {"@count": "8", "@label": "200712"}, {"@count": "8", "@label": "200710"}, {"@count": "8", "@label": "201305"}, {"@count": "8", "@label": "200507"}, {"@count": "7", "@label": "201001"}, {"@count": "7", "@label": "200907"}, {"@count": "7", "@label": "201405"}, {"@count": "7", "@label": "201404"}, {"@count": "7", "@label": "201403"}, {"@count": "7", "@label": "200605"}, {"@count": "7", "@label": "201009"}, {"@count": "7", "@label": "201401"}, {"@count": "7", "@label": "201310"}, {"@count": "7", "@label": "201106"}, {"@count": "7", "@label": "201304"}, {"@count": "7", "@label": "201210"}, {"@count": "6", "@label": "200604"}, {"@count": "6", "@label": "201311"}, {"@count": "6", "@label": "200704"}, {"@count": "6", "@label": "200801"}, {"@count": "6", "@label": "200803"}, {"@count": "6", "@label": "200806"}, {"@count": "6", "@label": "201211"}, {"@count": "6", "@label": "200810"}, {"@count": "6", "@label": "201010"}, {"@count": "6", "@label": "201510"}, {"@count": "6", "@label": "201505"}, {"@count": "6", "@label": "200902"}, {"@count": "6", "@label": "201201"}, {"@count": "6", "@label": "201408"}, {"@count": "6", "@label": "200904"}, {"@count": "6", "@label": "201508"}, {"@count": "6", "@label": "201109"}, {"@count": "5", "@label": "201008"}, {"@count": "5", "@label": "201402"}, {"@count": "5", "@label": "201102"}, {"@count": "5", "@label": "201308"}, {"@count": "5", "@label": "200701"}, {"@count": "5", "@label": "201306"}, {"@count": "5", "@label": "200703"}, {"@count": "5", "@label": "200708"}, {"@count": "5", "@label": "201303"}, {"@count": "5", "@label": "200906"}, {"@count": "5", "@label": "200805"}, {"@count": "5", "@label": "201301"}, {"@count": "5", "@label": "200807"}, {"@count": "5", "@label": "200808"}, {"@count": "5", "@label": "201209"}, {"@count": "5", "@label": "201204"}, {"@count": "5", "@label": "201410"}, {"@count": "5", "@label": "200411"}, {"@count": "4", "@label": "201409"}, {"@count": "4", "@label": "201411"}, {"@count": "4", "@label": "201407"}, {"@count": "4", "@label": "200911"}, {"@count": "4", "@label": "201006"}, {"@count": "4", "@label": "200407"}, {"@count": "4", "@label": "201007"}, {"@count": "4", "@label": "201503"}, {"@count": "4", "@label": "200802"}, {"@count": "4", "@label": "200412"}, {"@count": "4", "@label": "201506"}, {"@count": "4", "@label": "201103"}, {"@count": "4", "@label": "200707"}, {"@count": "4", "@label": "200603"}, {"@count": "4", "@label": "200602"}, {"@count": "4", "@label": "201309"}, {"@count": "4", "@label": "200511"}, {"@count": "4", "@label": "201612"}, {"@count": "4", "@label": "201512"}, {"@count": "4", "@label": "201205"}, {"@count": "4", "@label": "200509"}, {"@count": "4", "@label": "201203"}, {"@count": "4", "@label": "201509"}, {"@count": "4", "@label": "200505"}, {"@count": "4", "@label": "201507"}, {"@count": "4", "@label": "200706"}, {"@count": "3", "@label": "201504"}, {"@count": "3", "@label": "200101"}, {"@count": "3", "@label": "200006"}, {"@count": "3", "@label": "201605"}]}, {"@total": "44", "@label": "Active Controls", "@name": "trialActiveControls", "FilterOption": [{"@id": "8896", "@count": "24", "@label": "artemether + lumefantrine, Novartis"}, {"@id": "53051", "@count": "6", "@label": "artesunate + mefloquine combination tablet (malaria), DNDi"}, {"@id": "3268", "@count": "5", "@label": "Engerix B"}, {"@id": "53041", "@count": "3", "@label": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis"}, {"@id": "12242", "@count": "3", "@label": "calcipotriol"}, {"@id": "6050", "@count": "2", "@label": "metformin hydrochloride"}, {"@id": "3700", "@count": "2", "@label": "nevirapine"}, {"@id": "3257", "@count": "2", "@label": "halofantrine"}, {"@id": "64233", "@count": "2", "@label": "GSK-208108"}, {"@id": "10172", "@count": "2", "@label": "efavirenz"}, {"@id": "17210", "@count": "2", "@label": "chlorproguanil + dapsone (malaria), University of Liverpool/WHO/GlaxoSmithKline"}, {"@id": "2587", "@count": "2", "@label": "azithromycin"}, {"@id": "4508", "@count": "2", "@label": "tacalcitol"}, {"@id": "17091", "@count": "2", "@label": "agatolimod"}, {"@id": "23459", "@count": "2", "@label": "atovaquone + proguanil, GlaxoSmithKline"}, {"@id": "12862", "@count": "2", "@label": "Tritanrix HB"}, {"@id": "10593", "@count": "1", "@label": "Meningitec"}, {"@id": "3612", "@count": "1", "@label": "meningococcal C/CRM-197 conjugate vaccine, Chiron"}, {"@id": "61413", "@count": "1", "@label": "mometasone (dermatological), Merck & Co"}, {"@id": "10774", "@count": "1", "@label": "NeisVac-C"}, {"@id": "44316", "@count": "1", "@label": "zidovudine"}, {"@id": "44363", "@count": "1", "@label": "trimethoprim + sulphamethoxazole"}, {"@id": "44408", "@count": "1", "@label": "polio vaccine, Sanofi Pasteur"}, {"@id": "4144", "@count": "1", "@label": "Prevnar"}, {"@id": "6342", "@count": "1", "@label": "rabies vaccine, Aventis Pasteur"}, {"@id": "4236", "@count": "1", "@label": "risperidone"}, {"@id": "12813", "@count": "1", "@label": "Rotarix"}, {"@id": "11459", "@count": "1", "@label": "Synflorix"}, {"@id": "14289", "@count": "1", "@label": "malaria vaccine, GlaxoSmithKline/Malaria Vaccine Initiative"}, {"@id": "55852", "@count": "1", "@label": "linagliptin"}, {"@id": "59534", "@count": "1", "@label": "LEO-29102"}, {"@id": "3474", "@count": "1", "@label": "lamivudine"}, {"@id": "3412", "@count": "1", "@label": "ivermectin"}, {"@id": "21955", "@count": "1", "@label": "Inflexal V"}, {"@id": "8832", "@count": "1", "@label": "glimepiride"}, {"@id": "3130", "@count": "1", "@label": "filgrastim"}, {"@id": "58762", "@count": "1", "@label": "empagliflozin"}, {"@id": "6047", "@count": "1", "@label": "eflornithine"}, {"@id": "57760", "@count": "1", "@label": "colchicine (oral, gout/familial Mediterranean fever), Takeda"}, {"@id": "44281", "@count": "1", "@label": "betamethasone"}, {"@id": "2577", "@count": "1", "@label": "atovaquone"}, {"@id": "2807", "@count": "1", "@label": "atorvastatin"}, {"@id": "53724", "@count": "1", "@label": "artenimol + piperaquine (malaria), Sigma-Tau"}, {"@id": "12132", "@count": "1", "@label": "albendazole"}]}, {"@total": "100", "@label": "Trial Interventions Primary Alone Name Display", "@name": "trialInterventionsPrimaryAloneNameDisplay", "FilterOption": [{"@id": "8896", "@count": "135", "@label": "artemether + lumefantrine, Novartis"}, {"@id": "53724", "@count": "61", "@label": "artenimol + piperaquine (malaria), Sigma-Tau"}, {"@id": "53041", "@count": "59", "@label": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis"}, {"@id": "23459", "@count": "39", "@label": "atovaquone + proguanil, GlaxoSmithKline"}, {"@id": "14289", "@count": "27", "@label": "malaria vaccine, GlaxoSmithKline/Malaria Vaccine Initiative"}, {"@id": "53051", "@count": "21", "@label": "artesunate + mefloquine combination tablet (malaria), DNDi"}, {"@id": "58508", "@count": "17", "@label": "PlaMavax"}, {"@id": "17210", "@count": "17", "@label": "chlorproguanil + dapsone (malaria), University of Liverpool/WHO/GlaxoSmithKline"}, {"@id": "53751", "@count": "13", "@label": "pyronaridine + artesunate (oral), Medicines for Malaria Venture/Shin Poong/WHO"}, {"@id": "50840", "@count": "10", "@label": "Sanaria PfSPZ Vaccine"}, {"@id": "44719", "@count": "10", "@label": "malaria vaccine, NIAID"}, {"@id": "9752", "@count": "10", "@label": "tafenoquine"}, {"@id": "44363", "@count": "10", "@label": "trimethoprim + sulphamethoxazole"}, {"@id": "63927", "@count": "9", "@label": "artefenomel mesylate (Plasmodium infections), MMV/UNMC/STPI/Monash University"}, {"@id": "25498", "@count": "9", "@label": "artemotil"}, {"@id": "12132", "@count": "9", "@label": "albendazole"}, {"@id": "16755", "@count": "8", "@label": "pafuramidine"}, {"@id": "2587", "@count": "7", "@label": "azithromycin"}, {"@id": "54590", "@count": "6", "@label": "chlorproguanil + dapsone + artesunate (malaria), WHO/University of Liverpool/GlaxoSmithKline/Medicines for Malaria Venture"}, {"@id": "58045", "@count": "5", "@label": "FMP2.1/AS02A"}, {"@id": "64288", "@count": "5", "@label": "FMP1/AS02A"}, {"@id": "17253", "@count": "5", "@label": "pyronaridine"}, {"@id": "61408", "@count": "5", "@label": "merozoite surface protein 3 long synthetic peptide vaccine (Plasmodium infection), African Malaria Network Trust"}, {"@id": "74347", "@count": "5", "@label": "E-2006"}, {"@id": "65208", "@count": "5", "@label": "SERA5-targeted malaria vaccine, BIKEN"}, {"@id": "8708", "@count": "4", "@label": "vaccine (malaria), WHO/Llorente"}, {"@id": "50974", "@count": "4", "@label": "calcipotriol + betamethasone dipropionate, LEO"}, {"@id": "14681", "@count": "4", "@label": "lopinavir + ritonavir"}, {"@id": "58438", "@count": "4", "@label": "arterolane maleate + piperaquine phosphate, Ranbaxy"}, {"@id": "73303", "@count": "4", "@label": "artesunate (iv, malaria), WRAIR/Sigma-Tau"}, {"@id": "3700", "@count": "4", "@label": "nevirapine"}, {"@id": "9340", "@count": "4", "@label": "bulaquin + chloroquine combination"}, {"@id": "72924", "@count": "3", "@label": "circumsporozoite protein vaccine (modified Vaccinia Ankar Virus vector, malaria), EMVI"}, {"@id": "61123", "@count": "3", "@label": "cipargamin"}, {"@id": "32077", "@count": "3", "@label": "MalariVax"}, {"@id": "83844", "@count": "3", "@label": "circumsporozoite vaccine (fowlpox virus vector, malaria), Gates Malaria Partnership/ London School of Hygiene and Tropical Medicine/ Research Council and University of Oxford"}, {"@id": "9283", "@count": "3", "@label": "DNA vaccine (malaria), Vical"}, {"@id": "60199", "@count": "3", "@label": "sevuparin sodium"}, {"@id": "41077", "@count": "3", "@label": "malaria vaccine (virosomes, PeviPRO), Mymetics"}, {"@id": "56581", "@count": "3", "@label": "GMZ-2"}, {"@id": "19980", "@count": "3", "@label": "HE-2000"}, {"@id": "16943", "@count": "3", "@label": "MSP-1(42)-C1"}, {"@id": "44279", "@count": "3", "@label": "amoxicillin"}, {"@id": "50975", "@count": "3", "@label": "calcipotriol + hydrocortisone, LEO"}, {"@id": "6050", "@count": "3", "@label": "metformin hydrochloride"}, {"@id": "19337", "@count": "3", "@label": "AQ-13"}, {"@id": "2577", "@count": "3", "@label": "atovaquone"}, {"@id": "41758", "@count": "2", "@label": "ferroquine"}, {"@id": "16702", "@count": "2", "@label": "Quilimmune-M"}, {"@id": "60876", "@count": "2", "@label": "mometasone furoate (topical, eczema/psoriasis), Almirall"}, {"@id": "56080", "@count": "2", "@label": "Ad35.CS.01"}, {"@id": "82840", "@count": "2", "@label": "malaria vaccine (EBA-175 RII-NG), NIAID"}, {"@id": "49420", "@count": "2", "@label": "arterolane"}, {"@id": "6877", "@count": "2", "@label": "miltefosine"}, {"@id": "64756", "@count": "2", "@label": "fosmidomycin + clindamycin (oral, malaria), Jomaa"}, {"@id": "67921", "@count": "2", "@label": "Plasmodium falciparum LSA-NRC vaccine, Walter Reed Army Institute of Research"}, {"@id": "4225", "@count": "2", "@label": "vepoloxamer"}, {"@id": "22614", "@count": "2", "@label": "glyminox"}, {"@id": "39618", "@count": "2", "@label": "artemisone"}, {"@id": "64233", "@count": "2", "@label": "GSK-208108"}, {"@id": "73905", "@count": "2", "@label": "Pfs25-EPA vaccine (adjuvanted, malaria), NIAID"}, {"@id": "6074", "@count": "2", "@label": "levamisole"}, {"@id": "42957", "@count": "2", "@label": "PfCS-102"}, {"@id": "61398", "@count": "2", "@label": "PfAMA-1"}, {"@id": "3803", "@count": "2", "@label": "paclitaxel"}, {"@id": "59674", "@count": "2", "@label": "artemether (sublingual mouth spray, malaria), Star Medical/Suda/LondonPharma"}, {"@id": "12242", "@count": "2", "@label": "calcipotriol"}, {"@id": "66138", "@count": "2", "@label": "CDRI-97/78"}, {"@id": "11459", "@count": "2", "@label": "Synflorix"}, {"@id": "55317", "@count": "2", "@label": "MVA-85A"}, {"@id": "53871", "@count": "2", "@label": "albitiazolium bromide"}, {"@id": "72913", "@count": "2", "@label": "circumsporozoite protein vaccine (adenovirus vector ch-63, Malaria), EVI"}, {"@id": "70881", "@count": "2", "@label": "V-109"}, {"@id": "31831", "@count": "2", "@label": "belimumab"}, {"@id": "66250", "@count": "2", "@label": "azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine"}, {"@id": "7600", "@count": "2", "@label": "AZD-9773"}, {"@id": "68255", "@count": "2", "@label": "DSM-265"}, {"@id": "17091", "@count": "2", "@label": "agatolimod"}, {"@id": "12978", "@count": "2", "@label": "moxifloxacin"}, {"@id": "3564", "@count": "2", "@label": "malaria vaccine, Biotech Australia/La Trobe University/Vaccine Solutions/QIMR"}, {"@id": "58762", "@count": "2", "@label": "empagliflozin"}, {"@id": "55477", "@count": "2", "@label": "ASF-1075"}, {"@id": "8976", "@count": "2", "@label": "rosiglitazone"}, {"@id": "55311", "@count": "2", "@label": "malaria vaccine (adenovector), GenVec/Naval Medical Research Center"}, {"@id": "59839", "@count": "2", "@label": "retagliptin"}, {"@id": "66505", "@count": "1", "@label": "MSP1 prime-boost vaccine (Plasmodium infection), University of Oxford"}, {"@id": "7264", "@count": "1", "@label": "onercept"}, {"@id": "71379", "@count": "1", "@label": "P-27A"}, {"@id": "11854", "@count": "1", "@label": "nitric oxide (inhaled), Ikaria"}, {"@id": "82887", "@count": "1", "@label": "MSP2-C1"}, {"@id": "83147", "@count": "1", "@label": "P47-targeting transmission-blocking vaccine (malaria), NIAID"}, {"@id": "41757", "@count": "1", "@label": "N-tert butyl isoquine"}, {"@id": "11089", "@count": "1", "@label": "nitazoxanide"}, {"@id": "44316", "@count": "1", "@label": "zidovudine"}, {"@id": "5265", "@count": "1", "@label": "valproic acid"}, {"@id": "42858", "@count": "1", "@label": "ustekinumab"}, {"@id": "9286", "@count": "1", "@label": "Typhim Vi"}, {"@id": "12862", "@count": "1", "@label": "Tritanrix HB"}, {"@id": "52796", "@count": "1", "@label": "tetrandrine, Millenia Hope"}, {"@id": "14493", "@count": "1", "@label": "tenofovir disoproxil fumarate"}]}, {"@total": "100", "@label": "Trial Date Start By Month", "@name": "trialDateStartByMonth", "FilterOption": [{"@count": "14", "@label": "201304"}, {"@count": "14", "@label": "201306"}, {"@count": "13", "@label": "201009"}, {"@count": "12", "@label": "200507"}, {"@count": "12", "@label": "201007"}, {"@count": "12", "@label": "201006"}, {"@count": "12", "@label": "201401"}, {"@count": "12", "@label": "200709"}, {"@count": "11", "@label": "201008"}, {"@count": "11", "@label": "201210"}, {"@count": "11", "@label": "201208"}, {"@count": "11", "@label": "200707"}, {"@count": "11", "@label": "201309"}, {"@count": "11", "@label": "201107"}, {"@count": "10", "@label": "200710"}, {"@count": "10", "@label": "201010"}, {"@count": "10", "@label": "201205"}, {"@count": "10", "@label": "201005"}, {"@count": "10", "@label": "201301"}, {"@count": "10", "@label": "200806"}, {"@count": "10", "@label": "201211"}, {"@count": "10", "@label": "201404"}, {"@count": "10", "@label": "201201"}, {"@count": "9", "@label": "200907"}, {"@count": "9", "@label": "201109"}, {"@count": "9", "@label": "200802"}, {"@count": "9", "@label": "201002"}, {"@count": "9", "@label": "200207"}, {"@count": "9", "@label": "200705"}, {"@count": "9", "@label": "200911"}, {"@count": "9", "@label": "200910"}, {"@count": "9", "@label": "200411"}, {"@count": "9", "@label": "200608"}, {"@count": "9", "@label": "200603"}, {"@count": "9", "@label": "200604"}, {"@count": "9", "@label": "200809"}, {"@count": "9", "@label": "201403"}, {"@count": "9", "@label": "201305"}, {"@count": "8", "@label": "201012"}, {"@count": "8", "@label": "201303"}, {"@count": "8", "@label": "201204"}, {"@count": "8", "@label": "200605"}, {"@count": "8", "@label": "201011"}, {"@count": "8", "@label": "201206"}, {"@count": "8", "@label": "200610"}, {"@count": "8", "@label": "201003"}, {"@count": "8", "@label": "201106"}, {"@count": "8", "@label": "200703"}, {"@count": "8", "@label": "200307"}, {"@count": "8", "@label": "200408"}, {"@count": "8", "@label": "200904"}, {"@count": "8", "@label": "200403"}, {"@count": "7", "@label": "200607"}, {"@count": "7", "@label": "200504"}, {"@count": "7", "@label": "200606"}, {"@count": "7", "@label": "201001"}, {"@count": "7", "@label": "201307"}, {"@count": "7", "@label": "200609"}, {"@count": "7", "@label": "201310"}, {"@count": "7", "@label": "200704"}, {"@count": "7", "@label": "200308"}, {"@count": "7", "@label": "200401"}, {"@count": "7", "@label": "200406"}, {"@count": "7", "@label": "200805"}, {"@count": "7", "@label": "201112"}, {"@count": "7", "@label": "201111"}, {"@count": "7", "@label": "199802"}, {"@count": "7", "@label": "201209"}, {"@count": "7", "@label": "201105"}, {"@count": "7", "@label": "200903"}, {"@count": "7", "@label": "201102"}, {"@count": "7", "@label": "200511"}, {"@count": "7", "@label": "201108"}, {"@count": "6", "@label": "200909"}, {"@count": "6", "@label": "200306"}, {"@count": "6", "@label": "200602"}, {"@count": "6", "@label": "199812"}, {"@count": "6", "@label": "200702"}, {"@count": "6", "@label": "200701"}, {"@count": "6", "@label": "200312"}, {"@count": "6", "@label": "200611"}, {"@count": "6", "@label": "200706"}, {"@count": "6", "@label": "200510"}, {"@count": "6", "@label": "201103"}, {"@count": "6", "@label": "200808"}, {"@count": "6", "@label": "201004"}, {"@count": "6", "@label": "200105"}, {"@count": "6", "@label": "200506"}, {"@count": "6", "@label": "201212"}, {"@count": "5", "@label": "201312"}, {"@count": "5", "@label": "200512"}, {"@count": "5", "@label": "201402"}, {"@count": "5", "@label": "200412"}, {"@count": "5", "@label": "200508"}, {"@count": "5", "@label": "200407"}, {"@count": "5", "@label": "201110"}, {"@count": "5", "@label": "201202"}, {"@count": "5", "@label": "200807"}, {"@count": "5", "@label": "199912"}, {"@count": "5", "@label": "200001"}]}, {"@total": "100", "@label": "Trial Company Sponsor", "@name": "trialCompaniesSponsor", "FilterOption": [{"@id": "28355", "@count": "72", "@label": "GlaxoSmithKline plc"}, {"@id": "22182", "@count": "70", "@label": "University of Oxford"}, {"@id": "20520", "@count": "46", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "23508", "@count": "38", "@label": "London School of Hygiene and Tropical Medicine"}, {"@id": "30573", "@count": "34", "@label": "Medicines for Malaria Venture"}, {"@id": "1043066", "@count": "27", "@label": "Gates Malaria Partnership"}, {"@id": "26857", "@count": "25", "@label": "Centers for Disease Control and Prevention"}, {"@id": "23137", "@count": "25", "@label": "Novartis AG"}, {"@id": "20947", "@count": "22", "@label": "World Health Organization"}, {"@id": "1069084", "@count": "18", "@label": "US Army Medical Research and Materiel Command"}, {"@id": "18767", "@count": "16", "@label": "Pfizer Inc"}, {"@id": "1013599", "@count": "16", "@label": "Drugs for Neglected Diseases Initiative"}, {"@id": "1009547", "@count": "14", "@label": "Sanofi"}, {"@id": "24773", "@count": "13", "@label": "University of California San Francisco"}, {"@id": "17774", "@count": "13", "@label": "LEO Pharma A/S"}, {"@id": "1036590", "@count": "12", "@label": "Makerere University"}, {"@id": "1054027", "@count": "12", "@label": "United Nations International Children's Fund"}, {"@id": "1038964", "@count": "11", "@label": "Bandim Health Project"}, {"@id": "1031299", "@count": "11", "@label": "Radboud University"}, {"@id": "21126", "@count": "10", "@label": "Queensland Institute of Medical Research"}, {"@id": "27025", "@count": "10", "@label": "Menzies School of Health Research"}, {"@id": "21242", "@count": "9", "@label": "The University of Liverpool"}, {"@id": "17195", "@count": "9", "@label": "Immtech Pharmaceuticals Inc"}, {"@id": "1039239", "@count": "9", "@label": "Institute of Tropical Medicine, Belgium"}, {"@id": "20606", "@count": "8", "@label": "Liverpool School of Tropical Medicine"}, {"@id": "1002549", "@count": "8", "@label": "Epicentre (MSF)"}, {"@id": "1039059", "@count": "8", "@label": "Kenya Medical Research Institute"}, {"@id": "1047287", "@count": "8", "@label": "US Army Office of the Surgeon General"}, {"@id": "26971", "@count": "8", "@label": "Artecef BV"}, {"@id": "21129", "@count": "8", "@label": "Walter Reed Army Institute of Research"}, {"@id": "1039067", "@count": "7", "@label": "African Malaria Network Trust"}, {"@id": "1008493", "@count": "7", "@label": "Sanaria Inc"}, {"@id": "15350", "@count": "7", "@label": "Central Drug Research Institute"}, {"@id": "1039250", "@count": "6", "@label": "Albert Schweitzer Hospital"}, {"@id": "30690", "@count": "6", "@label": "University of Cape Town"}, {"@id": "14881", "@count": "6", "@label": "Boehringer Ingelheim Corp"}, {"@id": "1009479", "@count": "6", "@label": "IPCA Laboratories Ltd"}, {"@id": "1039031", "@count": "6", "@label": "DBL -Institute for Health Research and Development"}, {"@id": "1039229", "@count": "6", "@label": "Armed Forces Research Institute of Medical Sciences"}, {"@id": "1061913", "@count": "6", "@label": "University of Bamako"}, {"@id": "28877", "@count": "6", "@label": "Mahidol University"}, {"@id": "28348", "@count": "5", "@label": "University of Heidelberg"}, {"@id": "19620", "@count": "5", "@label": "Eisai Inc"}, {"@id": "1040477", "@count": "5", "@label": "Centre Muraz"}, {"@id": "1089680", "@count": "5", "@label": "Bureau of Vector-Borne Disease (BVBD)"}, {"@id": "1081279", "@count": "5", "@label": "United Nations Development Program"}, {"@id": "16453", "@count": "5", "@label": "Glaxo Group Ltd"}, {"@id": "24166", "@count": "5", "@label": "GlaxoSmithKline Biologicals"}, {"@id": "23577", "@count": "5", "@label": "Imperial College London"}, {"@id": "1009888", "@count": "5", "@label": "Swiss Tropical & Public Health Institute"}, {"@id": "21159", "@count": "5", "@label": "Sigma-Tau Ind Farm Riunite SpA"}, {"@id": "26093", "@count": "5", "@label": "Karolinska Hospital"}, {"@id": "1025724", "@count": "4", "@label": "European Vaccine Initiative"}, {"@id": "1015721", "@count": "4", "@label": "Medical University of Vienna"}, {"@id": "1039423", "@count": "4", "@label": "Hospital Clinic of Barcelona"}, {"@id": "16994", "@count": "4", "@label": "Hospital for Sick Children"}, {"@id": "1082233", "@count": "4", "@label": "Department of Medical Research"}, {"@id": "21266", "@count": "4", "@label": "Ranbaxy Laboratories Ltd"}, {"@id": "1006925", "@count": "4", "@label": "Jiangsu Hengrui Medicine Co Ltd"}, {"@id": "1079686", "@count": "4", "@label": "Medical Research Council Unit, The Gambia"}, {"@id": "1038866", "@count": "4", "@label": "Medecins Sans Frontieres"}, {"@id": "16842", "@count": "4", "@label": "University of Western Australia"}, {"@id": "1032580", "@count": "4", "@label": "Bill & Melinda Gates Foundation"}, {"@id": "24869", "@count": "4", "@label": "Wellcome Trust"}, {"@id": "1038258", "@count": "3", "@label": "Kintampo Health Research Centre"}, {"@id": "22741", "@count": "3", "@label": "University of Antwerp"}, {"@id": "1039738", "@count": "3", "@label": "Medical Research Council Laboratories"}, {"@id": "23144", "@count": "3", "@label": "ETH Zurich"}, {"@id": "1023221", "@count": "3", "@label": "University of Tampere"}, {"@id": "1039051", "@count": "3", "@label": "Ministry of Health Tanzania"}, {"@id": "17237", "@count": "3", "@label": "Institut Pasteur"}, {"@id": "27038", "@count": "3", "@label": "Institut de Recherche pour le Developpement (IRD)"}, {"@id": "1084214", "@count": "3", "@label": "Institut de Recherche en Sciences de la Sante (IRSS), Burkina Faso"}, {"@id": "21296", "@count": "3", "@label": "Indian Council For Medical Research"}, {"@id": "CM28008", "@count": "3", "@label": "Seattle Biomedical Research Institute"}, {"@id": "1087788", "@count": "3", "@label": "Malaria Vaccine and Drug Development Center"}, {"@id": "23005", "@count": "3", "@label": "US Naval Medical Research Center"}, {"@id": "1082420", "@count": "3", "@label": "Australian Government, Department of Defence"}, {"@id": "24345", "@count": "3", "@label": "Harbor BioSciences Inc"}, {"@id": "1079445", "@count": "3", "@label": "Australian Army Malaria Institute"}, {"@id": "22292", "@count": "3", "@label": "Tulane University"}, {"@id": "19946", "@count": "3", "@label": "Sigma-Tau Pharmaceuticals Inc"}, {"@id": "1052691", "@count": "3", "@label": "University of Khartoum"}, {"@id": "1040733", "@count": "3", "@label": "Cheikh Anta Diop University"}, {"@id": "27657", "@count": "3", "@label": "University of Magdeburg"}, {"@id": "1041246", "@count": "3", "@label": "University of Indonesia"}, {"@id": "20519", "@count": "3", "@label": "National Cancer Institute"}, {"@id": "20596", "@count": "3", "@label": "Johns Hopkins University"}, {"@id": "18438", "@count": "3", "@label": "Medical Research Council (MRC)"}, {"@id": "1039207", "@count": "3", "@label": "Albert Schweitzer Ziekenhuis"}, {"@id": "1039412", "@count": "3", "@label": "University of Calabar"}, {"@id": "24974", "@count": "3", "@label": "St Georges University of London"}, {"@id": "1046214", "@count": "3", "@label": "National Institute Of Health Research & Development (Nihrd)- Ministry Of Health Of The Republic Of Indonesia"}, {"@id": "1039334", "@count": "3", "@label": "Muhimbili University College of Health Sciences"}, {"@id": "20653", "@count": "3", "@label": "Osaka University"}, {"@id": "1081347", "@count": "2", "@label": "Ministry of Health and Welfare, Vietnam"}, {"@id": "1070880", "@count": "2", "@label": "KEM Hospital and Research Center"}, {"@id": "1039035", "@count": "2", "@label": "Hospital Universit\u00e1rio Professor Edgar Santos"}, {"@id": "1082507", "@count": "2", "@label": "KEMRI-Wellcome Trust Collaborative Research Program"}, {"@id": "1092992", "@count": "2", "@label": "Tropical Medicine Research Institute"}]}, {"@total": "34", "@label": "Trial Interventions Control Alone Name Display", "@name": "trialInterventionsControlAloneNameDisplay", "FilterOption": [{"@id": "8896", "@count": "23", "@label": "artemether + lumefantrine, Novartis"}, {"@id": "53051", "@count": "5", "@label": "artesunate + mefloquine combination tablet (malaria), DNDi"}, {"@id": "12242", "@count": "3", "@label": "calcipotriol"}, {"@id": "12862", "@count": "2", "@label": "Tritanrix HB"}, {"@id": "4508", "@count": "2", "@label": "tacalcitol"}, {"@id": "3700", "@count": "2", "@label": "nevirapine"}, {"@id": "3257", "@count": "2", "@label": "halofantrine"}, {"@id": "3268", "@count": "2", "@label": "Engerix B"}, {"@id": "17210", "@count": "2", "@label": "chlorproguanil + dapsone (malaria), University of Liverpool/WHO/GlaxoSmithKline"}, {"@id": "17091", "@count": "2", "@label": "agatolimod"}, {"@id": "2587", "@count": "2", "@label": "azithromycin"}, {"@id": "23459", "@count": "2", "@label": "atovaquone + proguanil, GlaxoSmithKline"}, {"@id": "53041", "@count": "2", "@label": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis"}, {"@id": "44363", "@count": "1", "@label": "trimethoprim + sulphamethoxazole"}, {"@id": "53724", "@count": "1", "@label": "artenimol + piperaquine (malaria), Sigma-Tau"}, {"@id": "4236", "@count": "1", "@label": "risperidone"}, {"@id": "6342", "@count": "1", "@label": "rabies vaccine, Aventis Pasteur"}, {"@id": "44408", "@count": "1", "@label": "polio vaccine, Sanofi Pasteur"}, {"@id": "10774", "@count": "1", "@label": "NeisVac-C"}, {"@id": "61413", "@count": "1", "@label": "mometasone (dermatological), Merck & Co"}, {"@id": "6050", "@count": "1", "@label": "metformin hydrochloride"}, {"@id": "3612", "@count": "1", "@label": "meningococcal C/CRM-197 conjugate vaccine, Chiron"}, {"@id": "10593", "@count": "1", "@label": "Meningitec"}, {"@id": "14289", "@count": "1", "@label": "malaria vaccine, GlaxoSmithKline/Malaria Vaccine Initiative"}, {"@id": "55852", "@count": "1", "@label": "linagliptin"}, {"@id": "59534", "@count": "1", "@label": "LEO-29102"}, {"@id": "21955", "@count": "1", "@label": "Inflexal V"}, {"@id": "2807", "@count": "1", "@label": "atorvastatin"}, {"@id": "64233", "@count": "1", "@label": "GSK-208108"}, {"@id": "3130", "@count": "1", "@label": "filgrastim"}, {"@id": "58762", "@count": "1", "@label": "empagliflozin"}, {"@id": "10172", "@count": "1", "@label": "efavirenz"}, {"@id": "57760", "@count": "1", "@label": "colchicine (oral, gout/familial Mediterranean fever), Takeda"}, {"@id": "44281", "@count": "1", "@label": "betamethasone"}]}, {"@total": "15", "@label": "Trial Actions Primary Interventions Control", "@name": "trialActionsPrimaryInterventionsControl", "FilterOption": [{"@id": "8805", "@count": "2", "@label": "AMP activated protein kinase stimulator"}, {"@id": "94", "@count": "2", "@label": "Calmodulin inhibitor"}, {"@id": "7827", "@count": "2", "@label": "TLR-9 agonist"}, {"@id": "756", "@count": "2", "@label": "Vitamin D3 receptor agonist"}, {"@id": "13", "@count": "1", "@label": "5-HT 2 receptor antagonist"}, {"@id": "135", "@count": "1", "@label": "DHFR inhibitor"}, {"@id": "5537", "@count": "1", "@label": "Dipeptidyl peptidase IV inhibitor"}, {"@id": "138", "@count": "1", "@label": "DNA polymerase inhibitor"}, {"@id": "150", "@count": "1", "@label": "Dopamine D2 receptor antagonist"}, {"@id": "3151", "@count": "1", "@label": "GCSF receptor agonist"}, {"@id": "205", "@count": "1", "@label": "HMG CoA reductase inhibitor"}, {"@id": "297", "@count": "1", "@label": "Ornithine decarboxylase inhibitor"}, {"@id": "551", "@count": "1", "@label": "RNA DNA polymerase inhibitor"}, {"@id": "4020", "@count": "1", "@label": "Sodium glucose transporter-2 inhibitor"}, {"@id": "35746", "@count": "1", "@label": "Tubulin beta inhibitor"}]}, {"@total": "100", "@label": "Indications", "@name": "indications", "FilterOption": [{"@id": "267", "@count": "403", "@label": "Plasmodium falciparum infection"}, {"@id": "268", "@count": "296", "@label": "Plasmodium infection"}, {"@id": "270", "@count": "69", "@label": "Plasmodium vivax infection"}, {"@id": "158", "@count": "32", "@label": "HIV infection"}, {"@id": "17", "@count": "29", "@label": "Anemia"}, {"@id": "281", "@count": "23", "@label": "Psoriasis"}, {"@id": "837", "@count": "16", "@label": "Non-insulin dependent diabetes"}, {"@id": "221", "@count": "9", "@label": "Mycobacterium tuberculosis infection"}, {"@id": "271", "@count": "5", "@label": "Pneumocystis carinii infection"}, {"@id": "360", "@count": "5", "@label": "Pneumonia"}, {"@id": "502", "@count": "5", "@label": "Plasmodium malariae infection"}, {"@id": "298", "@count": "5", "@label": "Schistosomiasis"}, {"@id": "303", "@count": "4", "@label": "Sickle cell anemia"}, {"@id": "65", "@count": "4", "@label": "Stroke"}, {"@id": "40", "@count": "4", "@label": "Bacterial infection"}, {"@id": "150", "@count": "4", "@label": "Helminth infection"}, {"@id": "3191", "@count": "4", "@label": "Iron deficiency anemia"}, {"@id": "291", "@count": "3", "@label": "Rheumatoid arthritis"}, {"@id": "159", "@count": "3", "@label": "HIV-1 infection"}, {"@id": "717", "@count": "3", "@label": "Seizure disorder"}, {"@id": "3441", "@count": "3", "@label": "Membranous glomerulonephritis"}, {"@id": "252", "@count": "3", "@label": "Parasitic infection"}, {"@id": "336", "@count": "3", "@label": "Trypanosomiasis"}, {"@id": "313", "@count": "3", "@label": "Streptococcus pneumoniae infection"}, {"@id": "1020", "@count": "3", "@label": "Acidosis"}, {"@id": "201", "@count": "2", "@label": "Liver disease"}, {"@id": "325", "@count": "2", "@label": "Thromboembolism"}, {"@id": "1137", "@count": "2", "@label": "Leishmania donovani infection"}, {"@id": "1138", "@count": "2", "@label": "Leishmania braziliensis infection"}, {"@id": "285", "@count": "2", "@label": "Rabies virus infection"}, {"@id": "626", "@count": "2", "@label": "Heart disease"}, {"@id": "1262", "@count": "2", "@label": "Non-small-cell lung cancer"}, {"@id": "269", "@count": "2", "@label": "Plasmodium knowlesi infection"}, {"@id": "3", "@count": "2", "@label": "Acne"}, {"@id": "279", "@count": "2", "@label": "Pruritus"}, {"@id": "224", "@count": "2", "@label": "Myocardial infarction"}, {"@id": "227", "@count": "2", "@label": "Neisseria gonorrhoeae infection"}, {"@id": "427", "@count": "2", "@label": "Uterine cervix tumor"}, {"@id": "706", "@count": "2", "@label": "Prophylaxis"}, {"@id": "411", "@count": "2", "@label": "Pregnancy disorder"}, {"@id": "230", "@count": "2", "@label": "Neoplasm"}, {"@id": "799", "@count": "2", "@label": "Ovary tumor"}, {"@id": "1557", "@count": "2", "@label": "Cardiac arrest"}, {"@id": "55", "@count": "2", "@label": "Cardiac failure"}, {"@id": "57", "@count": "2", "@label": "Cardiovascular disease"}, {"@id": "394", "@count": "2", "@label": "Otitis media"}, {"@id": "1258", "@count": "2", "@label": "Spinal cord injury"}, {"@id": "52", "@count": "2", "@label": "Skin burns"}, {"@id": "114", "@count": "2", "@label": "Sepsis"}, {"@id": "239", "@count": "2", "@label": "Ocular disease"}, {"@id": "88", "@count": "2", "@label": "Cystic fibrosis"}, {"@id": "102", "@count": "2", "@label": "Diarrhea"}, {"@id": "215", "@count": "2", "@label": "Muscular dystrophy"}, {"@id": "1489", "@count": "2", "@label": "Lung injury"}, {"@id": "1833", "@count": "2", "@label": "Fever"}, {"@id": "1803", "@count": "2", "@label": "Bacterial meningitis"}, {"@id": "684", "@count": "1", "@label": "Nutritional disorder"}, {"@id": "246", "@count": "1", "@label": "Osteoporosis"}, {"@id": "255", "@count": "1", "@label": "Parkinsons disease"}, {"@id": "3140", "@count": "1", "@label": "Pelvic inflammatory disease"}, {"@id": "453", "@count": "1", "@label": "Pharyngitis"}, {"@id": "396", "@count": "1", "@label": "Papillomavirus infection"}, {"@id": "319", "@count": "1", "@label": "Non-Hodgkin lymphoma"}, {"@id": "2955", "@count": "1", "@label": "Weight loss"}, {"@id": "344", "@count": "1", "@label": "Viral infection"}, {"@id": "739", "@count": "1", "@label": "Urogenital ulcer"}, {"@id": "2951", "@count": "1", "@label": "Urethritis"}, {"@id": "337", "@count": "1", "@label": "Ulcerative colitis"}, {"@id": "3387", "@count": "1", "@label": "Trypanosoma brucei infection"}, {"@id": "515", "@count": "1", "@label": "Transplant rejection"}, {"@id": "2345", "@count": "1", "@label": "Tonsillitis"}, {"@id": "2000", "@count": "1", "@label": "Tay Sachs disease"}, {"@id": "1475", "@count": "1", "@label": "Streptococcus pyogenes infection"}, {"@id": "1476", "@count": "1", "@label": "Streptococcus agalactiae infection"}, {"@id": "127", "@count": "1", "@label": "Stomach tumor"}, {"@id": "3034", "@count": "1", "@label": "Status epilepticus"}, {"@id": "308", "@count": "1", "@label": "Staphylococcus aureus infection"}, {"@id": "2223", "@count": "1", "@label": "Splenomegaly"}, {"@id": "816", "@count": "1", "@label": "Septic shock"}, {"@id": "299", "@count": "1", "@label": "Schizophrenia"}, {"@id": "2908", "@count": "1", "@label": "Sandhoff disease"}, {"@id": "348", "@count": "1", "@label": "Salmonella typhi infection"}, {"@id": "1024", "@count": "1", "@label": "Reperfusion injury"}, {"@id": "999", "@count": "1", "@label": "Renal tumor"}, {"@id": "3108", "@count": "1", "@label": "Renal injury"}, {"@id": "69", "@count": "1", "@label": "Renal failure"}, {"@id": "286", "@count": "1", "@label": "Renal disease"}, {"@id": "3546", "@count": "1", "@label": "Pulmonary edema"}, {"@id": "1781", "@count": "1", "@label": "Psoriatic arthritis"}, {"@id": "276", "@count": "1", "@label": "Prostate tumor"}, {"@id": "1108", "@count": "1", "@label": "Glioma"}, {"@id": "3078", "@count": "1", "@label": "Genital tract infection"}, {"@id": "1027", "@count": "1", "@label": "Female genital tract infection"}, {"@id": "120", "@count": "1", "@label": "Escherichia coli infection"}, {"@id": "119", "@count": "1", "@label": "Epilepsy"}, {"@id": "113", "@count": "1", "@label": "Endometriosis"}, {"@id": "85", "@count": "1", "@label": "Cryptococcus infection"}, {"@id": "84", "@count": "1", "@label": "Crohns disease"}, {"@id": "353", "@count": "1", "@label": "Cognitive disorder"}, {"@id": "1185", "@count": "1", "@label": "Chronic obstructive pulmonary disease"}]}, {"@total": "14", "@label": "Trial Phase", "@name": "trialPhase", "FilterOption": [{"@id": "NS", "@count": "355", "@label": "Phase not specified"}, {"@id": "C1", "@count": "187", "@label": "Phase 1 Clinical"}, {"@id": "C4", "@count": "164", "@label": "Phase 4 Clinical"}, {"@id": "C3", "@count": "163", "@label": "Phase 3 Clinical"}, {"@id": "C2", "@count": "114", "@label": "Phase 2 Clinical"}, {"@id": "C12", "@count": "48", "@label": "Phase 1/Phase 2 Clinical"}, {"@id": "C23", "@count": "37", "@label": "Phase 2/Phase 3 Clinical"}, {"@id": "C2B", "@count": "22", "@label": "Phase 2b Clinical"}, {"@id": "C2A", "@count": "16", "@label": "Phase 2a Clinical"}, {"@id": "C1B", "@count": "12", "@label": "Phase 1b Clinical"}, {"@id": "C1A", "@count": "6", "@label": "Phase 1a Clinical"}, {"@id": "C0", "@count": "5", "@label": "Phase 0 Clinical"}, {"@id": "C3B", "@count": "3", "@label": "Phase 3b Clinical"}, {"@id": "C3A", "@count": "1", "@label": "Phase 3a Clinical"}]}, {"@total": "11", "@label": "Trial Region", "@name": "trialRegions", "FilterOption": [{"@id": "CSAF", "@count": "514", "@label": "Central & Southern Africa"}, {"@id": "EAPO", "@count": "183", "@label": "East Asia & Pacific Ocean"}, {"@id": "NSWE", "@count": "107", "@label": "Northern, Southern & Western Europe"}, {"@id": "USCA", "@count": "95", "@label": "US & Canada"}, {"@id": "SOCA", "@count": "89", "@label": "Southern & Central Asia"}, {"@id": "SOAM", "@count": "43", "@label": "South America"}, {"@id": "AUNZ", "@count": "30", "@label": "Australia & New Zealand"}, {"@id": "MENA", "@count": "28", "@label": "Middle East & North Africa"}, {"@id": "EEUR", "@count": "11", "@label": "Eastern Europe"}, {"@id": "CAAC", "@count": "3", "@label": "Central America & Caribbean"}, {"@id": "INDO", "@count": "2", "@label": "Indian Ocean"}]}, {"@total": "7", "@label": "Trial Recruitment Status", "@name": "trialRecruitmentStatus", "FilterOption": [{"@id": "4", "@count": "620", "@label": "Completed"}, {"@id": "2", "@count": "172", "@label": "Recruiting"}, {"@id": "12", "@count": "124", "@label": "Status not specified"}, {"@id": "1", "@count": "90", "@label": "Not yet recruiting"}, {"@id": "3", "@count": "71", "@label": "No longer recruiting"}, {"@id": "6", "@count": "50", "@label": "Terminated"}, {"@id": "5", "@count": "6", "@label": "Suspended"}]}, {"@total": "22", "@label": "Registry Id", "@name": "trialRegistries", "FilterOption": [{"@id": "1000", "@count": "662", "@label": "CT.gov"}, {"@id": "1002", "@count": "106", "@label": "ISRCTN"}, {"@id": "1011", "@count": "70", "@label": "ANZCTR"}, {"@id": "1001", "@count": "52", "@label": "EudraCT"}, {"@id": "1012", "@count": "36", "@label": "CTRI"}, {"@id": "1016", "@count": "29", "@label": "PACTR"}, {"@id": "1004", "@count": "10", "@label": "WHO ICTRP"}, {"@id": "1023", "@count": "6", "@label": "UKCRN"}, {"@id": "1021", "@count": "5", "@label": "NMRR"}, {"@id": "1003", "@count": "5", "@label": "UMIN"}, {"@id": "1014", "@count": "2", "@label": "IRCT"}, {"@id": "1006", "@count": "2", "@label": "JapicCTI"}, {"@id": "1038", "@count": "2", "@label": "PHRR"}, {"@id": "1020", "@count": "2", "@label": "ReBec"}, {"@id": "1030", "@count": "2", "@label": "RSRM CTR"}, {"@id": "1009", "@count": "1", "@label": "HKClinicalTrials.com"}, {"@id": "1005", "@count": "1", "@label": "JMACCT CTR"}, {"@id": "1015", "@count": "1", "@label": "NTR"}, {"@id": "1010", "@count": "1", "@label": "CRiS"}, {"@id": "1035", "@count": "1", "@label": "Singapore HSA CTR"}, {"@id": "1018", "@count": "1", "@label": "SLCTR"}, {"@id": "1039", "@count": "1", "@label": "CDE"}]}, {"@total": "3", "@label": "Trial Source", "@name": "trialSources", "FilterOption": [{"@id": "CTGOV", "@count": "462", "@label": "ClinicalTrials.gov only"}, {"@id": "OTHERS", "@count": "450", "@label": "Others only"}, {"@id": "CTGOVOTHERS", "@count": "199", "@label": "ClinicalTrials.gov and others"}]}, {"@total": "6", "@label": "Trial Terms Endpoint", "@name": "trialTermsEndpoint", "FilterOption": [{"@id": "SIEEFC", "@count": "967", "@label": "Efficacy"}, {"@id": "SIESFT", "@count": "865", "@label": "Safety"}, {"@id": "SIEPCK", "@count": "218", "@label": "Pharmacokinetics"}, {"@id": "SIEPCD", "@count": "51", "@label": "Pharmacodynamics"}, {"@id": "SIEBAV", "@count": "13", "@label": "Bioavailability"}, {"@id": "SIEBEQ", "@count": "8", "@label": "Bioequivalence"}]}, {"@total": "2", "@label": "Trial Outcome Available", "@name": "trialOutcomesAvailable", "FilterOption": [{"@id": "NO", "@count": "666", "@label": "No"}, {"@id": "YES", "@count": "467", "@label": "Yes"}]}, {"@total": "2", "@label": "Trial Commercially Significant", "@name": "trialIsCommerciallySignificant", "FilterOption": [{"@id": "NO", "@count": "801", "@label": "No"}, {"@id": "YES", "@count": "332", "@label": "Yes"}]}, {"@total": "3", "@label": "Trial Endpoint Achieved", "@name": "trialEndpointsAchieved", "FilterOption": [{"@id": "UNSPECIFIED", "@count": "423", "@label": "Unspecified"}, {"@id": "YES", "@count": "11", "@label": "Yes"}, {"@id": "NO", "@count": "4", "@label": "No"}]}, {"@total": "1", "@label": "Primary Completion Filter by Month", "@name": "trialPrimaryCompletionDateByMonth", "FilterOption": {"@count": "1", "@label": "200709"}}, {"@total": "1", "@label": "Funder Type", "@name": "trialFunderType", "FilterOption": {"@id": "ACA", "@count": "1", "@label": "Academic"}}]}, "SearchResults": {"Trial": [{"ActionsSecondaryInterventionsControl": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "PrimaryCompletionDate": "", "PatientCountEnrollment": 900, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Others - Pediatric Subjects", "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "InterventionsControlDisplay": {"Intervention": "chlorproguanil + dapsone (malaria), University of Liverpool/WHO/GlaxoSmithKline alone"}, "InterventionsPrimaryDisplay": {"Intervention": "chlorproguanil + dapsone + artesunate (malaria), WHO/University of Liverpool/GlaxoSmithKline/Medicines for Malaria Venture alone"}, "IndicationsAdverse": {"Indication": ["Abdominal pain", "Anemia", "Cough", "Diarrhea", "Emesis", "Fever", "Headache", "Plasmodium infection", "Pneumonia", "Rhinorrhea"]}, "Teaser": "...in chlorproguanil + dapsone + artesunate and chlorproguanil + dapsone groups, respectively; and the most frequent AEs were <b>malaria</b> (13 and 15%), pyrexia (6 and 10%), cough (4 and 4%), vomiting (3 and 5%), anemia (2 and 3%), diarrhea (3 and 1%), rhinorrhea...pregnancy testFemale subjects who will be breast-feeding an infant for the duration of the studyAcute, uncomplicated P falciparum <b>malaria</b>, microscopically confirmed infection of 2000 to 200,000 parasites/microlTemperature at screening of 37.5degC or over or confirmed...", "Phase": "Phase 3 Clinical", "@Id": "12400", "DateStart": "2006-04-30T00:00:00Z", "Countries": {"Country": ["Burkina Faso", "Ghana", "Mali", "Nigeria"]}, "Identifiers": {"Identifier": ["CDA 714703/006", "NCT00371735", "SB-714703/006"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "Chlorproguanil-dapsone-artesunate (CDA) versus chlorproguanil-dapsone (LAPDAP) for uncomplicated malaria", "RecruitmentStatus": "Completed", "CompaniesSponsor": {"Company": "GlaxoSmithKline plc"}, "TermsPatientSelection": {"Term": ["Infants", "Preschool Children", "Children", "Adolescents", "Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "CompaniesCollaborator": {"Company": ["Medicines for Malaria Venture", "World Health Organization"]}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Active Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsControl": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "PrimaryCompletionDate": "", "PatientCountEnrollment": 1395, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "InterventionsControlDisplay": {"Intervention": "artemether + lumefantrine, Novartis alone"}, "InterventionsPrimaryDisplay": {"Intervention": "chlorproguanil + dapsone + artesunate (malaria), WHO/University of Liverpool/GlaxoSmithKline/Medicines for Malaria Venture alone"}, "IndicationsAdverse": {"Indication": ["Abdominal pain", "Anemia", "Appetite loss", "Cough", "Diarrhea", "Emesis", "Fever", "Parasitic infection", "Plasmodium infection", "Thrombocytopenia", "Upper respiratory tract infection"]}, "Teaser": "...anorexia (3 versus 3%), thrombocytopenia (3 versus 2%), vomiting (3 versus 2%), <b>malaria</b> (2 versus 2%), parasite blood test positive (2 versus 2%) and abdominal pain (2...serious AEs considered to be related to study medication were anemia (7 versus 0%), <b>malaria</b> (0 versus 1%), hemoglobin decrease (11 versus 0%), hematuria (5 versus 1%), hemoglobinuria...breast-feeding an infant for the duration of the studyAcute, uncomplicated P falciparum <b>malaria</b>, microscopically confirmedTemperature at screening of 37.5degC or or more or confirmed...", "Phase": "Phase 3 Clinical", "@Id": "12277", "DateStart": "2006-06-30T00:00:00Z", "Countries": {"Country": ["Burkina Faso", "Ghana", "Kenya", "Nigeria", "Tanzania"]}, "Identifiers": {"Identifier": ["CDA 714703/005", "NCT00344006", "SB-714703-005"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "Chlorproguanil + dapsone + artesunate (CDA) versus Coartem For uncomplicated malaria", "RecruitmentStatus": "Completed", "CompaniesSponsor": {"Company": "GlaxoSmithKline plc"}, "TermsPatientSelection": {"Term": ["Infants", "Preschool Children", "Children", "Adolescents"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "CompaniesCollaborator": {"Company": ["Medicines for Malaria Venture", "World Health Organization"]}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Active Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Protozoacide", "Ribosome binding agent"]}, "DateChangeLast": "2014-02-05T00:00:00Z", "Countries": {"Country": ["Burkina Faso", "Ghana", "Ivory Coast", "Kenya", "Mali"]}, "PatientSegmentTerms": {"PatientSegment": ["Anemia - Subjects at Risk of Anemia", "Anemia - Subjects with Hemolytic Anemia - Subjects with anemia due to malarial infection", "Plasmodium infection - Others - Pediatric Subjects", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Identifiers": {"Identifier": ["A0661157", "NCT00677833"]}, "TitleDisplay": "Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine for the Treatment of Uncomplicated P Falciparum Malaria in Children in Africa", "Indications": {"Indication": ["Plasmodium falciparum infection", "Plasmodium infection"]}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Active Control", "Parallel Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...smear positive for mixed infection with multiple Plasmodium sppSevere or complicated <b>malaria</b> including subjects with any of the following:Impaired consciousness (eg, obtundation...1); and >/= 6 to </= 59 months of age (Cohort 2) with uncomplicated, symptomatic <b>malaria</b> as indicated by the presence of the following:Blood smears positive for monoinfection...non-inferior to artemether + lumefantrine for the treatment of symptomatic, uncomplicated <b>malaria</b> due to Plasmodium falciparum in children in African countries.Patients were treated...", "DateEnd": "2010-09-30T00:00:00Z", "CompaniesSponsor": {"Company": "Pfizer Inc"}, "PatientCountEnrollment": 361, "Phase": "Phase 2/Phase 3 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine alone"}, "DateStart": "2008-06-30T00:00:00Z", "TermsPatientSelection": {"Term": ["Infants", "Preschool Children", "Children"]}, "@Id": "69472", "InterventionsControlDisplay": {"Intervention": "artemether + lumefantrine alone"}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 56, "PatientSegmentTerms": {"PatientSegment": "Malaria Vaccine - Subjects Naive to Malaria Vaccine"}, "InterventionsPrimaryDisplay": {"Intervention": "PfAMA-1 alone"}, "Teaser": "...ISA720.Arm 3: subjects would receive PfAMA1 formulated in ASO2A.All subjects would recieve 0.5 ml of two dosage 10 and 50 microg PfAMA1, sc vaccination.History of <b>malaria</b> or residence in <b>malaria</b> endemic areas within the past 6 monthsPositive serology for <b>malaria</b> antigenPfAMA-1Previously participated in any <b>malaria</b> vaccine studySymptoms, physical signs and laboratory values suggestive of systemic disorders, including renal, hepatic, cardiovascular, pulmonary, skin, immunodeficiency, psychiatric and...", "Phase": "Phase 1 Clinical", "@Id": "79855", "DateStart": "2005-11-30T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": "Plasmodium apical membrane protein modulator"}, "Countries": {"Country": "Netherlands"}, "Identifiers": {"Identifier": ["AMA-1_1_03", "EUDRACT No 2005-00232-24", "NCT00730782"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers", "RecruitmentStatus": "Completed", "DateEnd": "2008-08-01T00:00:00Z", "CompaniesSponsor": {"Company": "European Vaccine Initiative"}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Male", "Young Adults", "Middle-aged Adults"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Prophylactic vaccine", "Protein subunit vaccine"]}, "DateChangeLast": "2014-04-04T00:00:00Z", "CompaniesCollaborator": {"Company": ["Biomedical Primate Research Centre", "GlaxoSmithKline plc", "Radboud University", "SEPPIC SA"]}, "TermsDesign": {"Term": ["Interventional", "Prevention", "Randomized", "Single Blind", "No Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Protozoacide", "Unspecified drug target"]}, "DateChangeLast": "2013-09-11T00:00:00Z", "Countries": {"Country": "US"}, "Identifiers": {"Identifier": ["MMV_OZ439_09_001", "NCT00928083"]}, "TitleDisplay": "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ-439 in Healthy Male and Female Subjects", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control", "Crossover Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "The part A of the study would investigate the safety, tolerability and pharmacokinetics of single oral escalating doses of OZ-439. Up to six dose levels would be investigated to estimate dose proportionality. In Part B, the effect of food on a single oral dose of OZ-439 would be investigated in a two-way crossover design. Part C would investigate the safety, tolerability and pharmacokinetic (PK) profile of multiple oral doses of OZ-439. The starting oral dose would be 50 mg and the maximum single dose to be administered would not exceed 1600 mg per subject. The maximum duration of dosing proposed was 3 days.", "DateEnd": "2009-12-31T00:00:00Z", "CompaniesSponsor": {"Company": "Medicines for Malaria Venture"}, "PatientCountEnrollment": 52, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "artefenomel mesylate (Plasmodium infections), MMV/UNMC/STPI/Monash University alone"}, "DateStart": "2009-04-30T00:00:00Z", "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Young Adults", "Middle-aged Adults"]}, "@Id": "58273", "TermsEndpoint": {"Term": ["Safety", "Pharmacokinetics"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 800, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Others - Pediatric Subjects", "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria"]}, "InterventionsControlDisplay": {"Intervention": "amodiaquine plus sulfodoxine-pyrimethamine"}, "InterventionsPrimaryDisplay": {"Intervention": "chlorproguanil + dapsone + artesunate (malaria), WHO/University of Liverpool/GlaxoSmithKline/Medicines for Malaria Venture alone"}, "Teaser": "...chose amodiaquine+ sulfadoxine-pyrimethamine (AQ+SP) as the first line anti-<b>malaria</b> treatment. Although the clinical response to this combination was relatively...artesunate (CD+A): 800 children aged 12-59 months with uncomplicated P. falciparum <b>malaria</b> randomly allocated to AQ+SP or CD+A were followed up until day 28 after treatment...Coartem\u00ae. The drug arrived in the country in October 2006.Severe malariaMixed <b>malaria</b> infectionAny other concomitant illness or underlying diseaseKnown allergy to...", "Phase": "Phase not specified", "@Id": "12448", "DateStart": "2005-04-30T00:00:00Z", "Countries": {"Country": "Rwanda"}, "Identifiers": {"Identifier": ["CDA/RWD/2006", "NCT00461578"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "Tolerability and efficacy of chlorproguanil-dapsone plus artesunate compared to amodiaquine plus sulfadoxine-pyrimethamine for the treatment of P falciparum malaria in Rwandan children", "RecruitmentStatus": "Completed", "DateEnd": "2006-10-31T00:00:00Z", "CompaniesSponsor": {"Company": "London School of Hygiene and Tropical Medicine"}, "TermsPatientSelection": {"Term": ["Infants", "Preschool Children"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "CompaniesCollaborator": {"Company": "Institute of Tropical Medicine, Belgium"}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Active Control", "Parallel Assignment"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 41, "PatientSegmentTerms": {"PatientSegment": "Malaria Vaccine - Subjects Naive to Malaria Vaccine"}, "InterventionsPrimaryDisplay": {"Intervention": ["FMP2.1/AS01B alone", "FMP2.1/AS02A alone"]}, "IndicationsAdverse": {"Indication": ["Erythema", "Pain"]}, "Teaser": "...1518914].A total of 35 subjects aged 18 to 50 years would be enrolled to receive one of two investigational <b>malaria</b> vaccines. The vaccines were made of a <b>malaria</b> protein FMP2.1 mixed in two different adjuvants (AS01B and AS02A). Five subjects would get a small (10 microg...microg vaccine group) would undergo primary sporozoite challenge 14 to 30 days after dose 3 via bite of five <b>malaria</b>-infected mosquitoes. All subjects would have a blood slide prepared and read to check for asexual P falciparum...", "Phase": "Phase 1/Phase 2 Clinical", "BiomarkerNames": {"BiomarkerName": "Interferon gamma"}, "@Id": "9286", "DateStart": "2006-09-30T00:00:00Z", "Countries": {"Country": "US"}, "Identifiers": {"Identifier": ["#20060900", "A-13949", "ETrack Protocol No. 104936", "MAL-045", "NCT00385047", "WRAIR 1280"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "A Study to Determine Whether Two Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults", "RecruitmentStatus": "Completed", "DateEnd": "2007-04-01T00:00:00Z", "CompaniesSponsor": {"Company": "US Army Medical Research and Materiel Command"}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Young Adults", "Middle-aged Adults", "Native American Ancestry"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Prophylactic vaccine", "Protein subunit vaccine"]}, "DateChangeLast": "2014-01-30T00:00:00Z", "CompaniesCollaborator": {"Company": ["GlaxoSmithKline plc", "The PATH Malaria Vaccine Initiative", "United States Agency for International Development"]}, "TermsDesign": {"Term": ["Interventional", "Prevention", "Randomized", "Multiple Blind", "Placebo Control", "Parallel Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2008-04-01T00:00:00Z", "CompaniesCollaborator": {"Company": "Hong Kong University of Science & Technology"}, "DateStart": "2003-12-30T00:00:00Z", "TitleDisplay": "A phase I study to assess the safety and tolerability of artemisone against plasmodium infection", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment"]}, "RecruitmentStatus": "Completed", "Teaser": "By July 2004, results demonstrated that oral treatment of healthy male subjects with artemisone was safe and well tolerated [641340].This phase I trial of artemisone was initiated in December 2003 to assess the safety and tolerability of the drug against <b>plasmodium</b> <b>infection</b>.", "DateEnd": "2004-07-30T00:00:00Z", "CompaniesSponsor": {"Company": "Bayer AG"}, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "artemisone alone"}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Male"]}, "@Id": "9190", "TermsEndpoint": {"Term": "Safety"}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 252, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Pregnant Women", "Plasmodium infection - Subjects with Drug Resistant Malaria", "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "InterventionsControlDisplay": {"Intervention": "artesunate alone"}, "InterventionsPrimaryDisplay": {"Intervention": "artemether + lumefantrine, Novartis alone"}, "IndicationsAdverse": {"Indication": ["Allergy", "Anemia", "Emesis", "Mite infection", "Mycobacterium tuberculosis infection", "Parasitic infection", "Plasmodium vivax infection", "Respiratory tract infection", "Skin rash", "Tinnitus", "Urinary tract infection"]}, "Teaser": "...maternal death was reported due to hemorrhagic shock, which was considered unrelated to the artesunate treatment [975288].Due to <b>malaria</b> related anemia, nine patients were transfused. The only SAE that was definitely drug related was a parasitemia on the second...after a course of quinine for seven daysWilling and able to participate and comply with the study protocolAttend the Shoklo <b>Malaria</b> Research Unit (SMRU) AnteNatal Clinics (ANCs) regularlyAgree to deliver at SMRUIn December 2008, results were published. The...", "Phase": "Phase not specified", "@Id": "63028", "DateStart": "2004-04-23T00:00:00Z", "Countries": {"Country": "Thailand"}, "Identifiers": {"Identifier": ["ISRCTN86353884", "RPC043"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "A pilot, randomized, controlled, open-label study to compare the safety and efficacy of artemether-lumefantrine with artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy", "RecruitmentStatus": "Completed", "DateEnd": "2008-01-21T00:00:00Z", "CompaniesSponsor": {"Company": "Novartis AG"}, "TermsPatientSelection": {"Term": ["Female", "Asian Ancestry"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2013-09-12T00:00:00Z", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Active Control"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Glycosaminoglycan agonist", "Heparin agonist", "Protozoacide"]}, "DateChangeLast": "2010-10-05T00:00:00Z", "DateStart": "2009-05-05T00:00:00Z", "Identifiers": {"Identifier": "FTIM"}, "TitleDisplay": "FTIM: A phase I, randomized, double-blind, placebo-controlled, single- and multi-dose study assessing the safety, tolerability, pharmacodynamics and pharmacokinetics of DF-02 for the potential treatment of plasmodium infection", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Multiple Blind", "Placebo Control"]}, "RecruitmentStatus": "Completed", "Teaser": "...of drug and pharmacokinetic profiles were similar to that with single dosing. Minor dose dependent increases in activated partial thromboplastin time was seen with no relevant changes in prothrombin, thrombin time and platelet function [1126474]. This phase I, randomized, double-blind, placebo-controlled, single- and multi-dose study was designed to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of DF-02 for the potential treatment of <b>plasmodium</b> <b>infection</b> [1008167].", "DateEnd": "2009-10-12T00:00:00Z", "CompaniesSponsor": {"Company": "Dilafor AB"}, "PatientCountEnrollment": 33, "Phase": "Phase 1 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "sevuparin sodium alone"}, "BiomarkerNames": {"BiomarkerName": ["Blood platelets ", " Prothrombin ", " Tissue factor"]}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Male"]}, "@Id": "56183", "TermsEndpoint": {"Term": ["Safety", "Pharmacokinetics", "Pharmacodynamics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Radical donator", "Unspecified drug target"]}, "DateChangeLast": "2014-04-16T00:00:00Z", "IndicationsAdverse": {"Indication": ["Anemia", "Cough", "Emesis", "Fatigue", "Plasmodium infection", "Pneumonia"]}, "Countries": {"Country": "Liberia"}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Identifiers": {"Identifier": [7070, "ISRCTN51688713"]}, "TitleDisplay": "Efficacy of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Nimba County, Liberia", "Indications": {"Indication": "Plasmodium falciparum infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Single Blind"]}, "RecruitmentStatus": "Completed", "Teaser": "...to the World Health Organization (WHO) definitionSigns of severe/complicated <b>malaria</b> according to the WHO definition,Severe anemia (hemoglobin< 5 g/dl)Known history...the feet), orConcomitant febrile illness judged as due to causes other than <b>malaria</b> with the potential to confound study outcome (measles, acute lower tract respiratory...Coartem) among children between 6 and 59 months old suffering from uncomplicated <b>malaria</b> defined as the polymerase chain reaction (PCR)-adjusted genotype-corrected cure...", "DateEnd": "2009-07-01T00:00:00Z", "CompaniesSponsor": {"Company": "Drugs for Neglected Diseases Initiative"}, "PatientCountEnrollment": 300, "Phase": "Phase not specified", "InterventionsPrimaryDisplay": {"Intervention": ["artemether + lumefantrine, Novartis alone", "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis alone"]}, "DateStart": "2008-11-17T00:00:00Z", "TermsPatientSelection": {"Term": ["Infants", "Preschool Children"]}, "@Id": "151912", "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}}, {"ActionsSecondaryInterventionsControl": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "PrimaryCompletionDate": "", "PatientCountEnrollment": 301, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Others - Pediatric Subjects", "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "InterventionsControlDisplay": {"Intervention": "artemether + lumefantrine, Novartis alone"}, "InterventionsPrimaryDisplay": {"Intervention": "artesunate + amodiaquine combination tablet (malaria), DNDi/sanofi-aventis alone"}, "IndicationsAdverse": {"Indication": ["Abdominal pain", "Conjunctivitis", "Diarrhea", "Emesis", "Plasmodium infection", "Respiratory tract infection"]}, "Teaser": "...but six patients (ASAQ [n=1] and Coartem [n=5]) developed moderate or severe adverse events (SAEs) clinically associated with <b>malaria</b> (anemia, lethargy and convulsions). A total of 6.4 and 1.4% patients in ASAQ and Coartem groups, respectively, reported vomiting...related to the treatment. In areas of intense transmission, where multiple genotype infections were common, a second episode of <b>malaria</b> or a recurrent parasitaemia during the drug-free follow-up period might be due to the same infection or a different infection...", "Phase": "Phase not specified", "@Id": "86190", "DateStart": "2008-04-30T00:00:00Z", "Countries": {"Country": "Congo, The Democratic Republic of the"}, "Identifiers": {"Identifier": ["CPP 08013", "ESP/CE/012/2008", "Epicentre-MSF-OCBA", "NCT01567423"]}, "Indications": {"Indication": "Plasmodium falciparum infection"}, "TitleDisplay": "Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria", "RecruitmentStatus": "Completed", "DateEnd": "2009-04-30T00:00:00Z", "CompaniesSponsor": {"Company": "Epicentre (MSF)"}, "TermsPatientSelection": {"Term": ["Infants", "Preschool Children"]}, "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Radical donator"]}, "DateChangeLast": "2013-12-02T00:00:00Z", "CompaniesCollaborator": {"Company": "Medecins Sans Frontieres"}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Parallel Assignment"]}}, {"PrimaryCompletionDate": "", "PatientCountEnrollment": 2377, "PatientSegmentTerms": {"PatientSegment": "Plasmodium infection - Others - Pediatric Subjects"}, "InterventionsPrimaryDisplay": {"Intervention": "albendazole alone"}, "Teaser": "...either every 3 months or albendazole annually and monitored through periodic surveillance for clinical <b>malaria</b> episodes over 18 months. In addition, blood samples will be collected from sub-sample of children and screened for <b>malaria</b> specific immunoglobulin (Ig)G1 and IgG3 and helminth specific IgE, IgG2, IgG4 and IgM. Cell culture supernatants...modifies human host immune responses to plasmodia and helminth infections, and therefore alters the risk of <b>Plasmodium</b> <b>infection</b> and clinical disease.", "Phase": "Phase not specified", "BiomarkerNames": {"BiomarkerName": ["CD40 ligand ", " Ig gamma-3 chain C region ", " Immunoglobulin E ", " Immunoglobulin G ", " Interferon gamma ", " Interleukin-10 ", " Interleukin-2 ", " Interleukin-4 ", " Interleukin-5 ", " Tumor necrosis factor"]}, "@Id": "89949", "DateStart": "2013-01-31T00:00:00Z", "ActionsPrimaryInterventionsPrimary": {"Action": "Tubulin beta inhibitor"}, "Countries": {"Country": "Kenya"}, "Identifiers": {"Identifier": [2242, 241642, "NCT01658774"]}, "Indications": {"Indication": "Plasmodium infection"}, "TitleDisplay": "Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children", "RecruitmentStatus": "No longer recruiting", "DateEnd": "2015-12-31T00:00:00Z", "CompaniesSponsor": {"Company": "London School of Hygiene and Tropical Medicine"}, "TermsPatientSelection": {"Term": ["Healthy volunteers accepted", "Preschool Children", "Children", "Adolescents", "Young Adults"]}, "TermsEndpoint": {"Term": "Efficacy"}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Fungicide", "Microtubule modulator"]}, "DateChangeLast": "2014-02-19T00:00:00Z", "CompaniesCollaborator": {"Company": ["The European Union", "Wellcome Trust"]}, "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Single Blind", "Placebo Control", "Single Group Assignment"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2013-11-05T00:00:00Z", "CompaniesCollaborator": {"Company": "Department of Science & Technology"}, "Countries": {"Country": ["India", "Ivory Coast"]}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Others - Pediatric Subjects", "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Identifiers": {"Identifier": ["CTRI/2009/091/000531", "R11160082001"]}, "TitleDisplay": "Phase II Trial Of Dispersible Fixed Dose Combination Of Arterolane (Rbx 11160) Maleate And Piperaquine Phosphate In Pediatric Patients With Acute Uncomplicated Plasmodium Falciparum Malaria", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Open Label", "Single Group Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...drugsEvidence of any concomitant infection at the time of presentation (including P. vivax, P. ovale and P. <b>malaria</b>)Any other underlying disease that may compromise the diagnosis and the evaluation of the response to...the prevention of Pneumocystis carini pneumonia in children born to HIV+ womenPatients with severe <b>malaria</b> as per WHO criteria 2003Presence of general danger signs of severe <b>malaria</b> among children< 5 years old (as per WHO) *Female patients between the age group of 8 to 12 years (both...", "DateEnd": "2012-07-15T00:00:00Z", "CompaniesSponsor": {"Company": ["Daiichi Sankyo Co Ltd", "Ranbaxy Pharmaceuticals Inc"]}, "PatientCountEnrollment": 120, "Phase": "Phase 2 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "arterolane maleate + piperaquine phosphate, Ranbaxy alone"}, "DateStart": "2010-07-15T00:00:00Z", "TermsPatientSelection": {"Term": ["Infants", "Preschool Children", "Children"]}, "@Id": "123917", "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2014-04-16T00:00:00Z", "ActionsSecondaryInterventionsControl": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "Countries": {"Country": ["India", "Thailand"]}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Identifiers": {"Identifier": ["013118705-0711200739167", "CTRI/2007/091/000031", "R1ARTP1072015"]}, "TitleDisplay": "A phase II, multicenter, randomized, open-label study to compare the safety and efficacy of arterolane maleate + piperaquine phosphate with Coartem in treatment of patients with acute uncomplicated Plasmodium falciparum malaria", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label", "Active Control", "Parallel Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...Patients were followed for 28 days [1164854], [1329169]. Patients presenting with a mixed infection (ie, <b>malaria</b> due to more than one causative parasite)Patients with severe <b>malaria</b> as per WHO criteria 2000Any antimalarial treatment during 1 month prior to screening, as assessed by...35 kg at screeningMinimum Hemoglobin (Hb) level of > 8 g/dlPresence of acute symptomatic uncomplicated <b>malaria</b> with a diagnosis confirmed by a positive blood smear with asexual forms of P falciparum parasites onlyInitial...", "CompaniesSponsor": {"Company": "Ranbaxy Laboratories Ltd"}, "PatientCountEnrollment": 240, "Phase": "Phase 2 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "arterolane maleate + piperaquine phosphate, Ranbaxy alone"}, "DateStart": "2007-11-14T00:00:00Z", "TermsPatientSelection": {"Term": ["Children", "Adolescents", "Young Adults", "Middle-aged Adults", "Aged Adults"]}, "@Id": "74272", "InterventionsControlDisplay": {"Intervention": "artemether + lumefantrine, Novartis alone"}, "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Radical donator", "Unspecified drug target"]}, "DateChangeLast": "2013-09-11T00:00:00Z", "Countries": {"Country": "Thailand"}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Pregnant Women", "Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Plasmodium Malariae Malaria", "Plasmodium infection - Subjects with Plasmodium Ovale Malaria", "Plasmodium infection - Subjects with Plasmodium Vivax Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Identifiers": {"Identifier": ["DMA", "NCT01054248", "SMRU0905"]}, "TitleDisplay": "DMA: Randomized Trial of Three Artemisinin Combination Therapy for Malaria in Pregnancy", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Single Blind", "Parallel Assignment"]}, "RecruitmentStatus": "Recruiting", "Teaser": "...who have a positive peripheral smear at delivery and are at risk of congenital <b>malaria</b> will be actively screened weekly for 2 months. Known hypersensitivity to the...gestation as assessed by ultrasound scanningMicroscopically confirmed uncomplicated <b>malaria</b> (parasitaemia >/= 5/500 WBC) with Plasmodium falciparum or mixed infection (ie...a longer regimen of artemether-lumefantrine in the treatment of uncomplicated <b>malaria</b> in pregnant women. The primary objective is to determine if the efficacy of dihydroartemisinin-piperaquine...", "DateEnd": "2016-12-31T00:00:00Z", "CompaniesSponsor": {"Company": "University of Oxford"}, "PatientCountEnrollment": 1005, "Phase": "Phase 3 Clinical", "InterventionsPrimaryDisplay": {"Intervention": ["artemether + lumefantrine, Novartis alone", "artenimol + piperaquine (malaria), Sigma-Tau alone", "artesunate + mefloquine combination tablet (malaria), DNDi alone"]}, "DateStart": "2010-02-28T00:00:00Z", "TermsPatientSelection": {"Term": ["Female", "Young Adults", "Middle-aged Adults"]}, "@Id": "63583", "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}}, {"DateStart": "2013-03-18T00:00:00Z", "DateChangeLast": "2014-02-17T00:00:00Z", "CompaniesCollaborator": {"Company": "Medicines for Malaria Venture"}, "Countries": {"Country": "Indonesia"}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Mixed Malaria Infection", "Plasmodium infection - Subjects with Plasmodium Vivax Malaria"]}, "Identifiers": {"Identifier": ["ISRCTN82366390", "Vivax-primaquine-ACT-AS/EOCRU.2012.002"]}, "TitleDisplay": "Randomized, Open-label Trial of the Safety, Tolerability and Efficacy of Primaquine against Relapse when Combined with Pyronaridine Tetraphosphate-Artesunate or Dihydroartemisinin-Piperquine Phosphate for Radical Cure of Acute Plasmodium vivax Malaria in Soldiers", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Randomized", "Open Label"]}, "RecruitmentStatus": "Recruiting", "Teaser": "...primaquine administered after a rapidly excreted blood schizontocide may offer protection against relapse1. AS+PQ = one tablet of artesunate contains 50 mg base. Artesunate alone would use the same artesunate tablet from co-blister of Arsuamoon used for <b>malaria</b> therapy. Arsuamoon would be administered on days 0 to 6 (200 mg day 0; 100 mg days 1 to 6). After a 48 h pause, 0.5 mg/kg primaquine in tablets containing 26.3 mg of primaquine phosphate (15 mg base) qd for days 8 to 21.Arm 2: patients would receive...", "DateEnd": "2014-08-30T00:00:00Z", "CompaniesSponsor": {"Company": "ALERTAsia Foundation"}, "PatientCountEnrollment": 180, "Phase": "Phase not specified", "TermsPatientSelection": {"Term": ["Young Adults", "Middle-aged Adults", "Aged Adults", "Elderly Adults"]}, "@Id": "141921", "TermsEndpoint": {"Term": ["Safety", "Efficacy", "Pharmacokinetics"]}}, {"ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "DateChangeLast": "2014-02-13T00:00:00Z", "CompaniesCollaborator": {"Company": ["Jiangsu Institute of Parasitic Diseases", "Yunnan Institute of Parasitic Diseases"]}, "Countries": {"Country": "China"}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Plasmodium Vivax Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Identifiers": {"Identifier": "ACTRN12610001008011"}, "TitleDisplay": "Efficacy And Safety Of Artesunate And Dihydroartemisinin-Piparaquine (Dha-Pip) For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria And Chloroquine In Plasmodium Vivax Malaria In Yunnan And Jiangsu Province, China", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "Single Group Assignment"]}, "RecruitmentStatus": "Completed", "Teaser": "...general danger signs in children aged under 5 years or signs of severe falciparum <b>malaria</b> according to the definitions of WHOMixed or mono-infection with another Plasmodium...circumference< 110 mm)Presence of febrile conditions due to diseases other than <b>malaria</b> (eg, measles, acute lower respiratory tract infection, severe diarrhoea with dehydration...guardian in the case of childrenTreatment of uncomplicated Plasmodium falciparum <b>malaria</b> and chloroquine in Plasmodium vivax <b>malaria</b> in Yunnan and Jiangsu province, ChinaThe...", "CompaniesSponsor": {"Company": "National Institute of Parasitic Diseases"}, "PatientCountEnrollment": 240, "Phase": "Phase not specified", "InterventionsPrimaryDisplay": {"Intervention": ["artenimol + piperaquine (malaria), Sigma-Tau alone", "artesunate alone", "chloroquine alone"]}, "DateStart": "2008-07-10T00:00:00Z", "TermsPatientSelection": {"Term": ["Infants", "Preschool Children", "Children", "Adolescents", "Young Adults", "Middle-aged Adults"]}, "@Id": "123913", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"DateStart": "2010-07-01T00:00:00Z", "DateChangeLast": "2014-02-13T00:00:00Z", "Identifiers": {"Identifier": ["ACTRN12610000882022", "HREC 10-a/Ethics 2010"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Plasmodium Vivax Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Countries": {"Country": "Burma"}, "TitleDisplay": "Efficacy and Safety of Artemether-lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Falciparum Malaria, and Chloroquine for P.vivax in Budethaung (Rakhine), Thanphyuzayat (Mon State), and Kawthaung (Tanintharyi Division)", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "Single Group Assignment"]}, "RecruitmentStatus": "Recruiting", "Teaser": "...period to evaluate drug efficacy [1408735]. Presence of signs of severe falciparum <b>malaria</b> according to the definitions of World Health Organisation (WHO)Mixed or mono-infection...circumference< 110 mm)Presence of febrile conditions due to diseases other than <b>malaria</b> (eg, measles, acute lower respiratory tract infection, severe diarrhoea with dehydration...parent or guardian in the case of childrenTreatment of uncomplicated falciparum <b>malaria</b>, and chloroquine for P .vivaxThe purpose of the study was to evaluate efficacy and...", "CompaniesSponsor": {"Company": "Ministry of Health, Myanmar"}, "PatientCountEnrollment": 160, "Phase": "Phase not specified", "InterventionsPrimaryDisplay": {"Intervention": ["chloroquine alone", "artemether + lumefantrine, Novartis plus artenimol + piperaquine (malaria), Sigma-Tau"]}, "TermsPatientSelection": {"Term": ["Children", "Adolescents", "Young Adults", "Middle-aged Adults"]}, "@Id": "123912", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}, {"DateStart": "2011-04-30T00:00:00Z", "DateChangeLast": "2014-02-12T00:00:00Z", "Identifiers": {"Identifier": ["ACTRN12611000427976", "HREC TRC/C4/03/2011"]}, "ActionsSecondaryInterventionsPrimary": {"Action": ["Antiparasitic", "Unspecified drug target"]}, "PatientSegmentTerms": {"PatientSegment": ["Plasmodium infection - Subjects with Plasmodium Falciparum Malaria", "Plasmodium infection - Subjects with Symptomatic Malaria", "Plasmodium infection - Subjects with Uncomplicated Malaria"]}, "Countries": {"Country": "Zambia"}, "TitleDisplay": "Therapeutic Efficacy Testing for Artemether Lumefantrine in Treatment of Uncomplicated Plasmodium Falciparum Malaria in Three Sentinel Sites (Katete, Mansa and Chipata) in Zambia", "Indications": {"Indication": "Plasmodium infection"}, "PrimaryCompletionDate": "", "TermsDesign": {"Term": ["Interventional", "Treatment", "Non-Randomized", "Open Label", "Single Group Assignment"]}, "RecruitmentStatus": "Not yet recruiting", "Teaser": "...of general danger signs in children aged under five years or signs of severe falciparum <b>malaria</b> according to the definitions of World Health Organization (WHO)Mixed or mono-infection...mid-upper arm circumference< 110 mm)Presence of febrile conditions due to diseases other than <b>malaria</b> (eg, measles, acute lower respiratory tract infection, severe diarrhea with dehydration...testing for artemether + lumefantrine in treatment of uncomplicated Plasmodium falciparum <b>malaria</b> [1401078].", "CompaniesSponsor": {"Company": "Ministry of Health Zambia"}, "PatientCountEnrollment": 261, "Phase": "Phase 4 Clinical", "InterventionsPrimaryDisplay": {"Intervention": "artemether + lumefantrine, Novartis alone"}, "TermsPatientSelection": {"Term": ["Infants", "Preschool Children", "Children", "Adolescents", "Young Adults", "Middle-aged Adults"]}, "@Id": "119762", "TermsEndpoint": {"Term": ["Safety", "Efficacy"]}}]}, "@hits": "20", "@totalResults": "1133", "@offset": "0"}}